Predictive models for tongue carcinoma metastasis by Hannen, E.J.M.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/146809
 
 
 
Please be advised that this information was generated on 2018-07-07 and may be subject to
change.
Predictive Models for Tongue 
Carcinoma Metastasis 
Egied J.M. Hannen 

Predictive Models for Tongue 
Carcinoma Metastasis 
Egied J.M. Hannen 

Predictive Models for Tongue 
Carcinoma Metastasis 
Een wetenschappelijke proeve op het gebied van 
de Medische Wetenschappen 
Proefschrift 
ter verkrijging van de graad van doctor aan 
de Katholieke Universiteit Nijmegen 
volgens besluit van het College van Decanen in het openbaar 
te verdedigen op woensdag 24 October 2001 
des namiddags om 1.30 uur precies 
door 
Egidius Johannes Maria Hannen 
geboren op 16 november 1960 te Roermond 
Promotores: Prof. dr. DJ . Ruiter 
Prof. dr. J.J. Manni (U.M.) 
Co-promotor: Dr. P C M . de Wilde 
Manuscriptcommissie: Prof. dr. P.H.M. de Mulder 
Prof. dr. A.J. van der Kogel 
Prof. dr. P.J.W Stoelinga 
This study was financially supported by a grant (KUN 94-726) from The Dutch 
Cancer Society (Nederlandse Kankerbestrijding/Koningin Wilhelmina Fonds). 
Financial contributions in publishing this book were generously extended by (in 
alphabetical order): 
B.Braun Medical B.V., Curasan Benelux B.V., Christiaens B.V., Dental Union, 
Isodent B.V., Knoll B.V.—producent van o.a. Brufen Bruis 600, 
Leibinger-Stryker B.V., Liebrecht en Partners, Ortomed B.V., 
Schouten Zekerheid, Straumann B.V., 
and by: 
The Dutch Cancer Society (Nederlandse Kankerbestrijding/Koningin 
Wilhelmina Fonds). 
ISBN: 90-9015070-6 
© E.J.M. Hannen, Maastricht 2001. 
All rights reserved. No part of this publication may be reproduced or transmitted 
in any form or by any means, electronic or mechanical, including photocopy, 
recording, or any information storage and retrieval system, without prior 
permission in writing from the copyright owner. 
This thesis is dedicated to my family, to whom 
I am greatly indebted for their perseverance. 
The first copy of this book was proudly and 
in gratitude presented to my parents, 
who are my most sincere supporters. 

Table of Contents 
Preface 11 
General Introduction 13 
Introduction 14 
Epidemiology 15 
Clinic 16 
Pathology 19 
Diagnostics of Metastasis 21 
Genetic Oncogenesis Model 24 
Angiogenesis 29 
Outline of the Thesis 31 
Additional Remarks to the Methods 33 
Chapter 1 : An Image Analysis Study on Nuclear Morphology 
in Metastasized and Non-Metastasized Squamous Cell 
Carcinomas of the Tongue 37 
Abstract 38 
Introduction 39 
Material and Methods 40 
Results 44 
Discussion 51 
Chapter 2: Differences in Chromosomal Copy Number 
Changes between Metastasized and Non-Metastasized Tongue 
Carcinomas Identified by Comparative Genomic 
Hybridization 57 
Abstract 58 
Introduction 59 
Material and Methods 60 
Results 64 
Discussion 65 
Chapter 3: Quantification of Tumor Vascularity in Squamous 
Cell Carcinoma of the Tongue using CARD Amplification, a 
Systematic Sampling Technique, and True Color Image 
Analysis 71 
Abstract 72 
Introduction 73 
Material and methods 75 
Results 80 
Discussion 86 
Chapter 4: Computer Assisted Analysis of the 
Microvasculature in Metastasized and Non-Metastasized 
Squamous Cell Carcinomas of the Tongue 91 
Abstract 92 
Introduction 93 
Materials and Methods 94 
Results 99 
Discussion 102 
Chapter 5: Improved Prediction of Metastasis in Tongue 
Carcinomas, Combining Vascular and Nuclear Tumor 
Parameters 107 
Abstract 108 
Introduction 109 
Material and Methods I l l 
Results 114 
Discussion 115 
General Discussion 121 
Angiogenesis 123 
Genetic considerations 126 
Clinical considerations 129 
Summary 131 
Samenvatting 137 
Comprehensive References 143 
Acknowledgements 171 
Index 177 


Preface 
No part of this publication may be reproduced in any form without prior 
written permission by the copyright owner. 
The reader is provided with as much facilities as possible to accommodate 
enjoyable reading. Some are mentioned below. 
This thesis is written in English to be appreciated by a wide audience. 
Attempts have been made to employ US English throughout. Articles that 
appeared or were submitted to UK English journals have been edited to this 
extent. Format, figures and graphs have been edited for printing purposes, for 
most articles, and terminology has been harmonized to correspond in all sections. 
Therefore, applicable chapters have been designated Adapted from...'. However, 
the backbone and data remained unchanged. 
The introduction has been written to suit scientists of different background, 
not necessarily medical. It is not intended as an in-depth, state-of-the-art review, 
but merely to supply those not familiar with the specific subject of this thesis. 
When reference is made in general terms, the third person is used. The 
author chose to use 'he' in the text, for reasons of readability; however, the 
feminine form may in this respect be substituted. 
References are cited as footnotes in short format at the bottom of their 
referring page, to avoid the need of flipping to the end of the chapter. 
Furthermore, references are alphabetically listed in long format in the 
'Comprehensive References' section at the end of this book. 
The book is set in a two-column grid, without hyphenation, to 
accommodate the eye. Consequently, wider gaps may appear between words and 
letters of words. 
An index is provided in the last section. No completeness is suggested, 
however as many items as possible were included. Abbreviations can be found 
here. 
Quotation marks indicate citations, whereas apostrophes designate 
descriptive terminology. 
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Introduction 
Cancer ranks among the top 
causes of death worldwide.1 In the 
Netherlands (population 
15,500,000), 65,000 new cases of 
cancer were diagnosed in 1996, and 
37,000 people died of cancer that 
year.2 Male-female ratio's vary per 
tumor type; overall in 1996, 34,000 
males, and 31,000 females were 
diagnosed with cancer.2 
Cancer of the head and neck 
region refers to a heterogeneous group 
of malignancies, mainly originating in 
the mucous membranes of the upper 
airways and upper digestive tract. 
Likewise, a heterogeneous group of 
medical professionals is involved in 
the treatment of head and neck 
malignancies. In head and neck 
cancer centers in the Netherlands, 
treatment is usually coordinated in 
teams, composed of surgeons from 
different specialties, radiation 
oncologists, medical oncologists, 
radiologists, nuclear medicine 
specialists, and pathologists, 
supported by oral hygienists, speech 
therapists, physiotherapists, dietary 
assistants, and social workers. Such a 
head and neck tumor board together 
[1 ] The World Health Report 2000 - Health s) 
of cancer in The Netherlands 1996 (2000). 
decides on diagnostics, treatment 
plans, constitutes protocols, and 
registers patients for follow up. 
Head and neck cancer comprises 
a group of malignancies not 
uniformly constituted; in various 
centers, different sites and types of 
cancer are included. Especially in 
comparing epidemiological details, 
this should be considered carefully. 
Although cancer of the brain and 
cervical spine is located in the same 
region, it is most often considered 
separately, but differences between 
centers occur. Tumors of the skin of 
the head and neck and thyroid cancer 
are comparable in this respect, 
although the division appears less 
strict. In some centers, they are 
included in the head and neck tumor 
board; sometimes they are considered 
separately, e.g., by oncology-trained 
dermatologists, general, or plastic 
surgeons. 
Etiologic factors, such as tabacco 
smoking are known to cause lung 
cancer, but its strong relation to head 
and neck cancer is less well realized. In 
contrast to this relative 
unacquaintance, implications are no 
less severe. Head and neck cancer 
patients not only have to defeat 
;: Improving performance (2000).[2] Incidence 
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cancer, but also overcome the 
functional limitations accompanying 
cancer treatment. The impact of 
cancer treatment is high, and often, 
recovering patients need longtime 
support to regain an acceptable 
quality of life. Improving treatment, 
often consisting of multiple 
modalities such as surgery and 
radiation therapy, understanding 
cancer biology in order to design 
more specific interventions, and 
tailoring treatment plans to 
individuals are among the greatest 
efforts in battling head and neck 
cancer today. 
Epidemiology 
Almost 90% of all cancers in the 
head and neck region are squamous 
cell carcinomas (SCC).3 About 2400 
newly diagnosed head and neck SCC 
(HNSCC) patients were registered in 
the Netherlands in 1996, matching 
31 per 100,000 individuals, based on 
the European Standard Population.2 
Sites from the lip, oral cavity 
(including tongue), salivary glands, 
pharynx, nasal cavities, paranasal 
sinuses, and larynx are included.2 Skin 
cancer (i.e., basal cell carcinoma, 
squamous cell carcinoma, and 
melanoma) is not included. SCC of 
the larynx constitutes the bigger 
portion with one third of cases. The 
second largest group is located in the 
oral cavity and oropharynx. In this 
group, tongue SCC is represented 
with 168 new cases, 101 in males, and 
67 in females.2 In males, HNSCC 
ranks sixth on the list of most 
frequent cancers, and in the age range 
45-59 even third.2 In light of the 
composition of the population 
pyramid in the Netherlands, where a 
proportionally large cohort will reach 
the sixth and seventh decade around 
2020, a considerable rise in cancer 
incidence is to be expected in the 
future. 
Both cohort and case control 
studies have demonstrated significant 
dose-effect relations between tabacco 
and alcohol consumption, and cancer 
risk/ Tabacco and alcohol use 
separately carry the risk of cancer, but 
especially the interaction between 
tabacco and alcohol multiplicates the 
risk for HNSCC.5 Besides dose per 
period of time, e.g., the number of 
cigarettes per day, prolonged exposure 
also increases cancer risk, making 
[2] Incidence of cancer in The Netherlands 1996 (2000). [3]P. Boyle, In: Diseases of the Head 
and Neck, Nose and Throat (1998). [4] IARC working group on the evaluation of carcinogenic 
risks to humans (1986). [5]S. Franceschi, Int.J.Cancer 83, 1 (1999). 
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HNSCC a disease of the fifth 
decennium up. Because women 
started smoking later in the 20rh 
century than did men, traditionally 
lower incidences for women were 
reported, although a catch up is 
notable, parallel to lung cancer, with 
an average annual increase of 4-5%.2'6 
Genetic susceptibility in most 
phases of carcinogenesis has been 
shown.7,8 Large interindividual 
differences in genetic susceptibility 
probably account for the fact that 
only a minority of the exposed 
individuals develops cancer. 
The prognosis of HNSCC is 
dependent on site, stage, treatment, 
and comorbidity.9 The overall 5-year 
survival is approximately 55% in the 
Netherlands for all HNSCCs 
combined.10 Annually approximately 
200,000 patients die of HNSCC 
worldwide.11 In the past years major 
technical improvements have been 
made in HNSCC diagnosis and 
treatment. The overall survival 
however, has not risen 
proportionally.12 Advances have for 
the better part led to improved 
locoregional control, while overall 
survival is mainly determined by 
distant metastases. Improved 
locoregional control in HNSCC 
however, implies a substantial increase 
in quality of life. Highly specialized 
functions of the head and neck region, 
such as speech, chewing, and 
swallowing, determine largely the 
sense of well being of recovering 
HNSCC patients. Early diagnosis and 
refined surgical techniques of 
resection and reconstruction add to 
functional rehabilitation, and 
preservation or restoration of these 
functions. Quality of life of cancer 
patients has become an important 
factor in decision making. 
Clinic 
The presentation of HNSCCs 
largely depends on its originating site. 
Larynx SCC frequently causes early 
signs, tumors of the paranasal sinuses 
most often late. HNSCC usually 
presents as an ulcer, i.e., a defect due 
to loss of integrity of the epithelium 
that is destroyed by tumor growth. 
Depending on the site, growing 
tumor bulk is eventually discernible 
visually or indirectly from symptoms 
such as hoarseness. In hypopharynx 
[2] Incidence of cancer in The Netherlands 1996 (2000). [6] Cancer incidence in five continents 
(1997). [7] A. E. Bale, In: Cancer Principles and Practice of Oncology (1997). [8]J. Cloos, J.Nad.Cancer 
Inst. 88, 530 (1996). [9]J. E Piccirillo, Laryngoscope 110, 593 (2000).[10] Cancer incidence 
and survival in the southeast Netherlands, 1955-1984 (1995). [11]P. Pisani, Int.J.Cancer 83, 
18 (1999). [12]M. B. Sporn, Lancet 347, 1377 (1996). 
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SCC pain is more often 
accompanying the tumor, strikingly 
referred to the ear region on the 
affected side. Oral SCCs are less 
frequently painful, but symptoms 
relate to interference with chewing 
and speech. Some tumors are small at 
presentation, but the majority has 
reached considerable dimensions, 
apparently without manifestation. 
Because of the relatively low incidence 
of HNSCC and the complex anatomy 
of the head and neck region, the 
appearances of HN cancer like lesions 
can be difficult to interpret. Dentists 
could play a role in screening for oral 
and oropharyngeal cancer, as they see 
much of the population at risk every 
6-12 months for routine dental check 
up. A substantial part of the post 
academical education in the 
Netherlands is therefore directed at 
the dental profession.13 
Different clinical behavior 
between patients with tumors in 
different sublocations of HNSCC has 
led to grouping of tumors with joint 
characteristics. Precise anatomical 
location of origin created site 
differentiation, as defined in the 
International Classification of 
Diseases for Oncology (ICD-O, 
World Health Organization, 1976 
[for most recent version, see 
reference14]). The extent and spread 
are categorized in the tumor-node-
metastasis (TNM) classification 
system, introduced by the Union 
International Contre le Cancer, in 
Table 1 : TNM-classification for tongue SCC, 
obtained from ref.,\ 
Tumor classification 
T 0 No evidence of tumor 
Τ Extent can not be established 
Τ Carcinoma in situ 
Tj Smaller than or equal to 2cm 
T 2 Larger than 2cm, but no larger than 4cm 
T 3 Larger than 4cm 
T 4 Tumor invades adjacent structures 
Regional lymph node classification 
N0 
N., 
N3 
Η 
M, 
No nodal metastaiis 
One single ipsilateral nodal metastasis, no 
larger than 3cm 
One single ipsilateral nodal metastasis, larger 
than 3cm, but no larger than 6cm 
Multiple ipsilateral nodal metastases, none 
larger than 6cm 
Heterolateral nodal metastasis 
Nodal metastasis, larger than 6cm 
Distant metastasis classification 
No distant metastasis 
Distant metastasis 
[13]NWHHT, Vroegtijdige herkenning van kanker in het hoofd-halsgebied. Een leidraad voor 
de praktijk (1999). [14]D. M. Parkin, Histological Groups for Comparative Studies (1998). 
[15] TNM Classification of malignant tumours (1997). 
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Table 2: Incidence of neck-nodal metastases in tongue SCC on routine pathological examination, 
in relation to the T-classification, obtained fron ref.1<s. Number of metastases in parentheses. 
τ, 
7(2) 
29% 
τ 2 
34 (29) 
54% 
τ, 
11(8) 
73% 
τ 4 
29 (21) 
73% 
T M 
99(60) 
67% 
1958. Both are now integrated, in a 
periodically updated version.15 In 
1987, the American Joint Committee 
on Cancer (AJCC) issued 'Manual for 
Staging of Cancer', was made to 
correspond with the T N M 
classification. Both systems are now in 
use, where the TNM classification is 
more established in Europe and the 
AJCC version more widely used in the 
USA. Both ultimately share a 
common intent: to share experience 
between tumors of the same 
classification or stage. 
Table 1 defines the criteria for 
the TNM classification of SCC of the 
tongue15 as an example and because 
this is the main topic of this thesis. 
Metastases tend to be more frequently 
found in larger tumors, than in 
smaller ones (table 2).16 Between sites 
in HNSCC, a remarkable difference 
in metastasis formation is noticeable 
however and even for tumors of the 
same site, considerable interindividual 
variations have been reported. 
Metastasized HNSCC is distinctly 
different in prognosis and requires 
different treatment compared to non-
metastasized. Non-metastasized 
tumors can be cured by radical local 
treatment, but malignant spread to 
the neck requires adjuvant treatment, 
and distant metastasis is generally 
fatal. Clinically overt metastases are 
often accessible for cytology, and 
seldom pose a problem in diagnostic 
terms. A problem is posed by occult 
metastases, i.e., those that are present, 
but illusive, even with the best 
tracking devices. When confronted 
with a tumor without clinical 
evidence of metastasis, it is uncertain 
whether this finding is a shortcoming 
of the detection method or this 
actually is a tumor without propensity 
to metastasize. Regional metastasis 
after all, anticipates extended 
[15] TNM Classification of malignant tumours (1997). [16]J. A. Woolgar, Br.J.Oral Maxillofac.Surg. 
37, 175 (1999). 
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treatment of the neck, besides local 
resection of the primary tumor. The 
neck may be treated by either surgery 
or radiation therapy, with each their 
advantages and disadvantages17, yet 
both are accompanied by increased 
harm to the patient, in terms of 
morbidity. 
Pathology 
Almost ninety percent of HN 
cancers are SCCs, arising in the 
epithelial linings of the head and 
neck. However, tumors originating 
from mesenchymal tissues or 
combinations of epithelial and 
mesenchymal tissues are also found in 
this region. Especially the salivary 
glands and odontogenic structures 
provide a variety of different 
combinations; consequently, they 
seem constantly subject to new 
classifications. Sarcomas, lymphomas, 
melanomas, vasoformative tumors, 
metastases from sites outside the HN 
region, and tumors of peripheral 
nervous and muscular system are far 
less common. Basal cell carcinomas, 
almost exclusively limited to the 
epithelium of the skin, are more 
common in the HN region, but 
[17]R. R. Million, In: Management of Head 
(1994). [18]I. J. Fidler, In: Cancer: Principles 
Cancer Res. 38,2651 (1978). 
although cancer in sensu strictu, are 
generally categorized separately from 
HN cancer. In this respect it seems 
appropriate to point out that some 
benign tumors and diseases of the HN 
can be no less an encumbrance than 
full blown cancer, due to their 
anatomic localization, or tendency for 
recurrence. 
Cancer is defined by invasion, 
but more so by metastasis, the 
production of secondary growths in 
distant organs from the parent tumor. 
Although invasive growth patterns are 
found in some benign conditions, 
metastasis distinguishes exclusively 
malignant disease. The presence of 
metastases in cancer for the largest 
part determines the prognosis. Once 
a tumor has established metastases, 
chances of survival for the patient 
decrease considerably.18 
The process of metastasis is a 
complex sequential cascade of events, 
each of which requires specific 
conditions. It exhibits selective as well 
as stochastic elements, and requires 
both intrinsic properties of the tumor 
cells, as well as favorable host-tumor 
interactions.19 Focussing on HNSCC, 
this process schematically comprises 
id Neck Cancer: A Multidisciplinary Approach 
id Practice of Oncology (1997). [19]I.J. Fidler, 
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Malignant transformation; angiogcncsis; 
ECM degradation; motility 
'..•!• i 1—!—L 
<^B 
metastasis progression Overcome mechanical stresses; adhere to vessel wall; extravasate 
Response to microenvironmenl; 
proliferate 
Figure 1 : schematic representation of the metastasis cascade. 
disruption of the basal lamina and 
other extra-cellular matrix 
components20, developing motility21, 
gaining access to the vascularized 
compartment of connective tissue for 
transportation21, overcoming host 
defense mechanisms, attaching to 
vessel walls to exit the circulation2223, 
proceeding into the distant stroma24, 
and eventually establishing a vascular 
bed2526 (figure 1). Theoretically, 
bearing in mind that the above 
itinerary may not be completely 
accurate, any of these steps may 
impede metastasis, if not adequately 
transgressed. If not concluded, it can 
become a hurdle that blocks tumor 
cells to advance along the sequence, 
and metastasis can not establish. 
[20]S. Garbisa, Nat.Med. 5, 1216 (1999). [21]S. Aznavoorian, Cancer?!, 1368 (1993). [22]A. 
B. Al Mehdi, Nat.Med. 6, 100 (2000). [23]E. Ruoslahti, Annu.Rev.Immunol. 18, 813 (2000). 
[24]K. J. Luzzi, Am.J.Pathol. 153, 865 (1998). [25]J. Folkman, J.Nad.Cancer Inst. 82,4 (1990). 
[26]D. Hanahan, Cell 86, 353 (1996). 
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Neoplasms are biologically 
heterogeneous27 and subpopulations 
of cells that express favorable qualities 
have a selective growth advantage. It 
appears plausible that not all 
prerequisites for metastasis are united 
in a clone of carcinoma cells at a given 
point in time. Tumor cells however 
ultimately may metastasize, since their 
genetic instability enables to rapidly 
gain or loose certain characteristics in 
their life. Furthermore, paracrine 
effects play a role in facilitating 
favorable conditions to neighboring 
clones in the microenvironment.28 3I 
Thus, different clones may exhibit 
difiFerent combinations of qualities, to 
ultimately establish metastasis. On the 
other hand, if a particular tumor is 
capable to meet a quality especially 
well, without deficiencies otherwise, 
this tumor may have an advantage to 
metastasize over others. Any given 
step is necessary, but in itself 
insufficient for establishment of a 
clinically significant metastasis.18 
Diagnos t i c s of Metas tas i s 
Metastasis is present in varying 
proportions in HNSCC on 
presentation17 (table 2). As stated 
earlier, the occurrence of metastasis 
remains for a large part unpredictable. 
In general terms, a tumor's propensity 
metastasize can be assessed by one of 
two distinct paths, discovery and 
prediction. The most frequently used 
strategy amounts to locating 
established metastasis, i.e., discovery. 
Here, early detection of clinically 
significant deposits of malignant cells 
is crucial. The second approach 
predicts metastasis ahead in time, 
based on tumor and host features, 
related to the potential to metastasize. 
This approach carries an advantage, 
by assessing metastasis potential even 
before metastasis formation has taken 
place, but cannot render total 
certainty, since metastasis is also a 
matter of chance.32 Because of its 
[17]R. R. Million, In: Management of Head and Neck Cancer: A Multidisciplinary Approach 
(1994). [18]I. J. Fidler, In: Cancer: Principles and Practice of Oncology (1997).[27]A. K. el 
Naggar, Diagn.Mol.Pathol. 6, 305 (1997). [28]S. A. Eming, Am.J.Pathol. 154, 281 (1999). 
[29]I. J. Fidler, Cancer Chemother.Pharmacol. 43 Suppl, S3 (1999). [30]E. A Sheta, J.Nad.Cancer 
Inst. 92, 1065 (2000). [31]G. F. Greene, Am.J.Pathol. 150, 1571 (1997). [32]Wai-Yuan Tan, 
Stochastic models of carcinogenesis (1991). 
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impact on outcome, great efforts are 
being made to identify metastasizing 
cancer reliably. 
In HNSCC, most often 
metastases are localized to the regional 
lymph nodes of the neck, next in 
order, but less frequently to the 
lungs.17 Tracing metastasis in head 
and neck cancer is usually performed 
by sophisticated imaging techniques 
such as computed tomography (CT) 
and magnetic resonance imaging 
(MRI). Both have considerably 
improved metastasis detection over 
physical examination. Especially for 
nodal metastases in the neck, 
ultrasound examination (US) 
combined with fine needle aspiration 
biopsy (FNAB) appears to track 
metastases best33 (for an overview on 
test details, see ^ ε Γ ε ^ ε 1 4 ) . ΜοΓε 
recently, positron emission 
tomography (PET)3 5, and its less 
e x p e n s e countεrpart singte singte 
photon επιίββΐοη computεd 
tomography (SPECT)36, have entered 
the diagnostic panel, and are under 
evaluation. The most recent 
development is raising labekd 
antibodiεs direcœd against HNSCC 
cells37, and nucleic acid based 
methods for the detection of 
cancer. · 
The findings from diagnostic 
tests are set against the golden 
standard of routine pathological 
examination of the neck dissection 
specimen. Extended search for small 
deposits of malignant cells by serial 
sectioning lymph nodes40 or 
application of mokcular 
techniques41,42 has increased 
specificity of the tests, but also raised 
the q^stion wl^tl^r small groups of 
cells are of clinical importance.24·4'·44 
So far, the clinical significance 
remains l a ^ l y unknown. This issue is 
not yεt $ ε η ^ , but it has reœntly bεen 
suggested that any given localization 
of SCC cells in a lymph node 
evεntually will result in clinically ονεη 
metastasis 45 
[ 17] R. R. Million, In: Management of Head and Neck Cancer: A Multidisciplinary Approach 
(1994).[24]K. J. Luzzi, AmJ.Pathol. 153, 865 (1998) [33]R. RTakes, Radiology 198,819 (1996). 
[34]M. W. van den Brekel, Eur.Arch.Otorhinolaryngol. 250, 11 (1993). [35]J. W. Braams, 
J.Nud.Med. 36,211 (1995).[36]M. P. Stokkel, Ann.Surg. 231,229 (2000). [37]R. H. BrakenhofF, 
Clin.Cancer Res. 5,725 (1999). [38]D. Sidransky, SCIENCE 278,1054 (1997). [39]J. A. Brennan, 
Cancer Metastasis Rev. 15, 3 (1996). [40]J. A. Woolgar, Br.J.Oral Maxillofac.Surg. 37, 181 
(1999). [41]J. A. Brennan, N.Engl.J.Med. 332,429 (1995). [42]A. Zippelius, Ann.N.Y.Acad.Sci. 
906,110 (2000). [43]K. Pantel, J.Nad.Cancer Inst. 91,1113 (1999). [44]T. Reynolds, J.Nad.Cancer 
Inst. 90, 1690 (1998). [45]H. J. Gath, Cancer Metastasis Rev. 18, 109 (1999). 
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In spite of recent imaging 
developments in tracking neck node 
disease, including USFNAB, 
predictive values of staging are still 
open to debate when it comes to 
treatment planning/ 6 Especially 
debate on how to treat the neck 
without evidence of metastasis (N0-
neck) continues, since false negative 
test results even for USFNAB in the 
N0-neck mount up to 52%.^ In 
absence of absolute certainty, many 
HNSCC patients undergo elective 
neck dissections to remove possible 
occult malignant neck lymph nodes, 
in an attempt to cure the patient. Not 
all patients prove to indeed have 
therapeutically benefited from this 
treatment, when no metastases are 
found in the operation specimen on 
histopathological examination. Only 
if we could identify parameters that 
predict metastases sufficiently reliably, 
a neck dissection could be restricted to 
high-risk patients. 
Clinically overt metastases are 
often accessible for cytology, and 
seldom pose a problem. Excluding 
occult metastatic disease however, 
remains a dilemma. For the latter, 
trustworthy characteristics are 
wanted, since "to have or not to have" 
carries considerable consequences. In 
this respect, depth of invasion47·48, 
tumor size49",2, tumor growth 
pattern5 3 , 5 4, perineural and 
intravascular spread55, and 
differentiation grade53 have been 
considered. For large groups of 
patients, differences for these 
parameters between metastasized 
versus non-metastasized HNSCC 
have been found. More recently, 
genetically derived features became 
subject of investigations. DNA 
content56,57, alterations in expression 
of genes and gene products5 ' '5 2·5 5 5 8 62, 
and carrier status of Epstein-Barr 
virus63 to some extent showed relation 
[46]R. ETakes, InLj.Radiat.Onool.Biol.Phys. 40,1027 (1998). [46] R. ETaks, Int.J.Radiat.Oncol.Biol.Phys. 
40, 1027 (1998). [47]T. Asakage, Cancer 82, 1443 (1998). [48]H. Fukano, Head Neck 19, 
205 (1997). [49]A. S. Jones, Eur.J.Cancer Β Oral Oncol. 30B, 8 (1994). [50]H. P. Howaldt, 
J.Craniomaxillofac.Surg. 27, 275 (1999). [51]A. I. Dreyfiiss, Hematol.Oncol.Clin.North Am. 
5,701 (1991). [52]P. D. Lacy, Cancer 86,1387(1999). [53]E.W. Odell, Cancer 74, 789 (1994). 
[54]R. H. Spiro, Head Neck 21, 408 (1999). [55]J. A. Woolgar, Head Neck 17, 463 (1995). 
[56]G. Baretton, Oral Surg.Oral Med.Oral Pathol.Oral Radiol.Endod. 79, 68 (1995). [57]T. 
Saito, Int.J.Oral Maxillofac.Surg. 23, 28 (1994). [58]H. Mineta, Cancer 85, 1011 (1999). [59]X. 
Xie, Cancer 86,913 (1999). [60]U. Bockmiihl, Cancer Res. 56,5325. (1996).[61]X. Li, J.Nad.Cancer 
Inst. 86, 1524 (1994). [62]D. Sidransky, Curr.Opin.Oncol. 7, 229 (1995). [63]I. Kobayashi, 
J.Pathol. 189,34(1999). 
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Figure 2: Schematic representation of HNSCC 
to the capacity to metastasize. Less 
frequently, age and sex64, and cell 
adhesion molecules65 are reported 
involved in this context. 
Still, no trustworthy parameters 
in case of an N0-neck are available to 
warrant individual treatment 
planning, and thus, the quest for 
useful predictors continues. 
tumor progression model. 
Genetic Oncogenesis Model 
Genetic oncogenesis models are 
empirically based on clinical 
observations, associating specific 
genetic abnormalities with tumor 
progression. Genetic alterations are 
the motor that drives neoplastic 
progression, through expansion of 
selected clones of tumor cells.66 
Unraveling the molecular biology 
[64]M. Kuriakose, Eur.J.Cancer Β Oral Oncol. 28B, 113 (1992). [65]V. Mattijssen, Int.J.Cancer 
55, 580 (1993). [66]A. S. Perkins, In: Cancer: Principles and Practice of Oncology (1997). 
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behind tumor progression gives 
increasing insight into the machinery 
of this motor. Extensive research into 
specific tumors has identified 
common pathways, along which 
genetic damage accumulates, and 
these have been linked to clinical 
behavior.67 (figure 2) Through this 
progression model, cancer 
development can be routed along a 
series of subsequent steps, from 
normal tissue to invasive and 
metastasizing cancer. For HNSCC, 
attempts have been made to elucidate 
a corresponding pathway.68 7' Genetic 
changes in this model include 
aberrations of oncogenes and 
suppressor genes, thought to be 
related to cancer progression. Such 
alterations provide a selective growth 
advantage to a selection of cells, 
resulting in uncontrolled expansion 
that may eventually result in a 
neoplasm. The challenge is to 
establish clarity in the individual 
alterations, and distinguishing crucial 
from random changes. Expression of 
genes may be altered through 
mutations, but also through structural 
chromosome alterations68, errors in 
DNA metabolism, repair, 
recombination, or other 
rearrangements of the DNA 
sequence, or from misregulation of 
the cell cycle.72 
Cancer is thought to arise 
through clonal expansion of a single 
cell.73 The daughter cells share many 
of the genetic changes, but once 
genetic instability settles in, 
generations down stream start 
differing from their ancestors. The 
ultimate result is a heterogeneously 
composed tumor.27 This diversity in 
clones is the basis for a dispute when 
a HNSCC patient develops multiple 
tumors, at the same point in time (i.e., 
synchronous) or after a period of time 
(i.e., metachronous). The theory of 
'field cancerization' or 'carpet cancer', 
is either derived from the belief that 
prolonged exposure to carcinogens 
leads to independent transformation 
of a large mucosal surface, resulting in 
multiple primary tumors74, or from 
the alternative theory, based on the 
premise that the progeny of mutated 
[27]A. K. el Naggar, Diagn.Mol.Pathol. 6, 305 (1997). [67]E. R. Fearon, Cell 61, 759 (1990). 
[68]J. M. Cowan, J.Natl.Cancer Inst. 84, 793 (1992). [69]J. A. Veltman, Int.J.Cancer 91, 193 
(2001). [70]J. A. Veltman, J.Clin.Oncol. 18,1644 (2000).[71]J. Califano, Cancer Res. 56,2488 
(1996). [72]W. S. Saunders, Proc.NadAcad.Sci.U.SA 97,303 (2000). [73]T. E. Carey, Anticancer 
Res. 13, 2561 (1993). [74]J. P. Lavieille, Acta Otolaryngol.Stockh. 115, 334 (1995). 
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cells spread through the mucosa, to 
distinct geographical sites, which thus 
share the same pedigree.75 
Generally, point mutation of one 
allele is followed by deletion of its 
second counterpart, resulting in 
complete inactivation of the gene. 
Mutation or amplification of genomic 
regions harboring potential oncogenes 
is thought to drive uncontrolled 
proliferation of clones of cells. 
Detection of genetic damage involved 
in a tumor progression model is 
dependent on the technique used. 
One of the earliest methods used is 
karyotyping, where chromosomal 
metaphase spreads are 
morphologically studied after 
staining.68 76 Only gross aberrations 
are discernable this way, but a global 
view of all chromosomes is gained, 
and translocations are accessible. A 
newer technique employs 
hybridization of selected markers to 
chromosomes, either in situ {in situ 
hybridization, ISH) or after 
separation from tissue. Hereby, single 
strands of DNA are allowed to form 
pairs with corresponding bases from 
another strand, thus physically linking 
the two strands together. Since the 
base composition of the markers (e.g., 
micro satellites probes, centromere 
probes) is known, corresponding 
stretches in the test DNA are located. 
More detailed information about 
selected regions in the genome results, 
but the number of markers is limited. 
Depending on the markers selected, 
alterations in copy numbers of a part 
of, or of whole chromosomes can be 
distinguished.77 Introduction of the 
polymerase chain reaction (PCR) 
technique has opened DNA for 
further analysis, even when the 
amount of tissue available is 
limited.'8'62·70'78 Comparative genomic 
hybridization (CGH) compares equal 
parts of differentially labeled normal 
reference DNA and tumor DNA, by 
having this mixture compete in 
hybridization to normal metaphase 
chromosomes.79 An over- or 
underrepresentation of a specific 
chromosomal part in either test or 
reference DNA is thus reflected in 
corresponding changes in dye 
intensity. A leap forward is expected 
from the DNA-array technique, the 
[38]D. Sidransky, SCIENCE 278, 1054 (1997). [62]D. Sidransky, Curr.Opin.Oncol. 7, 229 
(1995). [68]J. M. Cowan, J.Natl.Cancer Inst. 84, 793 (1992). [70]J. A. Veltman, J.Clin.Oncol. 
18, 1644 (2000). [75]G. C. Bedi, Cancer Res. 56, 2484 (1996). [76]Y. Jin, Cancer Res. 55, 
3204(1995). [77]J. A. Veltman, Cytometry 34, 113(1998). [78]B. A. Yoshida, J.Natl.Cancer 
Inst. 92, 1717 (2000). [79]J. Houldsworth, Am.J.Pathol. 145, 1253 (1994). [ 
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so-called 'chip technology'.80 Known 
DNA, RNA, or protein probes, 
arranged in arrays on slides (the 
'chip'), are allowed to hybridize to test 
samples of corresponding origin. The 
advantage is the ease of assessing 
hybridization differences by 
employing image analysis to the slides, 
providing insight to a large number of 
probes in one overview. 
In the postulated HNSCC 
progression models, it is generally 
believed that multiplication resulting 
in tetraploidization occurs early, 
followed by deletion and 
amplification of certain chromosomal 
parts. These allelic losses or 
chromosomal deletions are now 
believed to mark inactivation of 
critical suppressor genes.62'70·78 
Consistent early losses (i.e., 
compatible with dysplastic lesions) 
from cytogenetic and karyotypic 
studies in HN oncogenesis involve 
chromosomes 3p, 9p, and 17p.71 
Additional losses found later in tumor 
progression (i.e., in carcinoma in situ 
and invasive HNSCC), reside at 4q, 
5q, 6p, 8p, 8q, l4q, 18q, 19q, and 
2Jq_27.62.68.71.73.81.82
 A r e a s o f 
chromosomal gain or amplification in 
dysplastic HN mucosa were found at 
l l q , 13q and I4q. In invasive 
HNSCC in addition gains at 3q, 5p, 
7p, and 8q were found.62·71'73 
Interestingly, the more markers are 
used, the more aberrations are 
retrieved, indicating a selection bias in 
this technique. This feature is 
furthermore reflected in the global 
representation of genomic 
imbalances, as demonstrated by 
CGH. In HNSCC, its use is restricted 
to a small series of reports60·81 ',0, still 
almost all chromosome arms are 
reported involved in some study. Only 
one study considers pre-neoplastic 
mucosa besides invasive carcinoma, 
wherein no abnormalities were 
found.89 Therefore, no progression 
model is confirmed or denied, based 
on CGH findings thus far. 
[27]A. K. el Naggar, Diagn.Mol.Pathol. 6, 305 (1997). [60]U. Bockmiihl, Cancer Res. 56, 5325. 
(1996). [62]D. Sidransky, Curr.Opin.Oncol. 7, 229 (1995). [68]J. M. Cowan, J.Natl.Cancer 
Inst. 84,793 (1992). [70]J. A. Veltman, J.Clin.Oncol. 18,1644(2000). [71]J. Califano, Cancer 
Res. 56, 2488 (1996). [73]T. E. Carey, Anticancer Res. 13, 2561 (1993). [78]B. A. Yoshida, 
J.Natl.Cancer Inst. 92, 1717 (2000). 80]M. Chee, SCIENCE 274, 610 (1996). [81]J. K. Field, 
Anticancer Res. 16, 2421 (1996). [82]H. Nawroz, Cancer Res. 54,1152 (1994). [83]U. Bockmiihl, 
Cancer Res. 57, 5213 (1997). [84] U. Bockmiihl, Head Neck 20,145 (1998). [85]M. A. Hermsen, 
Oral Oncol. 33,414 (1997). [86]M. Kujawski, Cancer Genet.Cytogenet. 114, 31 (1999). [87]M. 
Okafuji, J.Oral Pathol.Med. 28, 241 (1999). [88]M. R. Speicher, Cancer Res. 55, 1010 (1995). 
[89]N. D. Stafford, Arch.Otolaryngol.Head Neck Surg. 125, 1341 (1999). [90]E. Wolff, Oral 
Oncol. 34, 186(1998). 
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Limiting results to the 
chromosome arms, losses are located 
on lp 6 0 · 8 4 , 3p 6 0 · 8 6 ' 8 8- 9 0, 3q 8 9 , 4p 6 0 · 8 4 · 8 6, 
/ 60,84,86,87 C
a
60,84,88,90 ^60,84,90 gD60,84 
9p60,84,89) 1 1 ρ β 4 ) l lq60,84,88,90) 13q60,84,90) 
18p 8 9 , 18q 6 0 ' 8 4 ' 8 6 · 8 7 · 8 9, 19p 8 8 , and 
2|q6o,84 Q
a
j
n s W e r e most frequently 
found on l p 9 0 , l q 8 5 · 9 0 , 2q 8 9 · 9 0 , 3q84-
88,90) 5p85,87-90) 6 q 9 0 ) 7 p 8 5 > 8q60,84-87,89,90) 
9 p 8 5 , 9q85.86.8M0 ) 1 0 q 9 0 ) J lq60,84,89,90) 
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19q6o,84,90) 20p*7, 20q
8 4
·
8 7
·
9 0
, a n d 2 2 q 8 4 . 
Metastasis is considered the 
epitome of cancer progression. Studies 
comparing metastasized vs. non-
metastasized HNSCC, as well as other 
cancers
3 1 , 7 7 , 9 1 9 ,(for a review see 
reference78) are even less numerous.83 
Deletions on 10q25-q26 and 1 l p l 3 -
p l 4 in HNSCC in general83 were 
reported related to metastasis, whereas 
metastasizing larynx carcinomas 
specifically showed more losses at 18q, 
3p and 5q.86 
The major obstacle in 
interpreting observations based on 
clinicopathologic classifications 
remains that the results only assume 
that clinical progression is driven by 
the identified genetic aberrations. The 
mere finding that carcinoma exhibits 
more genetic aberrations is no proof 
for the assumption that these are 
actually mechanistically related to 
progression. It is after all conceivable, 
that particular lesions regress, as is 
known for e.g., dysplastic lesions of 
the uterine cervix.94 To prove which 
aberrations, or combination of 
aberrations are prone to progress into 
full blown cancer, a longitudinal 
prospective follow up study is desired, 
and such has so far not been 
established. 
Summarizing, progression in 
HNSCC is thought to arise in clones 
of genetically damaged cells. As an 
early event, tetraploidization occurs, 
followed by aneuploidization, loss of 
[31]G. F. Greene, Am.J.Pathol. 150, 1571 (1997).[60]U. Bockmiihl, Cancer Res. 56, 5325. 
(1996). [77]J. A. Veltman, Cytometry 34, 113 (1998).[78]B. A. Yoshida, J.Natl.Cancer Inst. 
92, 1717 (2000). [83]U. Bockmühl, Cancer Res. 57, 5213 (1997). [84]U. Bockmiihl, Head 
Neck 20, 145 (1998). [85]M. A. Hermsen, Oral Oncol. 33, 414 (1997). [86]M. Kujawski, 
Cancer Genet.Cytogenet. 114, 31 (1999). [87]M. Okafuji, J.Oral Pathol.Med. 28, 241 (1999). 
[88]M. R. Speicher, Cancer Res. 55, 1010 (1995). [89]N. D. Stafford, Arch.Otolaryngol.Head 
Neck Surg. 125,1341 (1999). [90]E. Wolff, Oral Oncol. 34,186(1998). [91]Y.Kitadai,Clin.Cancer 
Res. 1, 1095 (1995). [92]S. Pack, Lancet 350, 264 (1997). [93]P. O'Connell, J.Natl.Cancer 
Inst. 91, 1391 (1999). [94]L. G. Koss, JAMA 261, 737 (1989). 
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heterozygosity, amplifications, 
translocations, and mutations 
throughout the genome. Progressing 
genetic instability is marked by an 
increased number and percentage of 
damaged loci. Indirect evidence 
suggests that loss of loci on 3p, 9p and 
17p are early events, and that 
amplification of l l q l 3 is a relative 
important event, that occurs later 
during progression. 
Possibly involved genes on 3p 
have so far not been shown 
inactivated in primary tumors, 
although 3p26 harbors a cell adhesion 
molecule gene, and to 3p21.3, a 
putative tumor suppressor gene 
(FUS2) has been located. 
Chromosome 9p21 harbors pi6 (also 
known as CDKN2), a suppressor 
gene candidate involved in inhibition 
of CDK complexes, governing cell 
cycle control. P53 is located at 17pl3, 
also related in cell cycle control and 
apoptosis. Amplification at l l q l 3 
may be related to upregulation of 
Cyclin D l (PRAD1), a 
protooncogene related to the cell 
cycle, and FIBP, a gene coding for an 
intracellular receptor for acidic 
fibroblast growth factor. 
[95]J. Folkman, J.Natl.Cancer Inst. 92, 94 (2( 
(1984). [97]N. Weidner, N.Engl.J.Med. 324,1 
[99]W. Risau, Nature 386, 671 (1997). 
Angiogenesis 
Since HNSCC has an epithelial 
origin, the cancer cells are dependent 
for their vascular supply on the 
surrounding stroma, as are normal 
epithelia. Tumors in absence of 
adequate blood supply are limited in 
growth potential to spheres 0 .2-
2mm. in diameter.95 The tumor's 
ability to recruit vessels from the 
surrounding stroma differs between 
tumor type, and between tumors of 
the same type. Increased propensity to 
include vessels into the tumor stroma, 
not only provides improved oxygen 
and nutrient supplies, but also 
increases the probability of carrying 
malignant cells to distant sites. The 
shedding of cells into the vasculature 
has been established long ago, as has 
its relation to the occurrence of 
metastasis.96 Recently, a new impulse 
has been given to extensive research in 
this field97, especially now that 
therapeutic options are considered. 
Angiogenesis, the formation of new 
vessels from pre-existing ones (for a 
review see references98;99), has gained 
the most attention, although lately 
. [96]J. E. Price, J.Natl.CancerInst. 73, 1319 
91). [98]P. Carmeliet, Nat.Med. 6,389 (2000). 
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two other possibly involved 
mechanisms, so called co-option100, 
and vascular mimicry101, were 
introduced. The former refers to 
recruitment of pre-existing vessels 
into the tumor; the latter describes 
non-endothelium-lined channels, 
adopting blood vessel function. 
Angiogenesis is rigorously controlled 
by a series of factors and mechanisms 
in physiologic conditions such as 
wound healing and the female 
reproductive system. The tumor 
microenvironment modulates these 
mechanisms, and an important 
explanation for increased transporter 
capacity in tumor vessels is related to 
the resulting leakiness of the tumor 
microcirculation.102 Smolle et al. were 
among the first to quantify the 
relation between microvessel density 
and clinical behavior10', but since 
Weidner et al. found metastases more 
often with increasing vascular density 
in breast carcinomas97, both 
affirmative as well as contradictory 
results were reported (e.g., 
references104105). Although efforts to 
standardize protocols to measure 
microvessel density have been 
made106, a marked heterogeneity is 
found in the methodology used, e.g., 
the selection of antibodies, the 
inclusion criteria of microvessels, and 
the magnification. However, to a 
greater extent, differences in the 
selection of areas of interest, the so-
called hot spots, and the 
immunohistochemical protocols 
influence the results.104107109 
The role of lymph vessels in 
metastasis has received little attention 
until recently.110 A novel finding is a 
angiogenic receptor (VEGFR-3 and 
LYVE-1 ) (almost) exclusively located 
on lymph vessels.1""1" 
[97]N. Weidner, N.Engl.J.Med. 324, 1 (1991). [100]J. Holash, SCIENCE 284, 1994(1999). 
[101]A. J. Maniotis, Am.J.Pathol. 155, 739 (1999). [102]H. Hashizume, Am.J.Pathol. 156, 
1363 (2000). [103]J. SmoUe, Pathol.Res.Pract. 185,740 (1989). [104]K. Axelsson, J.Natl.Cancer 
Inst. 87,997(1995). [105]N.Weidner,J.Pathol. 184,119 (1998). [106]E B.Vermeulen,Eur.J.Cancer 
32A, 2474 (1996).[107]J. A. M. Belien, J.Clin.PathoI. 52,184 (1999).[108]J. S. De Jong, Lab.Invest. 
73, 922 (1995).[109]E. J. Hannen, Anal.Cell Pathol. (2001). [110]S. A. Ecdes, Recent Results 
Cancer Res. 157, 41 (2000). [111]M. Jeltsch, SCIENCE 276, 1423 (1997). [112]S. Banerji, 
J.Cell Biol. 144, 789 (1999). [113]T. Veikkola, Semin.Cancer Biol. 9, 211 (1999). 
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Although the quantitative link 
between microvessels-tumor 
progression appears more complicated 
than expected at first, some 20 drugs 
to counteract angiogenesis have 
entered the stage of clinical trials, and 
appear to carry promise in attacking 
cancer and cancer metastasis.114117 
Outline of the Thesis 
The subject of this thesis are 
models to predict HNSCC 
metastasis. For most of the research, 
we limited our studies on HNSCC to 
carcinomas of the mobile tongue. 
Consequently, possibly confounding 
factors that are the reason why SCC of 
e.g., the larynx metastasize less often 
than tongue SCC, were eliminated. In 
this thesis, we focussed on biologic 
determinants in metastasis, that hold 
possible key positions. In the previous 
paragraphs, a summary of the relevant 
literature and theoretical backgrounds 
of the studies was given. 
As a prerequisite, genetic damage 
has to take effect to express metastatic 
phenotype. We investigated genetic 
differences between metastasized and 
non-metastasized tongue carcinomas, 
as represented by morphologic 
karyometric features. DNA in the 
nucleus is stored in a tightly organized 
fashion that has been highly preserved 
throughout evolution, indicating that 
this packaging is important for 
survival of the species. During 
mitosis, the arrangement of DNA 
reaches its most condensed state, until 
the individual chromosomes are 
distinguishable. Unfolding the 
condensed DNA strands is necessary 
for transcription, and therefore plays 
a possibly crucial role in expression of 
genes. Genetic damage is also 
reflected the folding of the DNA, 
since chromosomes are localized to 
specific domains in the cell nucleus, 
and altered composition, will likely 
result in an altered morphology in 
stored DNA. In chapter 1, we report 
on our study on nuclear morphology 
with image analysis equipment. This 
approach enables to discern subtle 
differences in chromatin packaging, 
indistinct to the naked eye, between 
tumors that have metastasized and 
tumors that have not."8 Furthermore, 
we tested the capacity to predict the 
occurrence of metastases, based on 
these differences, using statistical 
methods."8 
[114]]. R. Westphal, Int.J.Cancer 86, 870 (2000). [115]G. Bergers, SCIENCE 284, 808 (1999). 
[116]A. L Harris, Lancet 349 Suppl 2, SII13-SII15 (1997). [117]A. P. Kudelka, N.Engl.J.Med. 
338,991 (1998). [118]E. J. Hannen, J.Pathol. 185, 175(1998). 
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Taking the concept a step 
further, in chapter 2 we report on our 
efforts to locate the chromosomal site 
of genetic differences between the 
metastasized and non-metastasized 
tumors, with the comparative 
genomic hybridization technique 
(CGH)."9 
In the last decade, the tumor's 
interactions with its stromal vascular 
bed, has gained attention of groups of 
investigators.120 For HNSCC, and to 
a lesser extent for other types as well, 
controversy seems to exist, on the 
implications of tumor 
vascularity.104121122 To address this 
issue, we accordingly focussed on 
tumor microvascular architecture, as a 
second putative critical determinant 
in metastasis. From the literature, it 
appeared that uniform methods of 
investigation are first needed to shed 
light on possible causes of 
discrepancy.106 Furthermore, the use 
of computerized image analysis was 
found to provide substantial extra 
information and consistency123, 
warranting the implementation of a 
new immunohistochemical 
protocol124, along with new image 
analysis software125, that enabled to 
yield maximum information. Chapter 
3 reports on the methods 
employed.109 Chapter 4 presents the 
clinical application of these 
techniques, and the results from 
studying differences in microvessel 
architecture between metastasized and 
non-metastasized tongue 
carcinomas.126 
Since the development of a 
malignant genotype takes place in 
multiple steps71, and not one appears 
to satisfy the demands of predicting 
metastasis singly, it is plausible to test 
combinations of factors for their 
governing metastasis. The observation 
that cancer development not only 
depends on cancer genes, but also on 
microenvironmental conditions127, 
further supports the integration of 
multiple biological findings into a 
statistical model. As stated earlier, not 
a single feature in the metastasis 
sequence alone is likely to be decisive 
for completion. Rather a combination 
of properties will enable a tumor to 
[71]J. Califano, Cancer Res. 56, 2488 (1996). [104]K. Axelsson, J.Natl.Cancer Inst. 87, 997 
(1995). [106]P. B. Vermeulen, Eur.J.Cancer 32A, 2474 (1996). [109]E. J. Hannen, Anal.Cell 
Pathol. (2001). [119]E. J. Hannen, submitted (2001). [120]T. G. Dray, Ann.Otol.Rhinol.Laryngol. 
104,724 (1995).[121]G. Gasparini, Int.J.Cancer 55,739 (1993). [122]S. R.Tahan, J.Cutan.Pathol. 
22,236(1995). [1231]. A-van der LakJ-PiuhoL 184,136(1998). [124]H.MKeistens,J.HistDchem.Cytochem. 
43,347 (1995).[125]J. A. van der Laak, Cytometry 39, 275 (2000). [126]E. J. Hannen, submitted 
(2001). [127]]. Bussink, Br.J.Cancer 77, 57 (1998). 
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develop into a metastatic phenotype. 
Combining data from our series from 
Chapters 1 and 4, the study in 
Chapter 5 reports the results from our 
efforts to construct a statistical model 
to predict metastasis based on nuclear 
features and vascular parameters.128 
The General Discussion elaborates on 
the possible implications of the 
presented studies, and provides 
suggestions for further research. 
Additional Remarks to the 
Methods 
In most of the studies in this 
thesis, notable techniques were 
employed to help answering our 
research questions. Most are not 
commonplace, and this paragraph is 
dedicated to put them into 
perspective. 
First, the use of computer aided 
image analysis is discussed here. 
Manually measuring tissue 
characteristics in stained sections can 
be a tedious task, when a continuous 
linear scale is used, i.e., when values 
are represented in discrete numbers 
versus intervals such as ' + ' , ' + + ', 
' - ' , ' — ' , for example. In the case of 
the study in Chapter 4, this would 
have implied that some 30,000 vessels 
had to be counted by hand, twice. 
Imaginable, this is not a tempting 
effort, and not suitable for routine 
practice. Furthermore, we were 
interested in other characteristics, 
such as vessel perimeter, representing 
the contact surface between 
endothelium and stroma, and the 
vessel diameter, the area of individual 
vessels, and the total area of all vessels 
in a particular field, to name a few. 
Such characteristics can be estimated 
by point counting using a grid129, but 
are best assessed by image analysis, 
with suitable software. Although the 
majority of microvessel density studies 
applies manual counting, the 
employment of image analysis returns 
many advantages. To fully exploit 
these, a certain investment is required, 
because image analysis demands high 
staining qualities, aimed at a high 
signal-noise ratio. As it turned out, 
standard protocols to stain sections 
were in a number of cases inadequate. 
Therefore, an amplification step to 
improve the quality was added, which 
is discussed in Chapter 3. Only few 
studies have used image analysis with 
amplification so far, but we feel it 
merits serious consideration, judged 
from its advantages. 
[128]E. J. Hannen, Cancer (2001).[129]E. G. Weibel, Stereological Methods; Theoretical Foundation 
(1980). 
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Second, the use of logistic 
regression in classifying cases as 
metastasized versus non-metastasized 
is discussed briefly. Ultimately, the 
goal of predicting metastasis as we do 
is selecting high-risk patients based on 
characteristics from that particular 
tumor itself, preferably on a biopsy. In 
other words, we are trying to identify 
prognostic factors to stratify 
individual patient into high-risk and 
low-risk in terms of metastasis, to be 
used for counseling purposes. This is 
in contrast to studies where groups of 
tumors are compared, e.g., to identify 
an association between a factor and 
disease characteristics. The latter can 
be viewed as screening for interesting 
hypotheses, whereas we try to validate 
a hypothesis, and prove its superior 
prediction qualities beyond 
recognized prognostic systems. The 
difference is parallel to phase I, II vs. 
phase III studies.130 The contrast also 
lies in 'individual' versus 'group'; 
logistic regression analysis takes 
prediction a step further in enabling 
to compute chances that an individual 
patient has a metastasizing tumor. 
Thus, it may help in medical decision 
making. Although the study design is 
retrospective, and true validation can 
[130]R. Simon, Br.J.Cancer 69, 979 (1994). 
only be warranted in a prospective 
setting, our results are considered with 
the utmost statistical and 
epidemiological care, and from a 
conceptual point of view, add to the 
standard prognostic systems. 
Third, the choice of comparative 
genomic hybridization is rationalized. 
Alterations in a tumor genome can be 
established in a number of ways, as 
was discussed earlier and is 
demonstrated in the literature. In 
view of the fact that any technique 
with a high resolution gives 
information on a limited number of 
detailed regions in the genome, and 
thus limited assessment of the genome 
as a whole, and as it is not exactly 
known where to look for genomic 
differences between metastasized and 
non-metastasized tumors, a technique 
with superior overall scanning 
qualities was chosen. The results leave 
a lot to be investigated, but indicate 
the direction, for more specific 
techniques. The present challenge is 
to identify genes that are functionally 
important in metastasis, and 
ultimately advance towards the 
patients' bedside. 
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Abstract 
In a retrospective case control study on 46 metastasized and 34 non-
metastasized primary tongue carcinomas, the nuclear morphology and 
chromatin pattern were assessed in three micrometer thick, formalin-fixed, 
paraffin-embedded and Feulgen-stained tissue sections of surgical resection 
specimens, by means of high resolution computer-assisted image analysis. The 
aim of this study was to disclose differences in karyometric features (i.e. nuclear 
size-, shape-, and chromatin pattern features) between these groups, intending 
to develop a discriminant function that enables to predict the occurrence of a 
metastasis for the individual patient. In addition, the lymph node metastases of 
31 patients and the normal tongue epithelium of 21 patients were also assessed, 
to study the possible diflFerences between these two groups and primary tumors. 
In the metastasized tumors the chromatin was significantly more condensed 
(p=0.01), and exhibited significantly less variation in chromatin condensation 
(p<0.001) than in the group non-metastasized carcinomas. Comparison of 
lymph node metastases with their primary tumors disclosed only minor 
differences in chromatin pattern. These findings suggest that only minor genetic 
differences exist between primary tongue carcinomas and their metastases. 
Tumor cells of tongue carcinomas showed highly significant differences from 
normal tongue mucosa cells for most karyometric features. 
Logistic regression analysis resulted in a classifier, based on the circularity 
of the nucleus (CIRC) and the standard deviation of the chromatin condensation 
(SD COND), to predict the occurrence of lymph node metastases. After cross 
validation the percentages of correct classifications in the group of metastasized 
and non-metastasized tumors were 72% and 62%, respectively. These results are 
comparable with classification results obtained from a classifier based on the 
clinical T-stage, but our karyometric classification results show an equal 
distribution between the sensitivity and specificity. Karyometric features 
appeared to be more appropriate to predict metastases than biomarkers such as 
p53, bcl-2 and Ki-67. 
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Introduction 
Squamous cell carcinomas 
constitute at least 90% of all 
malignancies in the head and neck 
region and represent 5% of newly 
diagnosed cancers in the western 
world. Head and neck cancer is 
characterized by a relatively poor 
prognosis which is partly determined 
by histological grade and UlCC-stage 
(International Union against Cancer) 
of the tumor at presentation. 
Locoregional lymph node metastases 
occur frequently in patients with head 
and neck cancer and the occurrence of 
metastases is related to the location 
and stage of the primary tumor'. 
Especially tongue carcinomas often 
have metastasized at the time of 
diagnosis and lymph node metastases 
occur more frequently in high T-
staged tumors (T -T4) than in low T-
staged tumors (T1-T2)2. However, it is 
a well-established fact that small 
tumors may already have metastasized 
at the time of diagnosis, while large 
tumors have not. 
A malignant tumor is composed 
of numerous clones of tumor cells 
dififering in their biological behavior, 
e.g. invasive and metastatic capacity, 
and therapy resistance, due to tumor 
cell progression resulting from genetic 
instability3 \ Only a fraction of the 
tumor cells is considered capable of 
successfully completing all steps in the 
complex multipath process of 
metastasis, and a metastasis is assumed 
to be the result of a clonal expansion 
of one or a few tumor cells of full 
metastatic capacity617. 
Numerous high resolution image 
cytometry studies on both complete 
nuclei isolated from thick tissue 
sections as well as truncated nuclei in 
thin tissue sections have shown that 
karyometric features such as size-, 
shape- and chromatin-pattern 
features89 can be used successfully to 
disclose differences in biologic 
behavior of malignant and 
premalignant lesions10 I4. An image 
cytometry study on dysplastic oral 
[1] RR. Million, In: Management of Head and Neck Cancer: A Multidisciplinary Approach 
(1994). [2] C.T. Brennan, Laryngoscope 101, 1175 (1991). [3] D. M. Goldberg, Clin.Chem. 
39, 2360 (1993). [4] D. L. Van Dyke, Genes Chromosomes.Cancer 9, 192 (1994). [5] P. H. 
Rao, Cancer Genet.Cytogenet. 77, 60 (1994). [6] C.W. Boone, J.Cell Biochem.Suppl. 19, 10 
(1994). [7] Y. Jin, Cancer Res. 53, 2140 (1993). [8] A. E. Dawson, Anai.Quant.Cytol.Histol. 
15, 227 (1993). [9] I. T. Young, Cytometry 7, 467 (1986). [10] M. Bibbo, Cancer Res. 50, 
147(1990). [11] B. Palcic, J.Cell Biochem.Suppl. 17G, 107(1993). [12] I. Salmon, Am.J.Clin.PathoI. 
97, 776 (1992). [13] I. Salmon, Anai.Quant.Cytol.Histol. 14, 47 (1992). [14] J. H. Tucker, 
Anal.Cell Pathol. 6, 117 (1994). 
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epithelium showed that karyometric 
features could be used to predict 
malignant transformation in these 
premalignant lesions with 87.5% 
accuracy15. Two further recent studies 
demonstrated that chromatin pattern 
features can be used to predict 
prostate cancer progression and the 
recurrence of low grade superficial 
transitional cell carcinoma of the 
bladder16,17. Lymph node involvement 
in patients with an invasive ductal 
mammary carcinoma could be 
predicted with an overall efficacy of 
72% by a multivariate classifier based 
on karyometric features measured in 
thin tissue sections18. As the 
chromosomes of the interphase cells 
are located in discrete areas of the 
nucleus, it is plausible that numerical 
and structural chromosome 
aberrations, accompanying tumor 
progression in squamous cell 
carcinomas of the head and neck, are 
associated with alterations in 
chromatin distribution. In a recent 
study, an association between 
fractional allelic loss and chromatin 
pattern was confirmed in colorectal 
cancer
19
. 
[15] M. Abdel-salam, Cancer 62, 1981 (1988) 
[17] R. W. Veltri, J.Cell Biochem.Suppl. 19, : 
185, 689 (1989). [19] J. W. Mulder, Am.J.Pai 
Carcinoma Metastasis 
The aim of this study was 1 ) to 
assess whether nuclear morphology 
features can be used to disclose 
differences between the tumors of 
metastasized and non-metastasized 
carcinomas of the tongue, in order to 
predict the metastatic behavior ofthat 
tumor for the individual patient, 2) to 
obtain indirect evidence that only 
minor genetic differences exist 
between primary carcinoma of the 
tongue and their lymph node 
metastases, and 3) to compare the 
nuclear morphology of tumor cells 
with those of normal epithelium. 
M a t e r i a l a n d M e t h o d s 
P a t i e n t s 
In this case control study 80 
patients with a squamous cell 
carcinoma of the mobile tongue (i.e., 
the anterior two-thirds of the tongue) 
were retrieved from the files of the 
University Hospitals of Nijmegen and 
Utrecht. This group of 80 patients 
consisted of 46 patients with a 
metastasized and 34 patients with a 
non-metastasized tongue carcinoma. 
The following inclusion criteria were 
[16] R. van Velthoven, Cancer 75, 560 (1995). 
49 (1994). [18] K. D. Kunze, Path.Res.Pract. 
ιοί. 141,797(1992). 
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Table 1: The number of patients (n) in the five different subgroups and the definitions of the 
subgroups. 
Group 
Group I 
Group II-1 
Group II-2 
Group III-l 
Group III-2 
η Definition 
39 
25 
Patients with a tongue carcinoma who underwent a neck dissection simultaneuosly with the 
tesection of the primary tumot, with one ot more lymph node metastases 
As group I, but without lymph node metastases in the neck dissection specimen, and no 
lymph node metastases in at least 24 months follow-up 
2 As group II-1, but these patients developed a metastasis during follow-up 
Patients with a tongue carcinoma without clinical evidence of metastasis, who did not 
undergo a neckdissection, and did not develop metastasis in at least 24 months follow-up 
As group III-l, but these patients developed a metastasis during follow up 
used to select patients for this study: 
1) none of the patients had been 
treated otherwise earlier, and 2) no 
patient had evidence of a second 
primary tumor in the head and neck 
at the time of operation or during 
follow-up. No patient had signs of 
distant metastasis at the time of 
operation. The patients in this study 
were divided into 5 different groups. 
The definitions of these 5 subgroups 
(I, II. 1, II.2, III.l, and III.2) are given 
in table 1. Eight patients in group II. 1 
and one patient in group III.l were 
post-operatively treated with a full 
course of external radiotherapy, 
because of unfavorable growth pattern 
or irradical resection margins. 
Image cytometry 
Three micrometer thick 
formalin-fixed and paraffin-
embedded tissue sections of the 
resection specimens were routinely 
stained with the stoichiometric 
Feulgen procedure. Analysis was 
performed using a VIDASplui' image 
analysis system (Kontron GmbH, 
Eching, Germany). Images were 
recorded by a 3 chip C C D camera 
(DXC-325P, Sony), mounted on top 
of a conventional light microscope 
(Axioscop, Carl Zeiss), using a 40 χ 
objective (numerical aperture=0.75). 
The resulting pixel size was 
a p p r o x i m a t e l y 
0.20 χ 0.20 micrometer. For each 
nucleus the gray level image was 
segmented in two ways: in the gray 
level histogram a threshold value was 
automatically determined between 
the peaks of the background and the 
nucleus, which was then applied to 
the image, and secondly a background 
image, estimated from the original 
image by gray level erosions, was 
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subtracted from the original image 
and a fixed gray level threshold was 
used to identify the nuclear area. One 
or both methods resulted in a binary 
image containing a nuclear mask that 
was used to calculate area and 
circularity. If both methods resulted in 
Table 2 : List of karyometric features used in 
this study. 
runlength 
s re 
Ire 
gfd 
rki 
rpc 
short rumnlenth emphasis 
long runlength emphasis 
gray level distribution 
runlength distribution 
run percentage 
co-occurency 
homog 
contr 
icontr 
entrop 
mxtrp 
dmoml 
trisy 
corre 
Young et al. 
marg 
hetero 
dump 
cond 
nuclear 
morphology 
arca 
cire 
homogeneity 
contrast 
inverse contrast 
entropy 
maximum transition probability 
first diagonal moment 
triangular symmetry 
correlation 
margi nation 
heteroheneity 
dumpiness 
condensation 
2D-area 
circularity 
a mask fulfilling criteria concerning 
smoothness of contour and area, the 
mask with the smoothest contour was 
selected. Images were further 
processed using a Vax-station 3200 
(Digital) to calculate the 19 
karyometric features. Of each nucleus 
2 geometric parameters and 17 
chromatin pattern features, i.e. 5 
runlength features, 8 co-occurrency 
features and 4 Young et al. features 
were calculated8;9;20:21. A list of these 
19 karyometric features is given in 
table 2. 
Tissue sampling and cell selection 
For each patient a section 
through the largest part of the 
primary tumor was selected and 
approximately 200 non-overlapping, 
well demarcated, mechanically not 
damaged and non-pyknotic 
interphase nuclei from tumor cells in 
the vicinity of the tumor-stroma 
borders in different and randomly 
chosen areas of the tumor were 
selected by an experienced, cytology-
trained technician, thus sampling the 
tumor without preference for a certain 
domain. In addition, approximately 
200 tumor cell nuclei, selected in the 
same way, were measured in tumor 
18] A. E. Dawson, Anal.Quant.Cytol.Histol. 15, 227 (1993). [9] I. T. Young, Cytometry 7, 
467 (1986). [20] M. M. Galloway, Comput.Graph.Image Processing 4, 172 (1975). [21] N. 
J. Pressman, J.Histochem.Cytochem. 24, 138 (1976). 
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positive lymph nodes of 31 group I 
patients, as well as approximately 200 
nuclei of histomorphologically 
normal tongue epithelium that was 
present in the resection specimen of 
21 group I patients. All karyometric 
measurements in this study were 
performed with the same resolution 
and magnification. The mean values 
and standard deviations (SD) of these 
features were used to assess the group 
differences between the metastasized 
and non-metastasized primary 
tumors, the metastasized primary 
tumors and their lymph node 
metastases, and tissue from 
metastasized tumors versus normal 
tongue epithelium. 
Statistics 
Univariate statistics 
In order to eliminate possible 
tumor size effects on the group means 
of the karyometric features, an 
analysis of covariance, with the 
clinically determined tumor size as 
covariate, was used to analyze the 
differences between the metastasized 
and non-metastasized primary 
tumors. The differences between the 
metastasized primary tumors and 
their lymph node metastases, as well 
as the differences between the 
metastasized primary tumors and 
adjacent normal epithelium (both 
paired observations) were analyzed by 
means of a two-factorial analysis of 
variance. Correlation analysis was 
used to assess the interrelations of 
karyometric features, and to analyze 
the relation between the karyometric 
features and the clinical tumor size 
(cT). 
Multivariate statistics 
A forward likelihood-ratio 
stepwise logistic regression analysis 
was performed on the mean values 
and SD of the karyometric features 
obtained from the learning set of the 
39 patients with a metastasized 
primary tumor (group I) and 34 
patients with a non-metastasized 
tumor (groups II. 1 and III.l) in order 
to select the best subset of karyometric 
features to discriminate between these 
two groups of patients. Based on the 
results of univariate analysis and the 
stepwise logistic regression analysis, a 
final feature selection was made for 
the construction of a discriminant 
function (DF), which is a linear 
combination of the ultimately 
selected, non-correlating karyometric 
features (KF). To avoid numerical 
instability due to overfitting, a 
maximum of three features was 
allowed in the logistic regression 
model. The posterior probability 
(corrected for unequal sample size) 
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that a primary tumor is metastasized, 
given the value of DF and assuming 
equal prior probabilities for the 
metastasized and non-metastasized 
tumors, is given by: 
P(meta|DF) = eDh/(l + eDF), with 
DF = B
n
+ZB x K F . 
0 ι ι 
The regression coefficients B0 
and their standard errors (SE) can be 
estimated with a logistic regression 
analysis by solving P(meta|DF) = 0.5, 
which results in the best compromise 
between false positive and false 
negative classifications. A primary 
tumor is classified as a metastasized 
tumor if P(meta|DF) > 0.5 and as a 
non-metastasized tumor if 
P(meta|DF) < 0.5. In terms of DF, a 
primary tumor is classified as a 
metastasized tumor if DF > 0, and as 
non-metastasized if DF < 0. 
The karyometric data of the 
learning set were used to construct the 
discriminant function that was 
subsequently used to classify the 
patients of that learning set. This 
procedure may give classification 
results that are optimistically biased. 
To reduce this bias, the 'leave-one-out' 
cross validation procedure was used in 
the logistic regression analysis. The 
classification results obtained with the 
'leave-one-out'-procedure will be 
further referred to as 'cross-validated'. 
A test set of seven metastasized tumors 
(groups II.2 and III.2), not included 
in the logistic regression analysis, was 
used for further validation of the 
classification results. Logistic 
regression analysis was also performed 
to obtain a classifier to discriminate 
between primary tumors and normal 
epithelium. All statistical analyses 
were performed with SPSS 6.0 for 
Windows 3.11. 
Results 
Normal epithelium versus 
primary tumors 
The two-factorial analysis of 
variance of karyometric features of 
normal epithelium and primary 
tumors disclosed highly significant 
differences between these groups for 
numerous features and standard 
deviations of these features (table 3). 
The mean nuclear size (AREA) and 
the variation in nuclear size 
(SD AREA) are significantly greater 
in the tumors than in normal 
epithelium (p<0.001). In normal 
epithelium the nuclei are more 
spherical (CIRC) than in the primary 
tumors (p<0.001), whereas tumors 
exhibit more variation in nuclear 
shape (SD CIRC, p=0.001). In 
chromatin pattern, there are also 
highly significant differences 
(p<0.001) between normal 
epithelium and tumor tissue (table 3). 
Some of the karyometric features 
(continued page 46) 
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Table 3: Mean values and standard deviations for all karyometric features in metastasized and 
non-metastasized primary tumors, lymph node metastases and normal tongue epithelium and 
the p-values of the statistical analyses. 
parameter 
area 
SD area 
circ 
SD circ 
marg 
SD marg 
epithelium 
mean ± SD 
1331 ±310 
283 ± 69 
0.854 ± 0.022 
0.048 t 0.010 
0.370 t 0.028 
0.042 ± 0.013 
hetero 0.540 ± 0.085 
SD hetero 
clump 
SD clump 
cond 
SD cond 
sre 
SDsre 
Ire 
SD Ire 
gld 
SDgld 
rid 
SD rid 
rpc 
SDrpc 
homog 
SD homog 
com 
SD contr 
icontr 
SD iœntr 
entrop 
SD entrop 
corre 
SD ecorre 
mxtrp 
SD mxtrp 
dmom 
SD dmom 
trysi 
SD trysi 
0.106 ±0.013 
0.947 l 0.022 
0.031 ± 0.008 
0.504 ± 0.069 
0.097 ± 0.012 
0.676 t 0.017 
0.039 t 0.009 
6.648 ± 0.753 
1.525 ±0.325 
0.136 ±0.001 
0.003 1 0.000 
0.426 ι 0.021 
0.046 t 0.010 
0.528 t 0.022 
0.043 ± 0.009 
0.048 t 0.003 
0.006 t 0.001 
1.129 ±0.146 
0.291 ± 0.059 
0.702 ± 0.016 
0.034 ± 0.007 
1.443 ± 0.022 
0.044 ± 0.007 
0.893 l 0.015 
0.028 ± 0.006 
0.116 ±0.010 
0.025 ι 0.004 
3.403 l 0.213 
0.455 ± 0.065 
0.107 t 0.025 
0.062 t 0.014 
non-metastasized metastasized 
mean ± SD 
1844 ± 506 
523 ± 186 
0.834 ± 0.024 
0.057 ± 0.010 
0.337 ± 0.022 
0.039 ± 0.009 
0.585 l 0.081 
0.098 ± 0.022 
0.930 ± 0.030 
0.033 ι 0.008 
0.540 ± 0.064 
0.087 t 0.019 
0.673 t 0.018 
0.038 ± 0.007 
6.580 t 0.812 
1.485 ± 0.354 
0.136 ± 0.001 
0.003 l 0.001 
0.422 ± 0.021 
0.043 ι 0.007 
0.528 t 0.023 
0.042 ι 0.006 
0.046 t 0.002 
0.005 ± 0.001 
1.060 ± 0.138 
0.250 ± 0.043 
0.703 l 0.018 
0.033 l 0,004 
1.444 ± 0.021 
0.041 ι 0.005 
0.899 ± 0.013 
0.024 ± 0.004 
0.106 ±0.006 
0.016 ι 0.004 
3.342 ι 0.208 
0.416 ± 0.053 
0.114 ±0.024 
0.046 ± 0.012 
mean ± S D 
2024 ± 416 
580 ι 161 
0.823 ± 0.023 
0.058 ± 0.010 
0.331 ± 0.022 
0.040 ι 0.008 
0.636 ± 0.058 
0.080 t 0.015 
0.915 ± 0.022 
0.032 ± 0.005 
0.580 t 0.043 
0.070 ± 0.014 
0.680 ±0.015 
0.036 ± 0.007 
6.383 ± 0.596 
1.369 t 0.239 
0.136 ±0.001 
0.003 t 0.000 
0.431 ± 0.018 
0.042 ± 0.006 
0.535 ± 0.018 
0.040 ι 0.005 
0.046 ι 0.002 
0.004 t 0.001 
1.074 ± 0.092 
0.241 ± 0.034 
0.697 ± 0.014 
0.032 ± 0.004 
1.450 ± 0.016 
0.039 ± 0.005 
0.899 ± 0.009 
0.023 ± 0.003 
0.106 ±0.006 
0.014 ± 0.003 
3.378 ± 0.144 
0.397 ± 0.048 
0.107 ι 0.018 
0.042 t 0.009 
lymph node 
mean ± S D 
1898 ± 508 
516± 175 
0.829 ± 0.025 
0.057 ± 0.010 
0.342 t 0.025 
0.041 ± 0.009 
0.635 ± 0.063 
0.081 ± 0.017 
0.917 ±0.019 
0.031 ± 0.005 
0.580 ± 0.052 
0.072 ι 0.015 
0.689 ± 0.017 
0.035 t 0.006 
6.363 ± 0.731 
1.383 ±0.218 
0.136 ι 0.001 
0.003 ± 0.000 
0.435 ± 0.021 
0.043 t 0.006 
0.537 ± 0.022 
0.041 ± 0.004 
0.046 ± 0.002 
0.004 ± 0.000 
1.086 ±0.121 
0.247 l 0.041 
0.696 t 0.017 
0.032 ± 0.003 
1.451 ±0.019 
0.040 ± 0.004 
0.897 l 0.012 
0.024 ι 0.004 
0.105 ± 0.006 
0.014 ± 0.003 
3.382 ± 0.176 
0.407 l 0.050 
0.113 ±0.022 
0.044 t 0.008 
pi 
0.118 
0.225 
0.027 
0.426 
0.067 
0.712 
0.014 
<0.001 
0.062 
0.188 
0.011 
<0.001 
0.169 
0.444 
0.279 
0.120 
0.618 
0.010 
0.185 
0.548 
0.314 
0.263 
0.165 
0.026 
0.884 
0.312 
0.336 
0.321 
0.318 
0.169 
0.890 
0.264 
0.286 
0.034 
0.569 
0.234 
0.277 
0.283 
P2 
0.884 
0.897 
0.378 
0.629 
0.072 
0.087 
0.287 
0.497 
0.396 
0.099 
0.274 
0.739 
0.185 
0.264 
0.989 
0.921 
0.029 
0.008 
0.194 
0.478 
0.554 
0.812 
0.706 
0.030 
0.408 
0.863 
0.441 
0.895 
0.664 
0.681 
0.553 
0.855 
0.016 
0.049 
0.518 
0.510 
0.648 
0.157 
P3 
0.330 
0.314 
0.290 
0.826 
0.049 
0.922 
0.995 
0.939 
0.805 
0.905 
0.920 
0.571 
0.309 
0.853 
0.698 
0.954 
0.905 
0.040 
0.291 
0.589 
0.519 
0.619 
0.364 
0.881 
0.452 
0.347 
0.720 
0.468 
0.541 
0.404 
0.390 
0.291 
0.223 
0.514 
0.723 
0.442 
0.231 
0.337 
p4 
<0.001 
<0.001 
<0.001 
0.001 
<0.001 
0.915 
0.001 
<0.001 
<0.001 
0.977 
0.001 
<0.001 
0.126 
0.096 
0.101 
0.043 
0.709 
0.001 
0.161 
0.133 
0.139 
0.248 
0.004 
<0.001 
0.228 
0.007 
0.201 
0.295 
0.166 
0.033 
0.238 
0.010 
<0.001 
<0.001 
0.761 
0.005 
<0.001 
<0.001 
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Previous page: *: Area is given in pixels. p l= two tailed p-value for the difference between the 
group of metastasized tumors and the group of non-metastasized tumors, obtained from an 
analysis of covariance. p2= significance level of'clinical T-size' dependency, obtained from the 
analysis of covariance. p3= two-tailed p-value for the difference between the group of metastasized 
tumors and their lymph node metastases, obtained from a two-factorial analysis of variance. 
p4= two-tailed p-value for the difference between normal epithelium and tumor tissue from 
patients with a metastasized carcinoma, obtained from a two-factorial analysis of variance. 
(AREA, SD AREA, CIRC, 
SD CIRC, COND, and SD COND) 
are graphically represented for normal 
epithelium, primary tumors of 
metastasized and non-metastasized 
tongue carcinomas, and lymph nodes 
metastases (figures la-lf)· The CIRC 
(=4Karea/perimeter2) is a shape-
related parameter, which value equals 
1 for a perfect circle and gives lower 
values when the nucleus deviates from 
a circle. SD CIRC is a karyometric 
feature that represents the intra-tumor 
variation of CIRC, and is thus a 
measure for nuclear polymorphism 
within a tumor. C O N D reflects the 
fraction of large chromatin granules in 
the nucleus with respect to the total 
nuclear AREA9; SD C O N D is a 
measure for the intra-tumor variation 
of that fraction. 
The non-correlating karyometric 
features SD AREA and SD MXTRP 
(r=0.34, p=0.13) were selected as the 
most discriminating features by the 
forward stepwise logistic regression 
(continuedpage 48) 
Table 4: Non-cross validated and cross validated classification results using 'leave-one-out' procedure 
for normal epithelium and primary tongue carcinoma, of a bivariate discriminant function (DF). 
actual 
epithelium 
tumor 
predicted 
non-cross-validated 
epithelium 
21(100%) 
1(4.8%) 
tumor 
0(0%) 
20(95.2%) 
predicted 
cross-validated 
epithelium 
20(95.2%) 
1(4.8%) 
tumor 
1(4.8%) 
20(95.2%) 
[9] I. Τ Young, Cytometry 7, 467 (1986). 
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Figure 1: Error plots of six karyometric features selected from 38 features used in his study. 
The mean values ± 2x standard error of mean for area (la), SD area (lb), circ (le), SD circ (Id), cond (le), 
SD cond (lf)> are given for normal epithelium, primary tumors of non-metastasized carcinomas (PT non metast), 
primary carcinoma of metastasized carcinomas (PT metast), and metastatic tumor in lymph nodes. 
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Table 5: The logistic regression coefficients (B^, 
their estimated values and standard errors (SE), 
the absolute value of the value/SE ratios and 
their significance level (p) of the bivariate discriminant 
function (DF), to discriminate between metastasized 
and non-metastasized tongue carcinomas. The 
d i s c r i m i n a n t f u n c t i o n is g iven by: 
DF = B0 + Β, χ CIRC + B2 χ SD C O N D . 
parameter Bi value SE value/SE ρ 
cire Β, -13.384712.4378 1.076 0.2819 
SD cond B2 -60.8866 18.7582 3.246 0.0012 
constant B„ 15.9463 10.2779 1.550 0.1208 
analysis. A discriminant function 
based on these two karyometric 
features was able to discriminate 
almost perfectly between normal 
epithelium and tumor. Using this 
classifier, all cases of normal 
epithelium were correctly classified, 
whereas 20/21 tumors were correctly 
classified after cross validation (table 
4). 
Non-metastasized tumors 
versus metastasized tumors 
In an analysis of covariance, with 
the clinical tumor size as a covariate, 
statistically significant differences 
were found between the groups of 
metastasized and non-metastasized 
tumors (table 3). At the p=0.05 
significance-level, differences between 
both groups were found for 8 
karyometric features, namely CIRC, 
HETERO, SD HETERO, COND, 
SD C O N D , SD GLD, SD 
H O M O G and SD MXTRP. The 
most significant differences between 
these groups of patients were found 
for SD HETERO and SD C O N D 
(p<0.001)) but these two features 
appeared to be highly correlated 
^=0.97, p<0.001). Almost all of the 
parameters are independent of the 
clinical tumor size (table 3). 
In the group of metastasized 
tumors, the nuclei appeared to be less 
spherical and more chromatin is 
condensed than in the group of non-
Table 6: Non-cross-validated and cross-validated classification results of the DF as defined in 
table 5. 
predicted 
non-cross-validated 
predicted 
cross-validated 
actual non-metastasized metastasized non-metastasized metastasized 
non-metastasized 21(61.8%) 13(38.2%) 21(61.8%) 13(38.2%) 
metastasized 9(23.1%) 30(76.9%) 11(28.2%) 28(71.8%) 
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Figure 2: A gallery of Feulgen-stained nuclei of eight tumor cells. 
I » I mm' 
Two nuclei with values for AREA, CIRC, and C O N D approximately equal to the mean values 
of these features in the group of metastasized tumors (fig.2a-2b). The values of AREA, CIRC 
and COND are 1997, 0.819, and 0.585 for the nucleus in fig^a, and 1963, 0.818 and 0.575, 
respectively for the nucleus in fig. 2b. Two nuclei of the same size (AREA=1947, and 1953) 
and roundness (CIRC=0.760 and 0.759), but differing considerably in the relative amount of 
condensed chromatin per nucleus (COND=0.468 and 0.716, respectively) are given in fig. 2c 
and 2d. In fig. 2d there is relatively more condensed chromatin (=heterochromatin) in the nucleoplasm 
and beneath the nuclear membrane than in fig. 2c. Two nuclei with values for AREA, CIRC, 
and COND approximately equal to the mean values of these features in the group of non-metastasized 
tumors (fig.2e-2f). For the nuclei in fig. 2e and 2f the values for AREA, CIRC, and C O N D 
are 1822,0.830 and 0.540, and 1866, 0.833 and 0.534, respectively.Two nuclei with small values 
for CIRC (0.682 and 0.694) and high values for C O N D (0.633 and 0.673), representing a 
'highly metastatic phenotype', obtained from a primary tumor of a patient with a metastasized 
tongue carcinoma are given in fig. 2g and 2h. The posterior probability to have a metastasized 
tumor as determined by our bivariate classifier for this patient was P=0.83. (microphotographs 
courtesy of V.M.J.I Cuypers and J.A.WM. van der Laak) 
metastasized tumors (fig. 1c and le). 
In the group of metastasized tumors, 
smaller variations in chromatin 
condensation between the tumor cells 
than in the group of non-metastasized 
tumors were found (fig. If)· In fig· 2a 
and 2b two nuclei are shown whose 
values for AREA, CIRC and COND 
are approximately equal to the mean 
values of these features in the group of 
metastasized tumors (AREA=2024, 
CIRC=0.823 and COND=0.580). 
Two nuclei with approximately the 
same values for AREA and CIRC, but 
with COND=0.468 (fig. 2c) and 
COND=0.716 (fig. 2d) are given to 
demonstrate the visual difference 
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between a tumor cell with a small 
fraction of condensed chromatin and 
a high fraction of condensed 
chromatin. Fig. 2e and 2f show two 
nuclei with values for AREA, CIRC 
and COND approximately equal to 
the mean values of these features in 
the group of non-metastasized tumors 
(AREA=1844) CIRC=0.834) 
COND=0.540). Comparison of fig. 
2a and 2b with fig. 2e and 2f discloses 
that there are minor, but visible 
differences between the 'mean-
phenotype nucleus' in metastasized 
and non-metastasized tumors. 
The non-correlating karyometric 
features CIRC and SD COND 
^=0.15, p=0.l4) were selected by the 
stepwise logistic regression analysis as 
the most discriminating features to 
classify primary tongue carcinomas as 
metastasized or non-metastasized 
tumors (fig. 1c and f). The 
coefficients of the bivariate 
karyometric classifier DF are given in 
table 5. In the training set 30 of 39 
metastasized tumors (77%) and 21 of 
the 34 non-metastasized tumors 
(62%) were correctly classified (table 
6). The overall percentage of correctly 
classified cases in the training set was 
7 1 % . In order to show the nuclear 
morphology of tumor cells with a 
high metastatic capacity, two nuclei 
with small values for CIRC and high 
values for COND of a patient with a 
metastasized tongue carcinoma and a 
high posterior probability to have a 
metastasized tumor (P=0.83) are 
given in fig. 2g and 2h. 
The 'leave-one-out' cross 
validation procedure revealed that 
these classification results were 
somewhat optimistically biased (table 
6). In the metastasized and non-
metastasized tumors, respective 
percentages of 72% and 62% of 
correctly classified cases are likely to 
be more realistic. The cross-validated 
overall percentage of correctly 
classified cases is 68%. The non-cross-
validated classification results of the 
bivariate karyometric classifier for all 
patients in this study in relation to the 
clinically determined tumor stage are 
given in table 7. In the test set of seven 
patients who developed a lymph node 
metastasis during follow-up (groups 
II.2 and III.2), the bivariate 
karyometric classifier predicted a 
metastasis in five of the seven cases 
(71%, table 7). This percentage of 
correctly classified cases in the test set 
corresponds very well with the cross-
validated classification results in the 
group metastasized tongue 
carcinomas of the training set (72%). 
Of particular interest is the fact that in 
the 5 small (T^ primary metastasized 
tumors in the training (n=2) and test 
set (n=3), the presence or the 
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occurrence of a metastasis was 
correctly predicted in 4 cases (80%), 
whereas all three large (T3-T4) non-
metastasized tumors from the training 
set were correctly classified as non-
metastasized by the bivariate 
karyometric discriminant function 
(table 7). 
Using the tumor stage (T) as a 
predictor for the occurrence of a 
metastasis with T>T1 as threshold 
value for a metastasis, 41/46 (89.1%) 
were correctly classified as 
metastasized and 13/34 (38.2%) as 
non-metastasized tumors. The overall 
percentage of correctly classified cases 
is 67.5%. Using T>T2 as threshold 
value for the prediction of metastasis, 
13/46 (28.3%) were correctly 
classified as metastasized and 31/34 
(91.2%) as non-metastasized tumors, 
with an overall percentage of correct 
classification of 55% (table 7). Tumor 
stage as a predictor for the presence of 
metastases resulted in considerably 
less balanced classification results. 
Metastasized tumors versus 
their lymph node metastases 
The two factorial analysis of 
variance disclosed weakly significant 
differences between the lymph node 
metastases and their primary tumors 
for only two chromatin pattern 
features, namely MARG and SD 
GLD (table 3). 
Discussion 
Nuclear polymorphism, 
referring to variations in nuclear size 
and shape, and hyperchromatism due 
to an increased DNA content and 
chromatin condensation in the 
interphase nucleus, are widely used 
criteria to recognize dysplastic and 
neoplastic changes of mucosal 
epithelium. In the present study the 
diagnostic relevance of these nuclear 
alterations was substantiated and 
quantitated. It proved possible to 
discriminate between tumors and 
normal epithelium by means of a 
Table 7: Classification results of the karyometric 
classifier, for all patients in this study in relation 
to clinically determined tumor stage. The number 
of correcdy classified cases in each of the categories 
is given in parentheses. 
tumor T, T2 T3 T4 T M 
non-metastasized 13(10) 18(8) 2(2) 1(1) 34(21) 
metastasized 2(2) 26(19)11(9)0(0) 39(30) 
test set 3(2) 2(2) 2(1) 0(0) 7(5) 
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discriminant function based on only 
two karyometric features, in 95% of 
the cases. These results are in 
concordance with those of many 
other studies10·13·22-23. 
To the best of our knowledge, 
this is the first study to show that 
differences in metastatic behavior of 
squamous cell carcinomas of the 
tongue are associated with highly 
significant differences in nuclear 
morphology and that these differences 
are independent of tumor size. In the 
group of metastasized tumors the 
nuclei are significantly less spherical 
than in the group of non-metastasized 
tumors (p=0.03). In the primary 
tumors of metastasized tongue 
carcinomas the individual tumor cells 
have significantly more condensed 
chromatin defined in terms of the 
texture feature COND, and in terms 
of the texture feature HETERO the 
chromatin of the individual tumour 
cells of the metastasized tumours is 
more heterogeneously distributed 
than in the non-metastasized tumors 
(p=0.01). However, the variations in 
both the amount of condensed 
chromatin and chromatin 
heterogeneity between the individual 
tumor cells defined by SD COND 
and SD HETERO (=intra-tumor 
variations) are significantly smaller in 
the metastasized than in the non-
metastasized tongue carcinomas 
(p<0.001). An association between 
biological behavior of tumors and 
chromatin texture was also reported 
for bladder tumors26. In this study, it 
was shown that the chromatin pattern 
of superficial bladder tumors is 
markedly different from that of 
invasive tumors, which exhibit a 
considerably more dense and 
heterogeneous chromatin pattern. 
Furthermore, an increasing level of 
malignancy was shown to be 
accompanied by an increase in the 
overall chromatin condensation 
level26. The latter observation is in 
agreement with our finding that more 
condensed and more heterogeneously 
dispersed chromatin is present in the 
group of metastasized tongue 
carcinomas than in the group of non-
metastasized tongue carcinomas. A 
possible explanation for the 
association between biological 
behavior of tumors and chromatin 
texture is the reported inverse 
[10] M. Bibbo, Cancer Res. 50, 147 (1990).[13] I. Salmon, Anal.Quant.Cytol.Histol. 14, 47 
(1992). [22] J. J. Berman, Cancer Lett. 77, 103 (1994). [23] F. Collin, Hum.Pathol. 22, 191 
(1991). [24] M. G. Fleming, Am.J.Dermatopathol. 15,106 (1993). [25] M. Petein, Am.J.Clin.Pathol. 
96, 628 (1991). [26] R. van Velthoven, J.Pathol. 173, 235 (1994). 
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correlation between chromatin 
pattern and the fractional allelic loss, 
which is a global measure of genetic 
change19. In the latter study on 
colorectal tumors, it was concluded 
that both nuclear morphology and 
biological behavior appeared to be 
influenced by accumulated alterations 
in cancer associated genes. 
In our study is shown that the 
posterior probability that a tongue 
carcinoma has been metastasized is 
mainly determined by the intra-
tumor variation in the fraction of 
condensed chromatin (SD COND). 
Our bivariate classifier based on two 
karyometric features (CIRC and SD 
COND) resulted in 72% correctly 
classified cases in the group of 
metastasized tumors and in 62% 
correct classifications in the group of 
non-metastasized tumors. The overall 
percentage of correctly classified cases 
of 68% corresponds very well with 
that of 72% obtained by a 
karyometric classifier to predict the 
occurrence of lymph node metastases 
in breast cancer18. Of special clinical 
interest is that all three non-
metastasized TT and T. tumors were 
3 4 
correctly predicted by our bivariate 
classifier, whereas 4 out of 5 
metastasized Τ tumors were correctly 
classified. After validation on biopsy 
material from a larger series of 
patients, this finding may prove of 
clinical relevance, because in patients 
with a T 3 or T 4 tongue carcinoma with 
an enlarged cervical lymph node, but 
without evidence of malignancy on 
ultrasound-guided fine needle 
aspiration biopsy, a neck dissection 
can possibly be left undone if the 
tumor has low-risk to be metastasized, 
based on karyometric findings. In 
spite of the good classification results 
of approximately 80% in small (T^ 
and large (T and T^) tumors, our 
bivariate classifier has its limitations 
(32% overall misclassifications) due to 
37% misclassifications in the group of 
T 2 tumors (table 7). 
This study has shown that the 
clinically estimated tumor size (T) is 
not an alternative for a more reliable 
prediction of the occurrence of lymph 
node metastases in patients with a 
tongue carcinoma. Addition of 
microvessel density, as measured by 
the 'hot-spot'-procedure27 to our 
bivariate karyometric logistic 
regression model is unlikely to 
[18] K. D. Kunze, Path.Res.Pract. 185, 689 (1989). [19] J. W. Mulder, Am.J.Pathol. 141, 797 
(1992). [27] N. Weidner, Semin.Diagn.Pathol. 10, 302 (1993). 
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produce a more reliable multivariate 
classifier, since in a recent study on 
squamous cell carcinomas of the 
tongue no difference in microvessel 
density was found between 
metastasized and non-metastasized 
tumors28. These results are in 
agreement with our own unpublished 
observations. Nor is it likely that 
inserting features based on biomarkers 
p53, bcl-2 and Ki-67 into our model 
will give a substantial improvement of 
the classification results, because no 
differences between metastasized and 
non-metastasized squamous cell 
carcinomas of the larynx were 
established with regard to these 
biomarkers29. 
Comparison of primary tumors 
with their lymph node metastases 
revealed only weakly significant 
differences in only two chromatin 
texture features. These findings 
suggest that there are very few 
phenotypic differences between the 
nuclei of primary tumors and their 
metastases. As allelic loss has been 
associated with changes in chromatin 
texture, it is highly probable that the 
genotypic differences between 
squamous cell carcinomas of the 
tongue are also small. Further support 
for this assumption is provided in a 
recent study on squamous cell 
carcinomas of the larynx30. In this 
study, it was shown that lymph node 
metastases of laryngeal carcinomas, 
like distant metastases from colorectal 
carcinomas, share most of the allelic 
losses of their primary tumors, but 
differ from them in a limited number 
of loci. Other studies on breast and 
bladder cancer showed complete 
concordance between allelic losses in 
the primary tumors and their 
metastases,1",1. 
On the basis of the association 
between chromatin texture and the 
occurrence of lymph node metastases, 
disclosed in this study on tongue 
carcinomas and the reported 
association between chromatin 
texture and fractional allelic loss, it 
seems worthwhile to look for 
metastasis associated genetic 
alterations in order to obtain 
alternative or additional features for a 
more reliable prediction of the 
[28]D.A.LeBdy, Otolaryngol Had NediSuigll 1,417(1994). [29] M.ESpafeid,AidLOtDlaiyngDLHeadNedi 
Surg. 122, 627 (1996). [30] P. C. Sun, Genes Chromosom Cancer 145 (1995). [31] B. A. Bonsing, 
Cancer Res. 53, 3804 (1993). [32] L. C. Chen, J.Natl.Cancer Inst. 84, 506 (1992). [33] N. 
Miyao, Cancer Res. 53, 4066 (1993). 
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occurrence of metastases for the individual patient with a tongue carcinoma. 
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Abstract 
Cancer develops from accumulation of genetic damage. Tumors of different 
metastatic behavior possibly differ in genomic constitution, since this is the 
thought to be the motor behind metastatic phenotype. 
We studied chromosomal copy number changes in 9 metastasized and 7 
non-metastasized squamous cell carcinomas of the tongue by comparative 
genomic hybridization. Non-metastasized was defined by the absence of regional 
or distant metastases at the time of diagnosis to at least 24 month follow up. All 
metastases were pathologically proven. 
Metastasized tumors showed more aberrations, and did so more frequently. 
Most frequent changes were gains on chromosome 8q and 3q, both for 
metastasized and non-metastasized tumors. Third most affected in metastasized 
tumors was gain on 7q, where MET proto-oncogene is located, recently shown 
associated with metastasis in HNSCC. Significant differences were found for the 
number of gains and losses combined between the groups of metastasized versus 
non-metastasized tumors (p=0.04, Mann-Whitney-U-test). 
These results support the carcinogenesis progression model, whereby 
accumulation of genetic damage is associated with progressive disease. 
Chromosome 7q may harbor gene(s) that play a role in metastasis. 
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Introduction 
Malignant transformation is 
generally believed to be associated 
with accumulation of genetic 
alterations.1 For some tumor types 
genetic progression models have been 
established, and genes that potentially 
play a crucial role have been identified 
by cytogenetic and molecular genetic 
studies.2·' For head and neck 
squamous cell carcinoma (HNSCC) 
such models have recently been 
proposed, identifying genetic 
alterations associated with progression 
from dysplasia into invasive 
phenotype at 10 major chromosomal 
loci.4"6 Also, the relation between 
genetic variances in HNSCC of 
different clinical outcome has been 
studied7, as well as genetic differences 
between metastasizing and non-
metastasizing HNSCC8·9 
Assays used are either detailed 
molecular or genetic techniques with 
a selection of probes, aimed at 
chromosomal regions of potential 
interest,410 19 or aimed at global 
representations of genomic 
differences, such as DNA content20,21, 
karyotyping22, and comparative 
genomic hybridization (CGH)2 '24 in 
HNSCC.5·2"1 
Tumors in most HNSCC studies 
originate from different sites, possibly 
diluting characteristics of sites with 
high propensity for metastasis with 
sites known to metastasize seldom. In 
a previous DNA image cytometry 
[1]A. E. Bale, In: Cancer: Principles and Practice of Oncology (1997). [2]E. R. Fearon, Cell 
61,759 (1990). [3]G. Dalbagni, Lancet 342, 469 (1993). [4]J. Califano, Cancer Res. 56, 2488 
(1996). [5]U. Bockmiihl, Cancer Res. 56, 5325. (1996). [6]J. M. Cowan, J.Nati.Cancer Inst. 
84, 793 (1992). [7]U. Bockmiihl, Head Neck 20, 145 (1998). [8]U. Bockmiihl, Cancer Res. 
57,5213 (1997). [9]M. Kujawski, Cancer Genet.Cytogenet. 114,31 (1999). [10]X. Li, J.Nad.Cancer 
Inst. 86, 1524 (1994). [11]T. Callender, Cancer 74, 152 (1994). [12]J. A. Brennan, Cancer 
Metastasis Rev. 15, 3 (1996). [13]A. K. el Naggar, Cancer Res. 55, 2656 (1995). [14]D. L. 
Van Dyke, Genes Chromosomes.Cancer 9, 192 (1994). [15]J. K. Field, Br.J.Cancer 72, 1180 
(1995). [16]A. I. Soder, Cancer Res. 55, 5030 (1995). [17]A. K. el Naggar, Am.J.Pathol. 148, 
2067 (1996). [18]H. Nawroz, Cancer Res. 54, 1152 (1994). [19]J. K. Field, Anticancer Res. 
16, 2421 (1996). [20]D. L. Burgio, Arch.Otolaryngol.Head Neck Surg. 118,185 (1992). [21]A. 
K. el Naggar, Am.J.Clin.Pathol. 105, 102 (1996). [22]T. E. Carey, Anticancer Res. 13, 2561 
(1993). [23]J. Houldsworth, Am.J.Pathol. 145, 1253 (1994). [24]A. Kallioniemi, SCIENCE 
258, 818 (1992). [25]E. Gebhart, Int.J.OncoI. 12, 1151 (1998). [26]P. M. Brzoska, Cancer 
Res. 55, 3055 (1995). [27]M. R. Speicher, Cancer Res. 55, 1010 (1995). [28]Y. J. Chen, Genes 
Chromosomes.Cancer 25, 169 (1999). [29]E. Wolff, Oral Oncol. 34, 186 (1998). [30]M. A. 
Hermsen, Oral Oncol. 33, 414 (1997). [31]N. D. Stafford, Arch.Otolaryngol.Head Neck Surg. 
125, 1341 (1999). 
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study, we found indirect evidence that 
genetic changes play a role in 
switching to metastasizing phenotype 
in HNSCC because chromatin 
texture features between metastasizing 
and non-metastasizing tongue 
carcinomas differed significantly.32 It 
was shown that the chromatin 
condensation and the roundness of 
the nuclei showed good correlation 
with metastasis. Although these 
nucleomorphometric features are 
under the influence of complex 
cellular mechanisms, it is conceivable 
that the identified diversity is a 
reflection of the cell genomic 
constitution, related to metastatic 
behavior. To further investigate such 
differences, we studied chromosomal 
copy number changes between a 
group of 9 metastasized and 7 non-
metastasized tongue carcinomas using 
CGH. Chromosome regions that are 
over- or underrepresented in 
metastasized tumors may harbor 
genes, useful for metastasis prediction. 
[32]E. J. Hannen, J.Pathol. 185, 175 (1998). 
Material and Methods 
Tumor samples 
Tumor specimens were obtained 
from archival surgical resections of 
primary invasive carcinomas of the 
tongue. The presence or absence of 
any regional or distant metastasis 
from time of incidence to at least 24 
months post operatively, determined 
metastasizing phenotype. All 
metastases were pathologically 
proven. Patients that had received 
adjuvant treatment that would 
possibly mask occult metastasis such 
as radiation to the neck or 
chemotherapy were excluded. This 
resulted in a group of 9 metastasized 
and 7 non-metastasized tumors. 
CGH 
Tumor DNA was extracted from 
14 paraffin embedded and from 2 
frozen tumor tissue samples, and 
reference DNA from peripheral blood 
lymphocytes from a healthy donor. 
All hybridizations were matched for 
gender. Paraffin embedded tissue (50 
micrometer) was deparaffmized in 
xylene, rehydrated in graded ethanol 
series (100%, 96%, 70%), digested in 
extraction buffer (lOmM Tris, pH 
8.2,2mM ethylenediamine tetraacetic 
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acid, 1% sodium dodecyl sulfate, 
I67mg/ml proteinase), and incubated 
for 6 h at 55 0C. The DNA was 
extracted from this suspension by a 
salting out procedure, as described 
earlier.33 DNA was isolated from 
frozen tissue by direct immersing the 
50 micrometer tissue sections in 
extraction buffer, and incubating for 
1-16 h at 37 0C. Equal amounts of 
tumor and reference DNA were 
differentially labeled by nick 
translation with digoxigenin-dUTP 
and biotin-dUTP, respectively 
(Roche, Mannheim, Germany). 
Fragment length ranged from 200-
2000 base pairs (bp). CGH was 
performed as described by Jeuken et 
al.33 Four hundred to one thousand 
nanograms of each labeled DNA were 
precipitated in the presence of 
50 χ human COT-1-DNA (Gibco 
BRL Life Technologies, Gaithersburg, 
MD, USA) plus a 50 χ excess of 
herring sperm DNA and dissolved in 
hybridization buffer (50% 
formamide, 2 χ SSC, 10% dextran 
sulfate, pH 7.0). The target 
metaphase spreads were pretreated 
with 400 U/ml pepsin (Sigma-
[33]J. W. Jeuken, J.Neuropathol.Exp.Neurol, 
Aldrich Chemie, Zwijndrecht, The 
Netherlands) in 0.01 M HCl for 10 
minutes at 370C, then post-fixed with 
1% formaldehyde (Merck, 
Amsterdam, The Netherlands) in 1 
PBS for 5 minutes. The probe and 
metaphase slides were denatured 
simultaneously for 3 min at 74 0C on 
a hot plate, and hybridized for 48 h at 
370C. Post-hybridization washes were 
in 50% formamide, 2 χ SSC for 3 χ 5 
min at 42 0 C for paraffin-extracted 
DNA, and at 60 oC for frozen tissue 
extracted DNA. 
Immunohistochemical detection of 
biotin was performed by streptavidin-
fluorescein isothiocyanate (FITC, 
Roche, Mannheim, Germany) and 
digoxigenin was detected using sheep-
a n t i d i g o x i g e n i n - t e t r a m e t h y l 
rhodamine isothiocytate (TRITC, 
Boehringer, Mannheim, Germany). 
The chromosomes were 
counterstained with 4,6'-diamino-2-
p h e n y l i n d o l e - d i h y d r o c h l o r i d e 
(DAPI), diluted in 2 χ SCC for 5 min 
at RT, dehydrated, and coverslipped 
with Fluorogard (Bio-Rad, Hercules, 
CA, USA) anti-fading solution. 
58,606(1999). 
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Microscopy and image analysis 
Image acquisition and analysis 
was performed as described by Du 
Manoir et al..14 Digital gray-scale 
images were sequentially captured 
using IPLab software (Sygnal 
Analytics, Arlington, VA, USA) with 
a cooled CCD camera (Quantix/KAF 
1400 camera, Photometries, Tucson, 
AZ, USA) mounted on an 
epifluorescence microscope (Leica 
DMRBE, "Wetzlar, Germany). For 
CGH analysis, Quips software (Vysis, 
Downers Grove, IL, USA) was used. 
Definition of aberration 
For each tumor case an average 
green/red fluorescence ratio profile 
was calculated over the length of each 
chromosome. The number of 
individual chromosomes analyzed per 
case ranged between 11 and 24. The 
average ratio profiles were plotted in 
an ideogram with the standard 
deviation (SD). Losses were defined as 
chromosome regions with an average 
green/red ratio lower than 0.8, i.e., 
exceeded the 0.8 threshold line to the 
left. Gains are defined as chromosome 
regions with an average green/red 
ratio higher than 1.2, i.e., exceeding 
the 1.2 threshold line to the right. 
[34]S. du Manoir, Cytometry 19, 27 (1995). 
High copy number changes were 
defined as chromosome regions where 
the green/red SD interval exceeded 
the 0.8, or 1.2 limit line, respectively. 
Imbalances were only included if 
the SD of mean did not increase 
substantially around the region of 
interest, e.g., at telomeres, in our view 
indicating less trustworthy 
hybridization results. Centromeres 
and heterochromatin regions near the 
centromeres of chromosomes 1, 16, 
and Y were excluded from the CGH 
results. Chromosomes lp and 19 were 
included in the analysis (Jeuken et 
al."). In this overview, no distinction 
between complete and partial 
imbalances on chromosome arms was 
made. 
Statistics 
The number of gains (as 
determined by the number of 
chromosome arms with an increase in 
DNA copy number per patient), and 
the number of losses (as determined 
by the sum of chromosome arms with 
a reduction of DNA copy numbers 
per patient), as well as the number of 
gains and losses, were compared 
between the groups metastasized 
versus non metastasized with the 
Mann-Whitney-U-test. Differences 
(continued page 64) 
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Table 1 : summary of chromosomal imbalances per tumor case. Bold print represents high copy 
number changes. 
tumor case 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
p/F 
Ρ 
Ρ 
Ρ 
Ρ 
f 
f 
Ρ 
Ρ 
Ρ 
Ρ 
Ρ 
Ρ 
Ρ 
Ρ 
Ρ 
Ρ 
imbalances 
+3q; -Xq 
+8q; +3q 
-8p; +8q; +9p; -22q 
t8q 
+5p; +16p; +16q; +20p; +20q 
-lp; +20p; +Xq 
+3q; +8q; +Xq; -17q; -21q 
+ lq; -2q; +3q; +6p; +7q; +8q; 
+ 12p; -15q; +Xp; +Xq 
-9qi 
+ lq; +3q; -8p; +8q; +13q; +Xq 
+Kq 
+ 7 q ; + 8 q ; - 9 q ; + l l q ; - l l q ; + l · 
+17p; +22q 
+3q; -3p; +8p; -15q; +Xq 
iq; 
+5p; +7p; +7q; +8q; +l lq ; +13q; 
+ I4q ; -17p; -21q; -22q; -X 
+2q; +3q; +5p; -5q; +6q; +7q; 
+8q; +12p; -14q; -16p; -16q; -
-20q; +Xq; 
+3q; +8q; -18q 
+8q; -9p; -9q; +14q; +20q; 
-8p; 
18q; 
(non) 
metastasi­
zed 
non 
metastasized 
non 
metastasized 
non 
metastasized 
non 
metastasized 
non 
metastasized 
non 
metastasized 
non 
metastasized 
metastasized 
metastasized 
metastasized 
metastasized 
metastasized 
metastasized 
metastasized 
metastasized 
metastasized 
number 
of gainsb 
1 
: 
2 
1 
5 
2 
3 
X 
5 
1 
6 
3 
7 
« 
2 
3 
number 
of 
losses1" 
1 
0 
2 
0 
0 
1 
2 
3 
1 
0 
2 
2 
4 
7 
1 
2 
number of 
gains+lossesb 
2 
2 
4 
1 
5 
3 
5 
II 
Ê 
1 
X 
5 
11 
is 
3 
5 
r 
f 
πι 
m 
111 
111 
111 
111 
m 
111 
f 
f 
ill 
f 
m 
111 
m 
a
 paraffin or fresh sample material, respectively. h number of chromosome-arms with gains, losses, 
sum of gains and losses, respectively.c gender: f=female, m=male. 
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between metastasized and non 
metastasized tumors for individual 
chromosome arms were tested with a 
Chi-square and a Fisher-exact-test. All 
statistics were performed using 
Statistica 5.5 software (StatSoft, Tulsa, 
OK, USA). 
Results 
Metastasizing tongue carcinomas 
exhibited more chromosomal regions 
with gains and losses than non-
metastasizing, and did so more 
frequently. The total number of gains 
and losses was higher in metastasized 
than in non metastasized tumors. 
Gains were more frequently found 
than losses, both in metastasized and 
non-metastasized tumors (table 1,2). 
Most frequent aberrant chromosome 
arms in non-metastasized tumors 
were gains on 8q (57%) and 3q 
(43%). In metastasized tumors most 
frequent changes were seen on 8q 
(gain, 100%), 3q (gain, 56%), and on 
7q (gain, 44%) (fig. 1). Three or more 
chromosome arms with gains were 
found in 2 of 7 (29%) non-
metastasized tumors and in 7 of 9 
(78%) metastasized tumors (table 1). 
Losses were found in 4 of 7 (57%) 
non metastasized and in 8 of 9 (89%) 
metastasized tumors (table 1). High 
copy number changes were seen for 
gains at 13q and at 5p (table 1, bold 
print). 
Differences between the groups 
of metastasized versus non-
metastasized tumors for gains and loss 
separately, were marginally significant 
in the Mann-Whitney-U-test (table 
2). The number of gains plus losses 
showed a significant difference 
(p=0.04). 
For individual chromosome 
arms, gain on 8q showed a marginally 
significant difference between 
metastasized versus non-metastasized 
Table 2: Differences in chromosomal copy number changes between metastasized and non-metastasized 
SCC of the tongue. P-values from a Mann-Whitney-U-test. 
non 
metastasized 
median 
number of 
gains (range) 
2(1-5) 
metastasized 5(1-8) 
p-value 
r
 0.05 
median number 
of losses (range) 
1(0-2) 
2(0-7) 
0.07 
median number of gains+losses (range) 
3(1-5) 
6(1-15 
0.04 
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tumors (Chi-square p=0.02. Fisher-
exact p=0.06), as did gain on 7q (Chi-
square p=0.04, Fisher-exact p=0.07). 
The only chromosomes without 
imbalances in either group were 
chromosomes 4, 10 and 19. 
Discussion 
To the best of our knowledge, 
our series is the first that is uniformly 
composed of exclusively SCC of the 
tongue, thereby excluding possible 
biases from other HN tumor sites. 
Metastasized tumors showed 
more imbalances for both gains and 
losses than non metastasized tumors. 
Gains and losses combined differed 
significantly between the two groups. 
Strikingly, both in metastasized and in 
non-metastasized tumors, most 
frequent aberrations were identified 
on the same chromosome arms, i.e., 
gains on 8q and 3q. Only 
chromosomes 4, 10 and 19 were 
found to have no imbalances in either 
group. In comparison with the 
available HNSCC literature, we reach 
concordance for gains on 
chromosomes 3q and Sq.5·7-9·27·29·30·« 
Most of these studies used probes to 
specific chromosome regions, and 
report slightly higher percentages of 
tumor cases involved per imbalance. 
This is presumable because broadly 
oriented techniques such as CGH 
retrieve only gross aberrations of at 
least 2 million bp for gains and even 
10-20 million bp for losses.21 
Compared to HNSCC studies by 
Bockmuhl et al.8 and Speicher et al.27, 
who also used CGH, we found fewer 
regions with copy number changes. 
Similar discrepancies between series 
has been noted earlier in HNSCC31, 
and in breast carcinoma.1637 Factors 
that influence the CGH hybridization 
are quality of tumor DNA, reference 
DNA and reference metaphases. Only 
those hybridizations were included for 
full CGH analysis that were 
homogeneously stained, had a tumor 
hybridization signal to noise ration 
greater than 3, showed good 
chromosome morphology as assessed 
by distinct DAPI banding for 
chromosome identification. Besides 
[5]U. Bockmühl, Cancer Res. 56, 5325. (1996). [7]U. Bockmuhl, Head Neck 20, 145 (1998). 
[8]U. Bockmühl, Cancer Res. 57, 5213 (1997). [9]M. Kujawski, Cancer Genet.Cytogenet. 114, 
31 (1999). [23]]. Houldsworth, Am.J.Pathol. 145, 1253 (1994). [27]M. R. Speicher, Cancer 
Res. 55, 1010 (1995). [29]E. Wolff, Oral Oncol. 34, 186 (1998). [30]M. A. Hermsen, Oral 
Oncol. 33,414 (1997). [31]N. D.Stafford, Arch.Otolaryngol.Head Neck Surg. 125,1341 (1999). 
[35]M. Okafiiji, J.Oral Pathol.Med. 28,241 (1999). [36]A. Kallioniemi, Proc.NadAcad.Sci.U.SA 
91, 2156 (1994). [37]F. Courjal, Cancer Res. 57, 4368 (1997). 
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the quality of hybridization, the 
interpretation (especially the criteria 
used for defining gains and losses) of 
CGH ratio profiles influences the 
results.38 We chose relatively high 
thresholds by setting tumor/reference 
fluorescence ratios at 0.8 and 1.2, for 
losses and gains, respectively, whereby 
only cases whose mean ratio lie 
outside this interval were accepted as 
true imbalances. 
A central theme in modern 
genetics is the relation between 
genetic variability and phenotype. 
Many studies on HNSCC report 
complex aberrations, reflecting mixed 
populations within a tumor.22 
Through the process of selection, one 
or more subpopulations within a 
tumor eventually fulfill the qualities 
to establish a metastasis. Clones that 
fall short in this process are likely to 
differ in genetic composition from the 
former, since genetic differences are 
the motor that drives specific 
phenotypes. In which way genes 
located on the most frequently 
affected chromosome arms in fact 
contribute to cancer progression, in 
our opinion remains to be established. 
More detailed techniques such as high 
density DNA arrays39, may prove of 
help in this respect. 
The significant differences 
between metastasized and non 
metastasized tongue carcinomas 
support the theory that metastasized 
tumors in general exhibit more 
genetic damage, which is in 
agreement with the proposed 
progression models.4 6 Some of the 
chromosome regions frequently 
affected in our series, harbor putative 
genes related to cancer progression 
and metastasis. The most frequently 
found imbalance was gain at 8q (9/9 
metastasized tumors, and 4/7 non 
metastasized tumors) harboring MYC 
oncogene at 8q24, followed by gain at 
3q (5/9 metastasized tumors, and 3/7 
non metastasized tumors), with 
THPO (thrombopoietin, 
myeloproliferative leukemia virus 
oncogene ligand, megakaryocyte 
growth and development factor) at 
3q27, andTM4SFl (transmembrane 
4 superfamily member 1), at 3q21-
25. Chromosome 7q (4/9 
metastasized tumors), harboring 
BRAF (v-raf murine sarcoma viral 
oncogene homolog Bl) at 7q34, 
(continued page 68) 
[4]J. Califano, Cancer Res. 56, 2488 (1996).[5]U. Bockmuhl, Cancer Res. 56, 5325. (1996). 
[6]J. M. Cowan, J.Natl.Cancer Inst. 84, 793 (1992).[22]T. E. Carey, Anticancer Res. 13, 2561 
(1993). [38]D. H.Moore, Cytometry 28,183(1997). [39]M. Chee, SCIENCE 274,610 (1996). 
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Figure 1. CGH results. Red to green ratio profiles obtained from CGH analysis of the non-
metastasized (upper) and metastasized tumors (lower). Losses are indicated by lines to the left, 
gains as lines to the right of the chromosome ideograms. High copy number changes are in 
bold setting. Ideograms generated by hand. 
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MET (met proto-oncogene, a hepatocyte growth factor receptor) at 7q31, and 
the oncogene TIM at 7q33-35, was third most often affected. MET is of special 
interest, since it has recently been shown overexpressed in HNSCCs that 
metastasized40, and associated with high metastatic potential in thyroid 
carcinoma.'" Furthermore, 7q is the only frequently seen aberration in our series, 
that is exclusively found in metastasized tumors. Therefore, focussing on 7q may 
be worthwhile in locating metastasis related genetic aberrations. 
Further elucidation of the genetic structure behind a metastatic phenotype 
may provide insight in complex metastatic process and may help determine 
treatment plans and patient counseling. 
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Abstract 
The aims of this study of head and neck tissue samples were to develop an 
immunohistochemical protocol based on the catalyzed reporter deposition 
(CARD) technique to enhance staining results for use in automated true color 
image analysis, to assess the reproducibility of systematic tissue sampling in the 
angiogenic hot spot selection, and quantification of microvessel density (MVD) 
and other vessel characteristics. The latter data were compared between six 
metastasized tongue squamous cell carcinomas, vs. four non-metastasized. In 
comparison to the standard immunohistochemical protocol with anti-CD34 
antibodies, CARD amplification resulted in both more intensely stained and 
larger numbers of vessels. Averaging the 10 most vascularized fields of the 40 to 
60 systematically sampled fields in a tissue section resulted in an overall 
acceptable inter-observer reproducibility for most assessed vessel parameters 
(r > 0.76 and ρ < 0.01). The percentage vessels with diameter < 5 micrometer 
was significantly higher in the non-metastasized tongue carcinomas (p=0.02). 
However, for a number of tumors the effect of tissue sampling was significant. 
We conclude that CARD amplification is needed for reliable segmentation 
of vessels by image analysis systems, and that tumor heterogeneity is a limiting 
factor for all procedures in which tumor vascularity is assessed in a single tissue 
section. 
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Introduction 
The angiogenesis-inducing 
capacity of malignant tumors is 
regarded as an important factor 
influencing tumor growth and 
clinico-biological behavior.1 
Correlation between high microvessel 
density (MVD) and the occurrence of 
metastases have been reported for 
several types of malignancies1"3, 
including squamous cell carcinomas 
of the head and neck.1,3'9 
Measurement of MVD is mostly 
performed by manual counting of 
vascular profiles in tissue sections in 
which blood vessels are visualized by 
immunohistochemical procedures. 
Most widely used is a protocol 
described by Weidner et al.\ in which 
vessels are manually counted in the so-
called 'angiogenic hot spot'. The hot 
spot is defined as the area of a tumor 
with the highest degree of 
vascularization and MVD is defined 
as the number of microvessels in the 
hot spot3 or as the mean value of 
MVD assessed over a small number of 
the most vascularized areas of the 
tumor.2 The limitations of this 
procedure are discussed in a recent 
manuscript on an international 
consensus on the methodology and 
evaluation criteria of angiogenesis 
quantification.10 
In a recent study, it was shown 
that true color image analysis is a good 
alternative to manual counting, to 
quantify tumor vascularity in the hot 
spot." In that study on human 
melanoma xenografts, the whole 
tumor in a tissue section was 
completely sampled with non-
overlapping, consecutive standardized 
fields, and subsequently the average 
vessel density over the three highest 
vascularized fields was used to define 
the automated hot-spot MVD. This 
sampling procedure warranted that 
the highest vascularized fields were 
almost always found by independent 
observers, but it is a very time-
consuming method, especially for 
large tumors. A tissue sampling 
technique not yet well explored in 
studies on angiogenesis is the 
procedure of systematic sampling12 
that is often used in stereology.13'14To 
[1] S. B. Fox, Histopathology 30, 294 (1997).[2] E. R. Horak, Lancet 340, 1120 (1992).[3] 
N. Weidner, N.EnglJ.Med. 324, 1 (1991).[4] G. Gasparini, Int.J.Cancer 55, 739 (1993).[5] 
L. L. Gleich, Head.Neck 19, 276 (1997).[6] D. A. Leedy, Otolaryngol Head Neck Surg 111, 
417 (1994).[7] Τ Shpitzer, Arch.Otolaryngol.Head.Neck Surg. 122, 865 (1996).[8] S. R Tahan, 
J.Cutan.Pathol. 22, 236 (1995).[9] U. K. Zatterstrom, Head.Neck 17, 312 (1995).[10] P. B. 
Vermeulen, Eur.J.Cancer 32A, 2474 (1996).[11] J. A. van der Laak, J.Pathol. 184,136 (1998).[12] 
W. C. Cochran, Sampling Techniques (1977).[13] H. J. Gundersen, J.Microsc. 147 ( Pt 3), 
229 (1987).[14] E. G. Weibel, Stereological Methods; Theoretical Foundation (1980). 
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the best of our knowledge, only few 
published studies on microvessel 
counting used a systematic sampling 
procedure15 '7, and it is not considered 
in the aforementioned consensus 
report.10 
In a preliminary study on 
^ngiogenesis in squamous cell 
carcinomas (SCCs) of the tongue, we 
encountered the problem that the 
intensity of the 
immunohistochemically visualized 
vessels was sometimes very low. In 
some cases, the intensity of the 
immunohistochemical signal was so 
weak that the vessels were hardly 
visible. Furthermore, large variations 
existed between tumors of different 
patients (i.e., inter-tumor variation) 
and within the same tumor (i.e., 
intra-tumor variation). Especially the 
inter-tumor variations were 
considerable, even when a 
standardized immunohistochemical 
procedure was used. The results of 
recognition of vessel profiles by an 
image analysis system are mainly 
determined by the quality of the 
immunohistochemical procedure." 
Conventional immunohistochemical 
techniques, including those using 
antigen-retrieval procedures such as 
microwave and protease pre-
treatment, were clearly not suitable 
for a reliable recognition of vessels by 
automated image analysis systems. 
This may be explained by the 
extended fixation times required for 
large head and neck specimens. A 
solution for this problem may be the 
use of a signal amplification system 
based on the horseradish peroxidase 
catalyzed reporter deposition 
(CARD) of biotinylated tyramine at 
sites of immunoreactivity.181!' The 
CARD procedure is a highly sensitive 
and highly specific method for signal 
amplification in 
immunohistochemistry and in situ 
hybridisation.20 2 2 In a recent study, 
CARD amplification was used to 
enhance the immunohistochemical 
signal for the fully automated 
microvessel counting and hot spot 
selection by monochromatic image 
analysis.2' 
The aims of the present study 
were 1) to develop an 
immunohistochemical protocol based 
on CARD technique to enhance 
[10] Ρ Β Vermeulen, EurJ Cancer 32A, 2474(1996) [11] J A van der Laak, J Pathol 184, 
136(1998) [15] J S De Jong, Lab Invest 73,922(1995) [16] S Hansen, Lab Invest 78, 
1563(1998) [17] PWesselingJNeurosuig 81,902(1994) [18] Μ Ν Bobrow, J Immunol Methods 
125,279(1989) [19] Μ Ν Bobrow, J Immunol Methods 137, 103 (1991) [20] H M Kerstens, 
J Histochem Cytochem 43, 347 (1995) [21] Α Κ Raap, Hum Mol Genet. 4, 529 (1995) 
[22] G King, J Pathol 183,237(1997) [23] J A M Beben, J Clin Pathol 52,184(1999) 
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staining results for use in true color 
image analysis of head and neck 
specimens, 2) to assess the 
reproducibility of a systematic 
sampling procedure to quantify vessel 
parameters in SCCs of the head and 
neck, 3) to assess if vessels parameters 
enabled to discriminate between 
metastasized and non-metastasized 
tumors of the tongue. 
Material and methods 
Formalin-fixed, paraffin-
embedded tissue sections from 
resection specimens of SCCs of the 
tongue, which exhibited variable 
immunostaining intensities in the 
standard immunohistochemical 
procedure were used in several 
immunohistochemical experiments 
with CARD amplification in order to 
select the most suitable procedure for 
use in true color image analysis. 
Patient material 
From our archives we selected 10 
patients with a SCC of the mobile 
tongue, 6 patients with locoregional 
lymph node metastasis and 4 patients 
without metastasis during follow-up 
of two years or more. For each of these 
patients, the hematoxylin-eosin (HE) 
stained tissue sections of all tissue 
blocks obtained from the resection 
specimen were examined in order to 
select one block that contains a major 
Vascularity in Squamous Cell Carcinoma of the 
iystematic Sampling Technique, and True Color 
Image Analysis. 
part of the tumor. Tissue sections of 
these selected tissue blocks were 
immunohistochemically stained with 
the following CD34/CARD 
procedure. 
Immunohistochemistry 
Standard immunohistochemical 
procedure 
The standard 
immunohistochemical procedure 
used in this study started with 
formalin-fixed, paraffin-embedded 
tissue sections of 4 micrometer 
thickness that were mounted on 
Superfrost Plus slides (Menzel Gläser, 
Braunschweig, Germany) and dried 
overnight at 560C. Subsequently, the 
sections were deparaffinized, treated 
with 1% H 2 0 2 in methanol for 20 
minutes, and rinsed three times in 
phosphate buffered saline (PBS, 
pH 7.4) for 5 minutes. After pre-
incubation with normal horse serum 
100% (Vector Laboratories, 
Burlington, USA) for 20 minutes at 
room temperature (RT), an overnight 
incubation at 40C with CD34 (Qb-
END, Biogenex, San Ramon, USA) 
1:2 in PBS/1% bovine serum albumin 
(PBS/1% BSA, Sigma, St. Louis, 
USA) was performed, followed by 
three rinsing steps of 10 minutes in 
PBS, incubation with biotinylated 
horse-anti-mouse serum (Vectastain 
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ABC-kit, Vector Laboratories) 1:200 
in PBS/1% BSA (Sigma) for 30 
minutes at RT, and three rinsing steps 
of 5 minutes in PBS. Subsequently, 
the tissue sections were incubated for 
45 minutes with peroxidase (PO) 
labeled avidin-biotin-complex 
(ABCpo, ABC Elite, 1:100; Vector 
Laboratories) or with alkaline 
phosphatase (AP) labeled avidin-
biotin-complex (ABCAP, ABC 
Standard, 1:100, Vector 
Laboratories). After three rinsing steps 
of 5 minutes each in PBS, peroxidase 
was visualized with 0.05% 
diaminobenzidine/0.15% H 2 0 2 
(DAB, Sigma) in PBS for 5 minutes 
and alkaline phosphatase with Vector 
Red (alkaline phosphatase kit I, 
Vector Laboratories) for 30 minutes at 
RT, according to the suppliers 
instructions. Finally, the sections were 
rinsed in tap water, slightly 
counterstained with Mayer's 
hematoxylin, rinsed in tap water, 
dehydrated, and mounted with 
Permount (Fisher Scientific, Fair 
Lawn, USA). To avoid diffusion of the 
enzyme precipitate of Vector Red, the 
sections needed to be dehydrated 
rapidly. 
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Biotinylation of tyramine 
One hundred mg 
sulfosuccinimidyl-6-(biotinimide) 
hexanoate (NHS-LC-biotin) (Pierce, 
Rockford, USA) was dissolved in 40 
ml 50 mM borate buffer, pH 8.0. 
Next, 30 mg tyramine-HCl (Sigma) 
was added. The solution was agitated 
overnight at RT and filtered. Before 
application, biotinylated tyramide 
(BT) was diluted in PBS, with 0.01% 
HA-
Signal amplification experiments 
In order to optimize the CARD 
procedure, tissue sections of SCCs 
exhibiting intra- and inter-specimen 
variations in the intensities of 
immunohistochemically stained 
vessels were incubated with BT at 
different dilutions (1:25, 1:50, 1:100, 
1:500 and 1:1000) and different BT 
incubation times (1, 2, 4, 8 and 12 
minutes). Proceeding the CARD 
procedure, the standard 
immunohistochemical procedure was 
applied with the incubation time for 
ABCPO reduced to 30 minutes. After 
three rinsing steps of 5 minutes in 
PBS, incubations with BT at the 
aforementioned concentrations and 
incubation times were performed. 
After three rinsing steps in PBS for 5 
minutes the sections were incubated 
with ABCPO 1:100 or ABCAP 1:100 
for 20 minutes, and rinsed three times 
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in PBS for 5 minutes. Peroxidase was 
visualized with DAB incubation for 5 
minutes and alkaline phosphatase 
with Vector Red incubation for 30 
minutes. The processing steps that 
followed these DAB and Vector Red 
incubation were the same as described 
before. 
Tissue sampling 
The sections of each of the 10 
SCCs of the tongue were examined at 
low power magnification (objective 
4 χ) and the area of tumor tissue 
within the section was demarcated. 
The demarcated tumor tissue was 
manually sampled at higher 
magnification (objective 10 χ) with a 
systematic sampling technique.14 In 
short, neighboring fields in a 
horizontal and vertical direction were 
sampled subsequently, thus 
reciprocating from left to right, 
starting at the top going to bottom 
through the tissue section. In cases 
with a large tumor area, two or more 
neighboring fields were skipped in a 
horizontal direction, in order to limit 
the number of fields. Only fields 
including enough tumor tissue and 
tumor-stroma were included. Fields 
containing more than 50% of pre­
existing vessel-rich structures such as 
[14] E. G. Weibel, Stereological Methods; 
iscularity in Squamous Cell Carcinoma of the 
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striated muscle, lamina propria or 
peripheral nerves were skipped. Fields 
containing more than 50% of necrosis 
or artifacts were also skipped. In this 
manner, the whole tumor in the tissue 
section was sampled with 40 to 60 
fields. The actual size of each field was 
0.17mm2. All digitized images were 
stored on magneto-optical disks. 
Image analysis 
Image analysis was performed 
using a Vidasplu'' system (Kontron 
GmbH, Eching, Germany). Images 
were recorded by a three-chip CCD 
camera (DXC-325P, Sony, Tokyo, 
Japan) mounted on a conventional 
light microscope (Axioskop, Zeiss, 
Jena, Germany) using a 10 χ objective 
(numerical aperture = 0.3). At this 
magnification, the recorded fields 
measured 0.4 χ 0.425 mm (pixel size 
0.78 χ 0.83 micrometer). Digitized 
images were stored on magneto-
optical disc (Borsu Systema, Lelystad, 
The Netherlands) as true color (24-bit 
RGB) images. Prior to recording 
images of tissue specimens, an image 
of an empty microscopic field and a 
dark-current image were stored in 
order to correct for unequal 
illumination and dark current of the 
camera, respectively. 
Foundation (1980). 
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Recognition of the CD34 
stained objects was performed using 
an algorithm described elsewhere in 
detail.24 In short, the well-known red-
green-blue (RGB) to hue, saturation, 
intensity (HSI) conversion was 
applied to the optical densities for the 
three camera channels instead of the 
channel intensities. This hue, 
saturation, density (HSD) color 
model was found superior to the 
existing RGB and HSI color models 
for stain recognition in transmitted 
light microscopy.24 The HSD model 
was implemented on the Vidasplu'' 
system using the C free programming 
facilities. Application of the RGB to 
HSD conversion results in two 
chromatic co-ordinates for each image 
point (pixel). Due to camera 
limitations, the co-ordinates within 
the chromatic plane are confined to a 
triangular region. Each stain is 
represented by an ellipsoid 
subdomain in this chromaticity 
triangle. A number of test specimens, 
containing only pure DAB or Vector 
Red, was used to determine the 
locations and extensions of the 
subdomains of these stains in the 
chromaticity triangle. Recognition of 
vascular structures was performed as 
[24] J. A. van der Laak, Cytometry 39, 275 
(1992). 
follows. Image pixels with chromatic 
co-ordinates inside the ellipsoid 
regions of the used stains were labeled 
as positive. Pixels with optical density 
(OD) smaller than 0.2 were never 
labeled positive, whereas pixels with 
OD greater than 0.7 were always 
labeled positive, because chromatic 
information of pixels originating from 
very low or very high amounts of stain 
is inaccurate. Next, 8-connected 
neighboring pixels were grouped 
together to form objects that possibly 
represent vascular profiles. These 
binary objects were dilated twice, after 
which holes inside the objects were 
filled. Next, objects were eroded twice 
to restore their original size. These 
binary operations resulted in filling of 
lumina, closure of small gaps in the 
object contours, and slight smoothing 
of the object contours so that values of 
perimeter and diameter are more 
accurate.25 The final step consisted of 
removal of objects with area smaller 
than 50 pixels, as these were found 
too small to represent vascular 
structures. 
The resulting vessel contours 
were projected in the original color 
images, providing a facility for 
interactive deletion of incorrectly 
.[25] R. C. Gonzalez, Digital image processing 
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segmented vessel profiles, due to 
larger gaps in the vessel contour. 
Because it was not always possible to 
store fields that consisted entirely of 
vital tumor tissue, non-tumor regions 
could be interactively excluded from 
further analysis. 
Finally, parameters were 
calculated describing the MVD and 
characteristics of individual vessel 
profiles. Only vessel profiles entirely 
localized within the field were used to 
measure individual vessel parameters, 
whereas the 'forbidden line-method 
was used to measure MVD.13;26 In 
addition to parameters provided by 
the Vidasplus system (table 1), a 
measure for the diameter (DIAM) was 
implemented. The latter parameter 
was obtained as follows. The medial 
axis of an object was determined using 
binary erosions and for each pixel on 
this axis, the shortest distance to the 
object contour was measured using a 
distance transform. DIAM is defined 
as the maximum value of the shortest 
distances multiplied by a factor two. 
Inter-observer reproducibility 
In the aforementioned 
procedure, two observer dependent 
steps may cause inter-observer 
variations: 1) interactive correction of 
stored images and 2) field selection 
using the systematic sampling 
procedure. In order to assess the inter-
observer reproducibility of the 
interactive correction step, 10 SCCs 
of the tongue were sampled by one 
observer (EH) and the stored images 
were independently corrected by two 
observers (EH and VC). 
Parameter Description 
MVD Number of vessels per mm2, corrected for measured area 
AREA Area of individual vessels 
PERI M Perimeter of individual vessels 
DIAM Diameter of individual vessels 
% C Ä n Percentage of vessels with diameter smaller than 5 micrometer 
%CAT2 Percentage of vessels with diameter of at least 5 , but no larger than 10 micrometer 
%CAT3 Percentage of vessels with diameter of at least 10 , but no larger than 15 micrometer 
%CAT4 Percentage of vessels with diameter of at least 15 micrometer 
Table 1. Vessel parameters and their definitions used in this study. 
[13] H. J. Gundersen, J.Microsc. 147 ( Pt 3), 229 (1987). [26] H. J. Gundersen, J.Microsc. 
111,219(1977). 
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Subsequently, the same 10 SCCs of 
the tongue were sampled and 
corrected independently by a second 
observer (VC). 
Statistics 
Statistical analysis was performed 
using SPSS 8.0 for Windows (SPSS 
Inc., Chicago, USA). Based on MVD, 
for each tumor the 25 most 
vascularized fields were selected from 
the 40-60 sampled fields. Averages for 
all vessel parameters were calculated 
over all vessels in the most 
vascularized field (henceforth called 
the 'hot-spot') and in the 5, 10, 15, 
and 25 fields with highest MVDs. 
The vessel profiles were subdivided in 
4 diameter categories, consisting of 
profiles with DIAM < 5 micrometer, 
5 micrometer < DIAM < 10 micrometer, 
10 micrometer < DIAM < 15 mioometEr, 
and DIAM > 15 micrometer, 
respectively. Subsequently, the 
percentage of vessels in each category 
was calculated for the hot spot and the 
5, 10, 15, and 25 fields with highest 
MVDs. 
The inter-observer 
reproducibility of the interactive 
correction step and the systematic 
sampling procedure were assessed by 
a Spearman's rank correlation analysis 
and analysis of variance (ANOVA). In 
the ANOVA model, the main effects 
of patients and observers, as well as 
the interaction term between observer 
and patient were considered. ANOVA 
was also used to assess the differences 
between metastasized and non-
metastasized tongue carcinomas. 
Results 
Immunohistochemistry 
CARD amplification with BT 
dilution of 1:50 and BT incubation 
time of 5 minutes was ultimately 
selected to visualize vessels in SCCs of 
the head and neck for assessment by 
image analysis. This protocol resulted 
in very intensely stained vessels and 
sprouting and migrating endothelial 
cells, whereas the tumor stroma did 
not exhibit background staining. In 
contrast, the pre-existing structures 
such as striated muscle cells and 
peripheral nerves gave high 
background staining. The BT 
dilutions of 1:500 and 1:1000 did not 
amplify the signal enough for cases 
with very weak staining intensities of 
vessels using the standard procedure. 
The 1:25 BT concentration did not 
give a substantial improvement of the 
signal amplification in comparison to 
1:50. The shortest BT incubation 
times also resulted in insufficient 
signal amplification. In cases where 
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the standard immunohistochemical 
procedure resulted in unstained or 
very weakly stained vessels the effect 
of CARD amplification was 
considerable (Figs la- le) . In these 
cases, the CARD amplification step 
did not only result in an enhancement 
of the recognition of CD34 stained 
objects, but also in a larger number of 
immunohistochemically stained 
objects (Figs, la-lb). This was found 
in tissue sections in which the color 
was developed by incubating with 
DAB as well as Vector Red (Figs.lb-
1c). In tumors in which the vessels 
were more adequately stained by the 
standard immunohistochemical 
protocol, CARD amplification gave 
more intensely stained vessels, but the 
differences in the number of stained 
objects were less obvious (Figs. 1 d-1 e). 
In the DAB stained tissue 
sections, the contours of the vessel 
profiles were more sharply 
demarcated than in the Vector Red 
stained tissue sections (Figs. Ib-lc). 
In the Vector Red stained sections the 
boundaries of the vessels were not 
only more blurred, but exhibited also 
more inter-specimen variation in 
blurring than the DAB stained 
sections. Based on these differences in 
staining characteristics of DAB and 
Vector Red, the former was selected 
for the use in true color image 
analysis. In figure If, the results of the 
iscularity in Squamous Cell Carcinoma of the 
itematic Sampling Technique, and True Color 
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automatic recognition of DAB 
stained vessels, without interactive 
corrections, are given. Automatic 
recognition of vessels may be seriously 
hampered in regions (especially in 
striated muscles) with high 
background staining. The very 
elongated vessel transsections in the 
stroma of the tumor are sometimes 
erroneously segmented by the image 
analysis system as a string of multiple 
small vessels. 
ΚφίχχΙυαΒΐΗ^ of tissue sampling 
Correlation analysis revealed that 
the overall inter-observer 
reproducibility of the interactive 
correction step was good with inter-
corrector correlation rl > 0.75 
(p<0.01) for the MVD and size 
parameters in the systematically 
determined hot-spot (table 2). The 
percentages of vessels in the four 
categories were less reproducible, 
especially for %CAT1 and %CAT4. 
The inter-corrector correlation 
coefficients increased when vessel 
parameters were averaged across an 
increasing number of fields (table 2). 
Averaging parameters from vessels in 
the ten highest vascularized fields 
resulted in rl-values > 0.96 and in p-
values < 0.001 for all parameters with 
exception of %CAT1. Addition of 
more fields in the averaging did not 
(continued page 84) 
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Opposite page: Figure 1 : Immunohistochemical staining results for the standard procedure and 
in combination with CARD amplification. An immunohistochemically stained tissue section 
of tongue carcinoma, with very weakly stained and even unstained vessels using the standard 
procedure with DAB (a) and the successive, serial section using CARD amplification, disclosing 
more vessel profiles and more intensely stained vessels with DAB (b). A non-successive, serial 
section of the same area in the same tumor, with vessels visualized with Vector Red after CARD 
amplification also showed intensely stained vessels, however Vector Red gave more blurred vessel 
contours than DAB (c). Another SCC with stained vessels using the standard procedure with 
DAB (d) and the successive, serial section using CARD amplification exhibiting more intensely 
stained vessels, no background staining, and plasma cells of the inflammatory infiltrate remained 
unstained (e). The same image as (e), with vessel profiles found after automated recognition 
by the image analysis system, marked with green contours (f). For a color reproduction, kindly 
refer to http://www.esacp.org/2001/22-4/hannen.htm, with permission. 
Below: Table 2. The inter-observer correlations for the correction step (rl) and for the systematic 
sampling (r2) and their two-tailed p-values are given for the MVD and other parameters in 
the hot spot and averaged across the 5, 10, 15, and 25 highest vascularized fields, determined 
by systematic tissue sampling, n.s.: not significant. 
MVD 
AREA 
PERIM 
DIAM 
»/oCATl 
%CA.T2 
%CAT3 
%CAT4 
rl 
r2 
rl 
r2 
rl 
r2 
rl 
r2 
rl 
r2 
rl 
r2 
rl 
r2 
rl 
r2 
Hot 
t 
0.84 
0.48 
0.81 
0.37 
0.75 
0.57 
0.82 
0.50 
0.63 
-0.10 
0.69 
0.02 
0.67 
0.47 
0.28 
-0.41 
spot 
Ρ 
0.002 
n.s. 
0.005 
n.s. 
0.012 
n.s. 
0.004 
n.s. 
n.s, 
n.s. 
0.029 
l i s 
0.036 
η s 
n.s. 
n.s. 
Top 5 fields 
r 
0.97 
0.64 
0.95 
0.70 
0.96 
0.69 
0.96 
0.69 
0.83 
0.12 
0.94 
0.88 
0.92 
0.89 
0.97 
0.29 
Ρ 
•cO.OOl 
0.045 
<0.001 
0.026 
<0.001 
0.029 
<0.001 
0.028 
0.003 
n.s. 
<0.001 
0.001 
<0.001 
0.001 
<0.001 
n.s 
Top '. 
t 
0.98 
0.77 
0.99 
0.76 
0.99 
0.79 
0.99 
0.77 
0.87 
0.35 
0.96 
0.90 
0.98 
0.92 
0.99 
0.55 
10 fields 
Ρ 
<0.001 
0.009 
<0.001 
0.010 
<0.001 
0.006 
<0.001 
0.009 
0.001 
n.s. 
<0.001 
<0.001 
<0.001 
<0.001 
<0.001 
n.s 
Top 15 fields Top 25 fields 
r 
0.99 
0.84 
0.99 
0.81 
0.99 
0.83 
0.98 
0.78 
0.95 
0.45 
0.96 
0.92 
0.97 
0.88 
0.99 
0.66 
Ρ 
<0.001 
0.003 
•cO.OOl 
0.004 
<0.001 
0.003 
<0.001 
0.007 
<0.001 
n.s 
<0.001 
<0.001 
<0.001 
0.001 
<0.001 
0.044 
r 
0.99 
0.91 
0.99 
0.83 
0.99 
0.78 
0.99 
0.83 
0.93 
0.39 
0.99 
0.90 
0.99 
0.84 
0.99 
0.82 
Ρ 
<0.001 
<0.001 
<0.001 
0.003 
<0.001 
0.008 
<0.001 
0.003 
<0.001 
ILS. 
<0.001 
<0.001 
<0.001 
0.002 
<0.001 
0.004 
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give a substantial improvement of the 
reproducibility of the interactive 
correction step (table 2). 
Correlation analysis disclosed 
that the overall inter-observer 
reproducibility of systematic 
determination of the hot spot is poor 
with low and even negative values for 
the inter-observer correlation (r2) for 
all the vessel parameters (table 2). 
Using vessel parameters obtained 
from averaging all vessels in the five 
highest vascularized fields found by 
systematic tissue sampling resulted in 
a substantial improvement of the 
inter-observer reproducibility of the 
sampling procedure (r2>0.64, 
ρ < 0.05) for all parameters with 
exception of %CAT1 and %CAT4. 
Using the mean values obtained from 
the ten most vascularized fields 
resulted in acceptable inter-observer 
reproducibility of all vessel parameters 
with exception of %CAT1 and 
%CAT4, with inter-observer 
correlation coefficients r2 > 0.76 and 
p-values < 0.01 (table 2). Averaging 
vessel parameters across more than 10 
fields gave no substantial 
improvement of the inter-observer 
reproducibility of the systematic 
sampling procedure. Averaging vessel 
parameters across the ten most 
vascularized fields found by systematic 
tissue sampling was found to result in 
84 
an acceptable overall inter-observer 
reproducibility in SCCs of the 
tongue. 
For the interactive correction 
step, ANOVA calculated over data 
from the 10 most vascularized fields 
disclosed no significant interactions 
between observers and patients. A 
significant interaction would indicate 
that the inter-observer reproducibility 
varies between patients. The effect of 
interactive correction was not 
significant for any parameter, except 
for the MVD (p=0.01). However, 
variations between patients were 
found highly significant for almost all 
parameters. The effect of field 
sampling by two independent 
observers showed a significant 
interaction between observer and 
patient for a number of parameters 
(AREA, DIAM, and MVD), 
indicating a significant sampling 
effect for some patients for these 
parameters. This is shown graphically 
in fig. 2 for MVD and DIAM. For 
PERIM and %CAT3, a significant 
inter-observer effect was found 
(p=0.001 and p=0.02, respectively). 
Metastasized versus non-
metastasized tumors. 
Using the results obtained from 
the 10 most vascularized test fields, 
the mean values and standard 
deviations of the parameter 0/oCATl 
(continued page 86) 
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Figure 2. Inter-observer reproducibility for the interactive correction step and the systematic 
sampling of microvessel density and vessel diameter for 10 patients with a tongue carcinoma. 
For each patient, the mean values and 95% confidence intervals of the MVD and DIAM obtained 
from the 10 highest vascularized fields found by sampler 1 and corrector 1 (1-1), sampler 1 
and corrector 2 (1-2), sampler 2 and corrector 2 (2-2). 
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were 20.4 ± 3.0 and 16.7 ± 4.1 for 
non-metastasized and metastasized 
tumors, respectively. ANOVA 
disclosed that this difference is 
statistically significant (p=0.02). For 
the other parameters, no significant 
differences between these two groups 
were found. 
Discussion 
The results of the present study 
show the developed 
immunohistochemical protocol based 
on CARD signal amplification 
enhanced the staining results. The 
sensitivity, specificity, and signal-to-
noise ratio of the 
immunohistochemical detection of 
blood vessels with the monoclonal 
antibody directed against CD34 were 
improved. The combination of high 
intensity of the specific 
immunohistochemical signals and the 
absence of background staining is an 
important condition for successful 
automated recognition of 
immunohistochemically stained 
objects in tissue sections by image 
analysis systems. Background staining 
appeared to be a major limiting factor 
in the automated recognition of vessel 
profiles using true color image 
analysis.1' In a recent study on 
angiogenesis in breast cancer, 
application of CARD amplification 
proved necessary for the automatic 
recognition of vessels by 
monochromatic image analysis using 
the monoclonal antibody directed 
against CD31.23 Antibodies directed 
against CD31 have been proposed as 
standard for the visualization of 
vessels.10 However, it cannot be 
recommended for use in the 
automatic recognition of microvessels 
in chronically inflamed tumors, 
because plasma cells are also stained 
by CD31. This problem was 
encountered in the aforementioned 
study on breast carcinomas and 
required an interactive correction step 
to eliminate the falsely recognized 
plasma cells.23 
The Chalkley point counting 
procedure has been proposed as the 
standard method for quantification of 
intra-tumor MVD due to inadequate 
reproducibility of the automated 
recognition of vessel profiles in tissue 
sections due to the heterogeneity of 
microvessel morphology, e.g., size, 
length and anastomoses, and local 
[10] P. B. Vermeulen, Eur.J.Cancer 32A, 2474 (1996). [11] J. A. van der Laak, J.Pathol. 184, 
136 (1998). [23] J. A. M. Belien, J.Clin.Pathol. 52, 184 (1999). 
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differences in immunostaining 
intensity.10 In the present study it was 
shown that problems with regard to 
the intra- and inter-specimen 
variations of the 
immunohistochemical signal were 
considerably reduced by combination 
of the CARD amplification and true 
color image analysis using the HSD 
color model. The CARD procedure 
resulted in more uniform and 
enhanced staining intensities and 
sharply demarcated vessel boundaries 
when DAB was used. Because in the 
HSD model color information is used 
for recognition of vessels, intra- and 
inter-specimen variations in staining 
density had less effect on the 
segmentation of vessel profiles than 
when the widely used RGB or HSI 
models were applied. The advantages 
of the use of the HSD color model in 
transmitted light microscopy were 
recently reported.24 In the present 
study, it was shown that interactive 
correction of stored images by two 
independent observers resulted in a 
good inter-observer reproducibility. 
Only for the MVD, a weakly 
significant corrector effect was 
observed, probably reflecting the 
difficulty in defining criteria for 
individual vessel profiles. However, 
this problem hampers any procedure 
for quantification of the MVD. 
Reliable automated recognition 
of immunohistochemically stained 
vessels has important advantages in 
comparison to point-counting 
procedures, such as the recommended 
Chalkley method. Size and shape 
parameters can be used to subclassify 
blood vessels, enabling assessment of 
the relationship between subclasses of 
vessels and biological behavior of 
tumors. In a recent study on human 
melanoma xenografts with different 
metastatic behavior, no significant 
differences between the two 
melanomas were found for 
immunohistochemically stained 
objects with diameter < 3 micrometer 
and diameter > 12 micrometer, 
whereas the most significant 
differences were found for vessels with 
a diameter in the range of 6-9 
micrometer." The results of the latter 
study demonstrated the need to 
determine subgroups of microvessels 
preferentially used in the complex 
process of metastasis. In the present 
study on a very small series of patients 
with a tongue carcinoma, it was 
shown that significant differences 
between metastasized and non-
[10] P. B. Vermeulen, Eur.J.Cancer 32A, 2474 (1996). [11] J. A. van der Laak, J.Pathol. 184, 
136 (1998). [24] J. A. van der Laak, Cytometry 39, 275 (2000). 
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metastasized tumors were found for 
the percentages of vessels with a 
diameter smaller than 5 micrometer, 
whereas the MVD did not differ 
significantly. 
The systematic sampling 
procedure for SCCs of the tongue 
with 40-60 fields is unsuitable for a 
reliable hot spot selection in tissue 
sections, as was shown in the present 
study. Vessel parameters obtained 
from the field with the highest vessel 
density (i.e., systematically 
determined hot spot) were not 
reproducible. A substantial 
improvement of the inter-observer 
correlation was obtained by averaging 
these vessel parameters across a larger 
numbers of the most vascularized 
fields. Calculation of the moving 
average of these parameters revealed 
that the mean values obtained from 
the 10 most vascularized fields, found 
by systematic sampling, resulted in an 
acceptable overall inter-observer 
reproducibility. However, the inter-
observer reproducibility of field 
sampling varied between patients, and 
the differences between the two 
observers were significant for some 
patients even after averaging 10 or 
more of the highest vascularized fields. 
The inter-observer reproducibility of 
[15] J. S. De Jong, Lab.Invest. 73, 922 (1995). 
systematic tissue sampling is 
determined by both intra-tumor 
variations due to tumor heterogeneity 
and by the sampled tumor area, which 
is determined by the number of 
systematically sampled fields. Other 
studies using complete sampling of 
the whole tumor area in tissue 
sections disclosed that this procedure 
resulted in highly reproducible hot 
spot selection.11,23 However, it remains 
to be elucidated whether the MVD in 
the hot spot, found by complete 
sampling of the tumor area in one 
single tissue section, is more 
representative for the whole tumor 
than the MVD estimated by the mean 
value of the 10 most vascularized 
fields found by a systematic sampling 
procedure in one tissue section. De 
Jong et al.15 found a noteworthy 
heterogeneity in microvessel counts in 
breast tumors between different areas 
from the same section. This is in 
agreement with our observations in 
SCCs of the tongue. Heterogeneity in 
microvessel counts was also found 
between corresponding areas in 
different sections from the same tissue 
block, and between blocks from the 
same tumor. Differences between 
blocks caused the larger part of the 
total variance of microvessel counts.15 
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It is likely that the inter-block 
variations also cause a major part of 
the total variance in other tumor 
types, including squamous cell 
carcinomas of the tongue. 
In the literature, there is still no 
consensus concerning the number of 
highest vascularized fields in tumors 
that must be used to obtain a reliable 
and reproducible estimation of the 
intra-tumoral MVD.14 In a number of 
studies, the MVD in only one hot 
spot was used1,27; other investigators 
used the mean value of the three or 
four most vascularized spots in a 
tumor section.2,28,2'' It is questionable 
whether there is an unequivocal 
answer to this question, because the 
ideal number of'hot spots' needed for 
a reproducible estimation of the 
MVD representative for the whole 
tumor may depend on tumor type 
and on the tissue sampling procedure. 
In our opinion, for each tumor type 
the number of highest vascularized 
areas ('hot spots') that is required to 
obtain a reproducible estimation of 
intra-tumoral MVD must be 
determined by moving average 
experiments. 
We conclude that CARD 
amplification is needed for reliable 
recognition of vessels by automated 
image analysis of head and neck tissue 
samples. Tumor heterogeneity is a 
limiting factor for the application of 
systematic tissue sampling, but this is 
true for all other procedures in which 
hot spot selection is based on a single 
tissue section or on a biopsy specimen. 
Especially, when vessel parameters will 
be used to construct a discriminant 
function to predict the biological 
behavior of a tumor for individual 
patients, one must be aware of 
sampling errors that may cause 
misclassifications. 
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Abstract 
Quantification of microvessels in solid malignancies is regarded a potential 
test to predict their clinicobiological behavior. However, discordant results have 
been reported for head and neck cancer that may be explained by varying 
methodology. In this retrospective study, we therefore quantified the 
microvasculature in 20 non-metastasized and 20 metastasized squamous cell 
carcinomas of the tongue, using recently developed methods. 
For immunohistochemical visualization of the vessels, we used anti-CD34 
with a signal amplification step based on the catalyzed deposition of biotinylated 
tyramine. This protocol results in enhanced staining quality compared to 
standard protocols. For each tumor, a representative tissue section was 
systematically sampled with 40 to 60 standardized test fields. True color image 
analysis system was used to measure microvessels density (MVD) and to obtain 
additional information with regard to size categories of vessels. 
Remarkably, in the group of non-metastasized tumors the MVD was higher 
than in the metastasized tumors (p=0.007). However, the microvessels with a 
diameter in the range of 10-15 micrometer predominated in the group of 
metastasized tongue carcinomas (p=0.03). A logistic regression model based on 
the percentage of vessels smaller than 5 micrometer, classified 85% of patients 
with a metastasized tumor correctly, and 75% of patients with a non-
metastasized tumor, independently on the clinical stage of the tumor. 
These results suggest that only vessels with a diameter larger than 
10 micrometer, consistent with functional vessels, play a role in the process of 
metastasis. Further research more specifically into structural and functional 
characterization of blood and lymphatic vessels might help provide more insight 
in the relation between microvasculature and the pathogenesis of metastasis in 
tongue carcinomas. 
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Introduction 
Angiogenesis is essential for 
neoplastic progression and 
metastasis.' The microvessel density 
(MVD) was found to correlate with 
tumor progression and occurrence of 
metastasis in a variety of tumors.2 
Most often vessels are manually 
counted in so-called 'angiogenic hot 
spots', defined as the area with the 
highest density of microvessels in a 
tissue section, identified under low 
power magnification.' Many studies 
on angiogenesis in head and neck 
squamous cell carcinomas (HNSCCs) 
have been performed/ 19 Discordant 
results were found for the measured 
MVDs in different studies, but also 
for the relation between MVDs and 
the metastatic behavior. These 
discrepancies may be caused by 
differences in tumor location, the 
choice of antibodies and differences in 
immunohistochemical protocols to 
visualize the vessels.20 Furthermore, 
manual selection of hot spots is liable 
to inter-observer variation.2' 2 1 In 
tongue carcinoma studies, both 
higher and lower counts in 
metastasized tumors, as well as no 
differences between metastasized and 
non-metastasized tumor were 
reported.5·6·8·9 
To the best of our knowledge, no 
angiogenesis studies on HNSCCs 
addressed the possibility that 
subclasses of vessels are preferentially 
used for metastasis, as was shown for 
xenografts of melanoma cell lines.24 
Image analysis which is needed to 
identify such subclasses of vessels in 
immunohistochemically stained tissue 
sections, requires high standards of 
staining quality, such as low back-
[1] J. Folkman, J.Nad.Cancer Inst. 82,4 (1990). [2] N. Weidner, Semin.Diagn.Pathol. 10, 302 
(1993). [3] N. Weidner, N.Engl.J.Med. 324, 1 (1991). [4] T. G. Dray, Ann.Otol.Rhinol.Laryngol. 
104, 724 (1995). [5] L. L. Gleich, Head.Neck 18, 343 (1996). [6] L. L. Gleich, Head.Neck 
19,276 (1997). [7] J. Kiijanienko, Cancer 75, 1649 (1995). [8] D. A. Leedy, Otolaryngol Head 
Neck Surg 111,417 (1994). [9] T. Shpitzer, Arch.Otolaryngol.Head.Neck Surg. 122,865 (1996). 
[10] J. K. Williams, Am.J.Surg. 168, 373 (1994). [11] U. K. Zatterstrom, Head.Neck 17, 312 
(1995). [12] A. Hogmo, J.Clin.Pathol. 52, 35 (1999). [13] G. Gasparini, Int.J.Cancer 55, 739 
(1993). [14] S. RTahan, J.Cutan.Pathol. 22,236 (1995). [15] C. N. Penfold, Br.J.Oral Maxillofec.Surg. 
34, 37 (1996). [16] S. Pazouki, J.Pathol. 183, 39 (1997). [17] M. Moriyama, Oral Oncol. 33, 
369 (1997). [18] P. U. Hegde, Arch.Otolaryngol.Head.Neck Surg. 124, 80 (1998). [19] O. 
Gallo, J.Nad.Cancer Inst. 90, 587 (1998). [20] Ρ Β. Vermeulen, Eur.J.Cancer 32A, 2474 (1996). 
[21] M. Barbareschi, Appi Immunohistochem 3, 75 (1995). [22] G. Gasparini, J.Clin.Oncol. 
13, 765 (1995). [23] Ν. Weidner, Am.J.Pathol. 147,9 (1995). [24] J. A. van der Laak, J.Pathol. 
184,136(1998). 
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ground staining, high signal-to-noise 
ratio, and small intra- and inter-
specimen variations in staining 
intensity.25 
In a recent study on HNSCCs, it 
was shown that anti-CD34 
monoclonal antibodies with 
amplification at sites of 
immunoreactivity, facilitated the use 
of a modified true color model for 
recognition of stained objects by an 
image analysis system.26 In the latter 
study it was shown that averaging the 
ten most vascularized fields of view 
found by a systematic tissue sampling 
procedure resulted in an overall 
acceptable reproducibility. 
The aims of the present study 
were first to employ these recently 
developed protocols and procedures 
to assess the characteristics of the 
microvasculature in relation to 
metastatic behavior in tongue 
carcinomas, and second to explore the 
possibilities of microvascular 
parameters to predict the metastatic 
behavior of tongue carcinomas. 
[25] J. A. van der Laak, Cytometry 39, 275 
Materials and Methods 
Patients 
In a retrospective study, we 
retrieved from our archives 40 
resection specimens of primary SCCs 
of the mobile tongue (anterior two-
thirds), of which a follow-up of at 
least 24 months was available. The 
following inclusion criteria were used 
to select the patients. None of the 
patients had been treated otherwise 
earlier, nor in the follow-up. There 
was no evidence of a second primary 
tumor at the time of presentation, nor 
during follow-up. The distribution 
between metastasized and non-
metastasized tumors was 
predetermined on 20-20. In 16 of 20 
patients with a metastasized tumor, a 
neck dissection was simultaneously 
performed with treatment of the 
primary tumor and in all these cases 
lymph node metastasis was 
microscopically confirmed. The 
remaining four patients developed 
microscopically confirmed metastases 
during follow-up. In the group of 
patients with a non-metastasized 
tumor, there was no evidence of 
lymph node or distant metastases at 
the time of treatment, nor during 
.[26] E.J. Hannen, Anal.Cell Pathol. (2001). 
94 
Chapter 4—Computer Assisted Analysis of the Microvasculature in Metastasized and Non-
Metastasized Squamous Cell Carcinomas of the Tongue. 
Table 1. Clinical tumor size distribution. Observed frequencies per clinically determined T-
stage; predicted frequencies by the logistic regression model, after cross validation. N: number 
of patients perT-stage; percentage: correct classification perT-stage. N.a.: not applicable. 
Τ 
τ, 
τ. 
τ, 
τ, 
total 
metastasized 
observed predicted 
4 
12 
4 
0 
20 
6 
10 
5 
1 
22 
non-metastasized 
observed predicted 
9 
9 
1 
1 
20 
7 
11 
0 
0 
18 
Ν 
13 
21 
5 
1 
40 
percentage 
85% 
8 1 % 
80% 
n.a. 
80% 
follow-up. In 19 of the 20 patients 
with non-metastasized tongue 
carcinomas a neck dissection was 
performed at the time of surgical 
treatment of the primary tumor, and 
no evidence of metastasis was found 
by the pathologist during routine 
examination of the lymph nodes. 
After initial treatment, no adjuvant 
treatment to the neck was given, for 
this group. During follow-up, the 
patients were seen every two months 
for physical examination and chest X-
rays were taken every 6 months. The 
distribution between the clinical T-
stages according to the UICC 2 7 is 
given in table 1. 
Immunohistochemistry 
Four micrometer thick, 
formalin-fixed, paraffin-embedded 
tissue sections were mounted on 
Superfrostpll'b slides (Menzal Gläser, 
Braunschweig, Germany), and dried 
overnight at 56° C. The sections were 
deparaffinized, treated with 1% Η,Ο, 
in methanol (20 minutes) and rinsed 
in phosphate buffered saline (PBS, 
pH 7.4) 3 times for 5 minutes. After 
pre-incubation with normal horse 
serum 100% (Vector Laboratories, 
[27] T N M Classification of malignant tumours (1992). 
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Burlingame, USA) for 20 minutes at 
room temperature (RT), an overnight 
incubation with anti-CD34 (Qb-
END, Biogenex, San Ramon, USA) 
1:2 in PBS/ 1% bovine serum 
albumin (PBS/1% BSA, Sigma, St. 
Louis, USA) was performed at 4 0C, 
followed by three steps of 10 minutes 
rinsing in PBS. Next, incubation with 
biotinylated horse-anti-mouse 
antibodies (Vectastain ABC-kit, 
Vector Laboratories) 1:200 in PBS/ 
1%BSA (Sigma) for 30 minutes at 
RT, and three rinsing steps of 5 
minutes in PBS. Subsequently, the 
tissue sections were incubated during 
45 minutes with peroxidase (PO) 
labeled avidin-biotin complex 
(ABO"', ABC Elite kit, Vector 
Laboratories) 1:100, with three 
rinsing steps in PBS of 5 minutes. 
Signal amplification was performed 
by catalyzed amplification of reporter 
deposition (CARD) as described 
before.28 Biotinylated tyramide (BT) 
solution was prepared dissolving 100 
mg sulfosuccinimidyl-6-
(biotinimide)hexanoate (NHS-LC-
biotin) (Pierce, Rockford, USA) in 40 
ml 50 mM borate buffer, pH 8.0. 
Next, 30 mg tyramine-HCI (Sigma) 
was added. The mixture was agitated 
[26] E. J. Hannen, Anal.Cell Pathol. (2001). 
347(1995). 
overnight at RT and filtered. Before 
application, BT was diluted 1:50 in 
PBS, with 0.01% H 20 2 . Incubation 
with BT solution was performed 
during 5 minutes at RT, with 
precipitation of BT at sites of PO 
reactivity. Deposited BT was detected 
with an extra incubation with ABCpo 
for 15 minutes. Finally, peroxidase 
was visualized with 0.05% 
diaminobenzidine tetrahydrochloride 
(DAB, Sigma) during 5 minutes. The 
sections were rinsed in tap water, 
slightly counterstained with Mayer's 
haematoxylin, rinsed in tap water, 
dehydrated and mounted with 
Permount (Fisher Scientific, Fair 
Lawn, USA). 
Tissue Sampling 
The systematic tissue sampling 
procedure that was used in the present 
study has been described elsewhere in 
more detail.26 In short, the slides were 
examined under low power 
magnification (4 χ objective) to 
identify areas containing tumor tissue. 
Next, neighboring fields in a 
horizontal and vertical direction were 
stored on disk in true color format, 
Η. M. Kerstens, J.Histochem.Cytochem. 43, 
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with a higher magnification (10 χ 
objective), thus reciprocating from 
left to right, starting at the top, going 
to the bottom through the slide. In 
cases of a large tumor area, two or 
more neighboring fields were skipped 
in a horizontal direction, in order not 
to exceed 60 fields. Only fields 
containing enough vital tumor tissue 
were included. Fields containing more 
that 50% vessel rich structures such as 
striated muscle, lamina propria or 
peripheral nerves were skipped, 
because of the prevailing presence of 
pre-existing (i.e., non tumor induced) 
vessels in these structures. In this 
manner, 40-60 fields were sampled 
for each tumor section. After 
recognition of the vessel profiles by a 
computerized image analysis system 
(CIAS), the images with the 
highlighted vessel contours were 
shown on an image monitor for 
interactive removal of small areas in 
the fields containing nerves, muscle 
cells, lamina propria, necrotic tissue, 
artifacts, prominent keratin pearls and 
incorrectly recognized vessel profiles. 
From the corrected images, the 
vascular parameters were computed 
by CIAS. 
Computerized image analysis 
Details of the image analysis 
used in the present study are described 
elsewhere.25'26 In short, image analysis 
was performed using a Vidasp'us system 
(Kontron GmbH, Eching, Germany). 
Images were recorded with a three 
chip CCD camera (DXC-325P, Sony, 
Tokyo, Japan) mounted on a 
conventional light microscope 
(Axioskop, Carl Zeiss, Jena, 
Germany), using a 10 χ objective 
(numerical aperture=0.3). 
Microscopic fields were digitized and 
stored on magneto-optical disks 
(Borsu Systema, Lelystad, The 
Netherlands) as true color (24-bit 
RGB) images. The size of each field 
was 0.17 micrometer2, measuring 
0.400 χ 0.425 micrometer. The pixel 
size was 0.78 χ 0.83 micrometer. 
Segmentation was done with an 
algorithm based on an adaptation of 
the HSI model, in which the RGB to 
HSI transform is applied to optical 
densities for the individual RGB 
channels, instead of intensities.25 
MVD, defined as the number of 
CD34 positive objects in a 
measurement field was determined, 
after interactive correction. In 
[25] J. A. van der Laak, Cytometry 39, 275 (2000). [26] E. J. Hannen, Anal.Cell Pathol. (2001). 
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addition, the area (AREA), perimeter 
(PERIM), and diameter (DIAM) of 
the individual vessels were 
measured.26 On the basis of DIAM, 
the vessels were subdivided in the 
following four categories. CATl 
vessels with DIAM < 5 micrometer, 
CAT2 vessels with 
5 < DIAM < 10 micrometer, CAT3 
vessels with 
10 < DIAM < 15 micrometer, and 
CAT4 vessels with 
DIAM > 15 micrometer. Then the 
percentage of each diameter category 
per patient was computed and added 
as parameter %CAT1, %CAT2, 
%CAT3 and %CAT4, respectively. 
Statistics 
Data analyses were performed 
using SPSS statistical software 
package (SPSS 9.0 for Windows, 
SPSS Inc., Chicago, USA). Based on 
the results of a previous study, we 
chose to include only the ten most 
vessel rich fields per patient, as this 
gave the best combination of 
reproducibility and discriminating 
power between the groups.26 An 
ANOVA was used to assess differences 
between the groups of patients with 
metastasized and non-metastasized 
[25] J. A. van der Laak, Cytometry 39, 275 
tumors. A forward likelihood-ratio 
stepwise logistic regression analysis 
was performed on the aforementioned 
parameters in order to select the best 
discriminating parameters. The 
selected parameters were used to 
construct a linear discriminant 
function DF to predict the occurrence 
of metastasis. Cross validation was 
performed using the 'leave-one-out' 
0 - 5 5-10 10-15 >15 
vessel diameter category 
Figure 1. Proportional microvessel counts in 
relation to vessel diameter. Percentages microvessels 
within the goups metastasized versus non-metastasizBd 
tumors, per diameter category 0-5, 5—10, ΙΟ­
Ι 5, and > 15 micrometer. Bars represent upper 
limit of 95% confidence interval. (Plot counesy 
o f J A W M . van der Laak) 
. [26] E. J. Hannen, Anal.Cell Pathol. (2001). 
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Table 2.Vessel parameters used in this study with their means and standard deviation (SD) for 
the groups metastasized and non-metastasized tumors and the significance level as obtained 
from an ANOVA. 
parameter 
MVD 
AREA 
PERIM 
DIAM 
%CAT1 
%CAT2 
%CAT3 
%CAT4 
non-metastasized 
mean SD 
32.9 
161 
57.4 
7.8 
25.1 
53.6 
17.1 
4.2 
8.6 
56 
11.1 
1.0 
7.4 
6.8 
7.2 
3.5 
metastasized 
mean SD 
25.5 
174 
60.6 
8.4 
17.5 
55.7 
22.2 
4.6 
7.6 
4S 
9.0 
0.8 
4.5 
8.2 
7.3 
3.8 
Ρ 
0.007 
0.40 
0.30 
0.06 
< 0.001 
0.40 
0.03 
0.70 
Table 3. Prediction results. Observed frequencies of metastasized and non-metastasized 
t u m o r s and p r e d i c t e d frequencies by the logist ic regression m o d e l , given by 
DF= 4.6743 - 0.2262 χ %CATl, after cross-validation. 
Predicted 
Observed 
non-metastasized 
metastasized 
non-metastasized 
15 (75%) 
3 (15%) 
metastasized 
5 (25%) 
17 (85%) 
procedure to reduce possible bias, 
because the same data sets are used 
both to construct the model, as well as 
to assess the classification 
performance of the predictor. 
Results 
A total of 19,427 vessels were 
assessed in 2181 fields, distributed 
over 40 patients in two groups. The 
results are summarized in table 2. In 
the group of non-metastasized tongue 
carcinomas, the mean MVD was 
significantly higher than in the group 
of metastasized tumors (p=0.007). In 
the latter group a greater value of the 
diameter was found than in the group 
of non-metastasized tumors, but the 
difference was not significant 
(p=0.06). 
Comparison of the group of 
non-metastasized tumors revealed 
that in the former group the 
microvessels with 
DIAM < 5 micrometer (p<0.001) 
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predominated, whereas vessels with 
10 < DIAM < 15 micrometer were 
more numerous in metastasized 
tumors (p=0.03) (table 2, fig. 1). 
Differences between metastasized and 
non-metastasized tumors for the other 
vascular parameters and the clinically 
determined T-stage were not 
significant at significance level of 
0.05. The stepwise logistic regression, 
applied on all vascular parameters and 
T-stage, selected only one parameter, 
namely %CAT1 vessels. The 
discriminant function (DF) obtained 
by logistic regression analysis is given 
be the formula: DF = 4.6743-
0.2262 χ %CAT1. Application of this 
DF resulted in 80% overall correct 
classifications. In the groups of 
metastasized and non-metastasized 
tumors, the percentages of correct 
classifications were 85% and 75%, 
respectively. The 'leave-one-out' cross 
validation procedure resulted in the 
same classifications (table 3). For the 
Tj, Τ , and Τ, tumors, the percentages 
of correct classifications were 85%, 
81%, and 80%, respectively (table 1). 
In our series there was only one 
patient with a T 4 tumor, and this 
tumor was erroneously classified as 
metastasized by the logistic regression 
model. The estimated relative risk to 
(continued page 102) 
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cases from H N group18; f: median;6: value for single hottest field, as opposed to top 10 fields 
2; * : value for all fields in tissue section, as opposed to top 10 from table 2. 
[5] L. L. Gleich, Head.Neck 18, 343 (1996). [6] L. L. Gleich, Head.Neck 19, 276 (1997). [8] 
D. A. Leedy, Otolaryngpl Head Neck Surg 111,417 (1994). [9]T. Shpitzer, Arch.Otolaiyngpl.Head.Neck 
Surg. 122,865(1996). [13]G.Gasparini,Int.J.Cancer55,739(1993). [l4]S.R.Tahan,J.Cumn.Pathol. 
22, 236 (1995). [15] C. N. Penfold, Br.J.Oral Maxillofac.Surg. 34, 37 (1996). [16] S. Pazouki, 
J.Pathol. 183, 39 (1997). [17] M. Moriyama, Oral Oncol. 33, 369 (1997). [18] P. U. Hegde, 
Arch.Otolaryngol.Head.Neck Surg. 124, 80 (1998). [19] O. Gallo, J.Natl.Cancer Inst. 90, 587 
(1998). 
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have a metastasized carcinoma is 17 
times higher in patients with a 
DF value > 0, corresponding with 
%CAT1 < 20.7%, than patients with 
DF value < 0. 
A second observer independently 
measured the same tissue sections of 
10 patients in order to assess the inter-
observer reproducibility of the 
classification results of the 
discriminant function. In one case 
there was an inconsistent classification 
of the metastatic behavior between 
both observers. (Cohen's kappa = 
0.78, where kappa > 0.75 indicates a 
strong inter-observer agreement). 
Discussion 
The most remarkable result of 
the present study was that 
significantly higher MVDs were 
found in the group of non-
metastasized tumors than in the group 
of metastasized tumors. Other studies 
on HNSCC, which disclosed 
significant difference between 
metastasized and non-metastasized 
tumors, reported higher values of 
MVDs in the former group (table 4). 
Other investigators found lower 
MVDs in metastasized HNSCC than 
in the non-metastasized tumors, but 
the differences between both groups 
were not significant.814'7·29 Our 
observation in tongue carcinomas is 
not unique, because in a recent study 
on renal cell carcinomas it was also 
found that tumors without metastasis 
had a higher number of microvessels 
than tumors with metastases, and the 
difference was highly significant.30 
They found that MVD was the most 
important factor to predict the 
occurrence of metastatic disease, and 
conclude that the inverse correlation 
between MVD and metastatic disease 
implies that the relation between 
MVD and metastasis formation is 
more complex than assumed 
hitherto.10 
Indeed, an inverse correlation 
between MVD and metastatic 
behavior seems to be in conflict with 
Folkman's concept concerning the 
development of metastasis, in which 
the complex process of angiogenesis 
[8] D. A. Leedy, Otolaryngol Head Neck Surg 111,417 (1994). [14] S. R.Tahan, J.Cutan.Pathol. 
22, 236 (1995). [17] M. Moriyama, Oral Oncol. 33, 369 (1997).[29] S. S. Forootan, Cancer 
Detect.Prev. 23, 137 (1999). [30] C. Herbst, J.Cancer Res.Clin.Oncol. 124, 141 (1998). 
102 
Chapter 4—Computer Assisted Analysis of the Microvasculature in Metastasized and Non-
Metastasized Squamous Cell Carcinomas of the Tongue. 
plays an important role.' The process 
of angiogenesis is characterized by a 
series of events, namely migration of 
endothelial cells, sprout formation, 
endothelial cell proliferation, fusion of 
sprouts and eventually maturation of 
newly formed vessels by formation of 
basement membrane and the 
appearance of pericytes." 12 It is 
plausible to assume that only 
functional vessels, produced during 
angiogenesis, are involved in the 
transport of tumor cells from the 
primary tumor to lymph nodes or 
distant organs. Under this 
assumption, our results are less 
conflicting with Folkman's concept. 
We found that higher MVDs in the 
non-metastasized tumors was caused 
by the predominance of'microvessels' 
with a diameter smaller than 5 
micrometer. It is unlikely that 
'microvessels' with a diameter smaller 
than 5 micrometer are functional 
vessels. More probable is that these 
structures include a majority of the 
migrating and sprouting endothelial 
cells. In addition, we found that 
microvessels with a diameter in the 
range of 10-15 micrometer 
predominated in the metastasized 
tumors. The latter finding gives 
support to the assumption that only 
functional vessels are involved in the 
process of metastasis, but this remains 
to be established by more appropriate 
techniques. Antibodies to CD34 and 
other pan-endothelial markers are 
unsuitable for this purpose, because 
they are incapable of selective 
visualization of functional vessels or 
other vascular structures preferentially 
used by tumor cells to metastasize. A 
perfusion marker to visualize 
functional vessels may be more 
appropriate in this respect." In the 
present study, anti-CD34 antibodies 
were used to visualize vessels instead 
ofanti-CD31 antibodies proposed as 
standard for the visualization of 
vessels20, because the latter also stains 
plasma cells, often abundantly present 
in the inflammatory infiltrate of 
tongue carcinomas, hampering the 
automatic recognition of vessels by 
image analysis. CARD amplification 
enhanced the staining intensity, which 
appeared to be needed for the 
automatic recognition of vessels by an 
image analysis system, but also 
visualized more vessels than the 
standard procedure, especially in 
tumor where the immunoreactivity 
[1] J. Folkman, J.Natl.Cancer Inst. 82, 4 (1990). [20] P. B. Vermeulen, Eur.J.Cancer 32A, 2474 
(1996). [31] I. J. Fidler, In: Cancer: Principles and Practice of Oncology (1997). [32] P. Carmeliet, 
Nat.Med. 6, 389 (2000). [33] J. Bussink, Br.J.Cancer 77, 57 (1998). 
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was absent or the vessels were stained 
very weakly.26 In the metastasized 
tongue carcinomas we found MVDs 
in the range of MVDs found by 
Gleich et al.5,6 in squamous cell 
carcinomas of the tongue and floor of 
the mouth using antibodies directed 
against FVIII and CD31 (table 4). In 
contrast to the latter studies we found 
significantly higher MVDs in the 
non-metastasized tumors (table 4). A 
possible explanation is that the use of 
monoclonal antibody directed against 
CD34 in combination with the 
CARD amplification step visualized 
more vascular elements of the pre-
maturation phase of angiogenesis than 
standard immunohistochemical 
procedures using antibodies against 
CD31 and Factor VIII without signal 
amplification widely used in studies 
on angiogenesis. Anti-CD34 
antibodies generally react well with 
endothelial cells in large blood vessels, 
but their expression without CARD is 
diminished or absent from some 
microvessels in normal and many 
tumor tissues.34 
Metastasized and non-
metastasized tongue carcinomas 
differed most significantly for the 
[5] L. L. Gleich, Head.Neck 18, 343 (1996). [( 
E. J. Hannen, Anal.Cell Pathol. (2001). [34] 
A. Brennan, N.Engl.J.Med. 332, 429 (1995). 
percentage of microvessels with 
diameter smaller than 5 micrometer. 
This percentage was the only 
parameter selected by the stepwise 
logistic regression analysis, including 
all vascular parameters and the clinical 
Τ stage, to discriminate between 
metastasized and non-metastasized 
tongue carcinomas. The univariate 
classifier resulted in 85% and 75% 
correct classifications in the group of 
metastasized and non-metastasized 
tongue carcinomas, respectively. This 
classifier predicted the metastatic 
behavior independently of the tumor 
size, because the percentage of correct 
classifications for Τ , T 2 and Τ 
tumors were in the same range. Lower 
percentage of correct classifications in 
the group of non-metastasized tumors 
could be expected, as micro-
metastases have been missed in the 
routinely microscopic examination of 
the lymph nodes in neck dissection 
specimens. It was shown by molecular 
techniques that neoplastic cells could 
be identified in 6 of 28 lymph nodes 
(21 %) that were initially negative by 
histopathological assessment." 
L. L. Gleich, Head.Neck 19, 276 (1997). [26] 
. Kumar, Cancer Res. 59, 856 (1999). [35] J. 
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Although the results of the present study regarding the prediction of 
metastatic behavior of tongue carcinomas were encouraging, the applicability of 
our logistic regression model is limited for use in treatment planning of the 
individual patients. In our opinion, an overall percentage of misclassification of 
20% is still too high for use in clinical practice. When vessel parameters measured 
in biopsy specimens will be used in our logistic regression model in order to 
predict the metastatic behavior of the primary tumor at the time of diagnosis, 
higher percentages of misclassifications can be expected, due to tissue sampling 
errors. 
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Abstract 
Predicting the presence of metastasis, based on tumor or tumor related 
characteristics is of utmost importance. We studied the significance of tumor 
DNA features and tumor related angiogenesis, to predict the occurrence of 
metastasis in squamous cell carcinomas (SCCs) of the tongue. 
Paraplast blocks from resection specimens of 20 metastasized and 20 non-
metastasized SCCs of the tongue with a minimum follow-up of 24 months were 
used. Tissue sections were stained with anti-CD34 monoclonal antibodies for 
vessel visualization, and according to Feulgen to stain DNA. Using image 
analysis, data from both stainings were computed for each of the 40 carcinomas. 
A logistic regression model to predict the presence of metastasis, based on 
vascular and nuclear morphology features, was developed. 
The intra-tumoral variation of chromatin condensation and the percentage 
vessels smaller than 5 micrometer in diameter were selected for the model. The 
model correctly predicted metastasis in 90% of patients, and excluded metastasis 
correcdy in 75% of non-metastasized tumors. Taking into account the prevalence 
of metastasis in SCC of the tongue of between 30% and 60%, this means a 
predictive value for a negative outcome of between 95% and 83%. 
The proposed model shows an improvement of predictive values compared 
to previous models with single parameters. Therefore, a multiparameter model 
appears to predict the multiparameter process of metastasis better. 
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Introduction 
The presence or absence of 
metastases mainly determines survival 
from head and neck squamous cell 
carcinomas (HNSCCs).1 
Identification of metastatic disease 
therefore has major impact in 
selecting the appropriate treatment 
plan. Both tumor related and host 
related factors play a role in 
metastasis. Tumor factors include T-
classification2 5, DNA content6·7, 
differentiation grade8, and alterations 
in expression of genes and gene 
products/·5·9"14 Among host factors are 
age and sex15, and carrier status of 
Epstein-Barr Virus.16 Representations 
of tumor-host interaction are 
angiogenesis17, infiltration depth18,19, 
infiltration pattern8 20, perineural and 
intravascular spread9, and cell-
adhesion molecules.21 However, none 
of these singly has proven sufficient 
for predicting metastasis reliably, 
presumably because the complex 
character of metastasis formation 
includes multiple critical factors.' 2 2 · 2 , 
Accumulation of genetic damage 
that leads to expression of a malignant 
phenotype is a prerequisite for 
metastasis formation.14 Genetic 
alterations are likely to be reflected in 
the morphology of the cell nuclei, 
since DNA packaging alters along 
with altering DNA composition, in 
the highly organized nuclear 
chromosome domains. 2 4 2 5 Feulgen 
stained nuclei in tongue carcinomas 
have been assessed to predict 
metastasis.26 Computerized features 
regarding the chromatin 
condensation in the nuclei and the 
roundness of nuclei showed good 
association with metastasis, and 
[1]I. J. Fidler, Cancer Chemother.Pharmacol. 43 SuppI, S3 (1999). [2]A. S. Jones, Eur.J.Cancer 
Β Oral Oncol. 30B, 8 (1994).[3]H. P. Howaldt, J.Craniomaxillofac.Surg. 27, 275 (1999). [4]A. 
I. Dreyfuss, Hematol.Oncol.Clin.North Am. 5, 701 (1991). [5]P. D. Lacy, Cancer 86, 1387 
(1999). [6]G. Baretton, Oral Surg.Oral Med.Oral Pathol.Oral Radiol.Endod. 79, 68 (1995). 
[7]T. Saito, Int.J.Oral Maxillofac.Surg. 23, 28 (1994). [8]E. W. Odell, Cancer 74, 789 (1994). 
[9]J. A. Woolgar, Head Neck 17,463 (1995). [10]H. Mineta, Cancer 85, 1011 (1999). [11]X. 
Xie, Cancer 86,913 (1999). [12]U. Bockmiihl, Cancer Res. 56,5325. (1996). [13]X Li, J.Nad.Cancer 
Inst. 86, 1524 (1994). [14]D. Sidransky, Curr.Opin.Oncol. 7, 229 (1995). [15]M. Kuriakose, 
Eur.J.Cancer Β Oral Oncol. 28B, 113 (1992). [16]I. Kobayashi, J.Pathol. 189,34 (1999). [17]E. 
J. Hannen, submitted (2001). [18]T. Asakage, Cancer 82, 1443 (1998). [19]H. Fukano, Head 
Neck 19,205 (1997). [20]R. H. Spiro, Head Neck 21,408 (1999). [21]V. Mattijssen, Int.J.Cancer 
55, 580 (1993). [22]G. J. Petruzzelli, ORL J.Otorhinolaryngol.Relat Spec. 62, 178 (2000). 
[23] I. J. Fidler, In: Cancer Principles and Practice of Oncology (1997). [24] C. Giardina, Eur.J.Cancer 
Β Oral Oncol. 32B, 91 (1996). [25]S. K. Sarker, J.Laryngol.Otol. I l l , 141 (1997). [26]E.J. 
Hannen, J.Pathol. 185, 175 (1998). 
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identified metastasized tumors 
correctly in 72% of 70 cases.26 These 
results indicate that, although other 
factors than DNA composition 
influence nuclear morphology, it 
appears helpful in predicting 
metastasis in patients with tongue 
carcinoma. Genetic damage 
associated with neoplastic conversion 
such as disabling the p53 tumor 
suppressor gene is also associated with 
angiogenesis, i.e. tumor induced 
formation of new vessels.2728 A 
relation between vessel density and 
metastasis has been claimed for a 
number of tumors.29 Recently, we 
showed that computer derived 
features from the vascular bed can 
help predict metastasis in tongue 
carcinomas. Microvessels with a 
diameter < 5 micrometer were found 
significantly more numerous in non-
metastasized tumors. A prediction 
model, based on these findings, 
showed a sensitivity of 85% and 
specificity of 75%.17 
In the absence of 
unconditionally reliable predictors of 
metastasis in clinically non-
metastasized HNSCC, patients in 
many cancer centers undergo elective 
neck dissections to detect and treat 
possible occult metastatic neck 
disease.30 33 Other centers that favor a 
'wait and see' policy, sometimes face 
metastases in an advanced stage 
during follow up, that need adjuvant 
treatment besides a neck dissection, 
and show an elevated prevalence of 
distant metastasis.34 35 In an effort to 
further improve predictions, and thus 
to help decide which cN0 necks are 
safe left untreated, we combined data 
from our nuclear and vascular 
morphology studies in a 
multiparameter statistical evaluation. 
Based on a survey in Pubmed 
(http://www.ncbi.nlm.nih.gov: 80, 
from 1990 to present), this is to the 
best of our knowledge the first 
attempt to assess the predictive value 
of a combination of variables, in 
relation to metastatic behavior in 
SCC of the tongue. 
[17]E. J. Hannen, submitted (2001). [26]E. J. Hannen, J.Pathol. 185, 175 (1998). [27]K. M. 
Dameron, SCIENCE 265, 1582 (1994). [28]D. Hanahan, Cell 100, 57 (2000). [29]N. Weidner, 
J.Pathol. 184, 119(1998). [30]K. J. Haddadin, Head Neck 21, 517 (1999). [31]J. J. Manni, 
Am.J.Surg. 162, 373 (1991). [32]S. W. Beenken, Head Neck 21, 124 (1999). [33]R. M. Byers, 
Head Neck 19, 14 (1997). [34]H. Kurita, Int.J.Oral Maxillofac.Surg. 24, 356 (1995). [35]A. 
Alvi, Head Neck 19, 500 (1997). 
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Material and Methods 
Patients 
In a retrospective study, we 
retrieved from our archives 40 
paraplast blocks from resection 
specimens of primary SCCs of the 
mobile tongue (anterior two-thirds), 
of which a follow-up of at least 24 
months was available. The following 
inclusion criteria were used to select 
the patients. None of the patients had 
been treated otherwise earlier, nor in 
the follow-up. There was no evidence 
of a second primary tumor at the time 
of presentation or during follow-up. 
The distribution between 
metastasized and non-metastasized 
tumors was predetermined on 20-20. 
In 16 of 20 patients with a 
metastasized tumor, a neck dissection 
was performed simultaneously with 
treatment of the primary tumor and 
in all these cases lymph node 
metastasis was microscopically 
confirmed. The remaining four 
patients developed microscopically 
confirmed metastases during follow-
up. In the group of patients with a 
non-metastasized tumor, there was no 
[36]K. T. Robbins, Otolaryngol.Clin.North 
malignant tumours (1992). 
s in Tongue Carcinomas, Combining Vascular 
and Nuclear Tumor Parameters. 
evidence of lymph node nor distant 
metastases at the time of treatment or 
during follow-up. In 19 of the 20 
patients with non-metastasized 
tongue carcinomas, a neck dissection 
was performed at the time of surgical 
treatment of the primary tumor, and 
no evidence of metastasis was found 
by the pathologist during 
standardized routine examination of 
the lymph nodes.'6 After initial 
treatment, no adjuvant treatment to 
the neck or else was given, for this 
group. During follow-up, the patients 
were seen every two months for 
physical examination and chest X-rays 
were taken every 6 months. The 
distribution between the clinical T-
classifications, according to the 
UICC'7 is given in table 1. All 
assessments were performed without 
prior knowledge of clinical outcome. 
Vascular morphology 
Four micrometer thick formalin-
fixed, paraffin-embedded tissue 
sections were incubated overnight 
with an anti-CD34 antibody (Qb-
END, Biogenex, San Ramon, USA). 
Signal amplification was performed 
(continued page 113) 
. 31, 639 (1998). [37] TNM Classification of 
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Table 1 : Clinically determined T-classification, predicted and actual metastasizing behavior. 
See pg. 115 for details. 
Patient 
number 
1 
2 
3 
4 
s 
6 
7 
8 
9 
10 
η 
12 
13 
14 
H 
16 
17 
18 
19 
20 
21 
22 
23 
24 
2S 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
Clinical T-
classification 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
3 
3 
3 
3 
3 
4 
Actual 
meta 
non-meta 
meta 
non-meta 
non-meta 
meta 
meta 
non-meta 
non-meta 
non-meta 
non-meta 
non-meta 
non-meta 
non-meta 
non-meta 
meta 
meta 
meta 
meta 
meta 
meta 
meta 
meta 
non-meta 
non-meta 
meta 
non-meta 
non-meta 
non-meta 
non-meta 
non-meta 
meta 
meta 
meta 
meta 
meta 
meta 
meta 
non-meta 
non-meta 
Predicted 
meta 
non-meta 
meta 
non-meta 
non-meta 
meta 
meta 
non-meta 
non-meta 
meta 
non-meta 
meta 
non-meta 
non-meta 
non-meta 
meta 
meta 
non-meta 
meta 
meta 
non-meta 
meta 
meta 
meta 
non-meta 
meta 
non-meta 
non-meta 
meta 
non-meta 
non-meta 
meta 
meta 
meta 
meta 
meta 
meta 
meta 
meta 
non-meta 
Correct _ , 
- cTl 
per c i 
11/13 
(85%) 
25/40 
(63%) 
17/21 
(80%) 
4/5 (80%) 
1/1 (100%) 
cT2 
18/40 
(45%) 
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by catalyzed amplification of reporter 
deposition (CARD) during 5 minutes 
at room temperature. Ultimately, 
peroxidase was visualized with 0.05% 
diaminobenzidine tetrahydrochloride 
(DAB, Sigma, St. Louis, USA) during 
5 minutes. The sections were counter 
stained with hematoxylin, and 
examined under low power 
magnification (4 χ objective) to 
identify areas containing tumor tissue. 
Next, 40-60 fields were sampled in 
each tumor section with a higher 
magnification (10 χ objective).38 
Microscopic fields were digitized and 
stored on magneto-optical disks 
(Borsu Systema, Lelystad, The 
Netherlands) as true color (24-bit 
RGB) images. Segmentation was 
done by a computerized image 
analysis system (CIAS) with an 
algorithm based on an adaptation of 
the HSI model, in which the RGB to 
HSI transform is applied to optical 
densities for the individual RGB 
channels, instead of intensities.39 
Microvessel density (MVD), defined 
as the number of CD34 positive 
objects in a measurement field was 
determined, after interactive 
correction of artifacts. In addition, the 
area (AREA), perimeter (PERIM), 
and diameter (DIAM) of the 
individual vessels were measured. 
Based on the diameter (DIAM), 
percentages vessels per patient in four 
categories, i.e. vessels with 
DIAM < 5 micrometer, vessels with 
5 < DIAM <10 micrometer, vessels 
with 10 < DIAM < 15 micrometer, 
and vessels with DIAM > 15 
micrometer, were computed.38 
Nuclear morphology 
Three micrometer thick 
formalin-fixed, paraffin-embedded 
tissue sections were Feulgen stained.26 
Approximately 200 non-overlapping, 
well demarcated, not mechanically 
damaged and non-pyknotic 
interphase nuclei from tumor cells in 
the vicinity of the tumor-stroma 
border in different and randomly 
chosen areas of the tumor were 
selected by an experienced, cytology-
trained technician, thus sampling the 
tumor without preference for a certain 
area. Of each nucleus, 2 geometric 
parameters and 17 chromatin pattern 
features, i.e. 5 runlength features, 8 
co-occurrency features and 4 Young-
Mayall features were calculated.26,40 4 3 
[26]E. J. Hannen, J.Pathol. 185, 175 (1998). [38]E.J. Hannen, Anal.Cell Pathol. (2001). [39]J. 
A. van der Laak, Cytometry 39, 275 (2000). [40]I. T. Young, Cytometry 7,467 (1986). [4l]A. 
E. Dawson, Anal.Quam.Cytol.Histol. 15,227 (1993). [42]N. J. Pressman, J.Histochem.Cytochem. 
24, 138 (1976). [43]M. M. Galloway, Comput.Graph.Image Processing 4, 172 (1975). 
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Table 2: Prediction results of the linear predictor DF = (14.456 - 0.259 X [percentage vessels 
diameter 0-5 micrometer] - 124.002 x [SD of chromatin condensation]) after cross validation, 
compared to actual clinical outcome. 
Predicted 
Actual η metastasized non-metastasized 
metastasized 20 18 (90%) 2 (10%) 
non-metastasized 20 5(25%) 15(75%) 
The standard deviation of mean (SD) 
of each feature was included as 
separate feature. 
Statistics 
All statistics were performed 
using SPSS 9.0 for Windows (SPSS 
Inc., Chicago, USA). Forward 
likelihood-ratio logistic regression was 
used to select the most discriminating 
features, and to construct a linear 
predictor. To avoid bias from using 
the same set of patients to construct 
the model, as well as to test the model, 
the 'leave-one-out' method was 
applied to cross validate the results. 
The model's value thus estimates the 
probability of metastasis for a tumor, 
based on individual features of that 
tumor. The estimated probabilities 
from this model were then compared 
to the actual data in the patient's 
medical file, and percentages correct 
classifications were evaluated. 
Results 
Logistic regression selected one 
vessel related and one chromatin 
related parameter as the most 
discriminating. Based on these two 
parameters, a model was constructed: 
DF = 14.456 - 0.259 x (percentage 
vessels diameter 0-5 micrometer) -
124.002 x (SD of chromatin 
condensation). The posterior 
probability that a tumor has 
metastasized, given its value for the 
DF, is defined by P(meta|DF) = e l" / 
i\+cDr). Based on this model, 90% of 
the metastasized tumors, and 75% of 
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Table 3: Predictive values for positive (PV+), 
and negative (PV-) outcome of DF, calculated 
for 4 different prevalences of metastasis in SCC 
of the tongue46. 
Prevalence 
0.30 
0.40 
0.50 
0.60 
PV+ 
0.61 
0.71 
0.78 
0.84 
PV-
0.95 
0.92 
0.88 
0.83 
the non-metastasized tumors were 
correctly classified after cross-
validation (table 2). If we compare 
these data with the clinically 
determined tumor classification 
icTl 4) used as an indication for 
metastasis, we find results in favor of 
our classifier. Not only is the overall 
percentage correct classification 
higher (63% for the cT14, vs. 82.5% 
for the DF), also our model shows a 
more balanced distribution between 
the two groups. Table 1 summarizes 
all prediction results of both our 
model and the cT. If assumed that 
only cTj tumors would not 
metastasize, and all others would, 25 
of 40 (63%) tumors would have been 
predicted correctly. If cT2 were set as 
threshold, only 18 of 40 (45%) 
predictions would have been correct. 
This indicates that the DF is more 
suited for prediction purposes than 
the cT, ,, in this series. 
1-4' 
For clinical use, the predictive 
value for a negative and positive 
outcome, respectively, is more useful 
than the sensitivity and specificity. 
Since the predictive value for a test is 
dependent on the prevalence of the 
disease under investigation, we have 
used several prevalences of metastasis, 
as reported in literature for SCC of 
the tongue44^5, to compute the 
corresponding predictive values46. We 
have added these values for our model 
in table 3. 
Discussion 
Tongue SCCs are known to 
metastasize frequently4547, for which 
no trustworthy predictor is available. 
MRI and ultrasound guided fine 
needle aspiration biopsies of the neck 
have improved predictive values, but 
false negative results range up to 
50%.48 Tongue SCC patients 
developing a conversion of the 
[33]R. M. Byers, Head Neck 19, 14 (1997). [34]H. Kurita, Int.J.Oral Maxillofac.Surg. 24, 356 
(1995).[35]A. Alvi, Head Neck 19, 500 (1997). [44]J. A. Woolgar, Br.J.Oral Maxillofac.Surg. 
37, 205 (1999). [45]R. R. Million, In: Management ofHead and Neck Cancer: A Multidisciplinary 
Approach (1994). [46]T. J. Vecchio, N.Engl.J.Med. 274, 1171 (1966). [471M. Takagi, Cancer 
69, 1081 (1992). [48]R. P. Takes, Int.J.Radiat.Oncol.Biol.Phys. 40, 1027 (1998). 
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untreated neck, have a higher risk of 
distant metastases, and not 
infrequently need adjuvant 
radiotherapy.33"35·47 Thus, treatment of 
the cN0 neck in patients remains a 
dilemma for the head and neck 
surgeon. Performing neck dissection 
at the time of treatment of the 
primary tumor may imply 
overtreatment, especially in the cTj 
tumors, because in a substantial 
percentage of cases no lymph node 
metastases are found.30 In our series of 
13 cTj and 21 cT2 tumors, metastases 
were found in 4 (31%) and 12 (57%), 
respectively. Especially for patients 
with cTj tumors where radical 
resection can provide local cure 
relatively easy, it is important to 
estimate the risk of metastasis on the 
basis of tumor characteristics, 
preferentially determined on the 
biopsy specimen. 
As metastasis involves multiple 
steps, each of which is under the 
influence of regulatory mechanisms, 
not one single factor is probable to 
play the decisive role.1·23·'" Rather, 
several qualities must be united in a 
tumor environment to provide the 
necessary conditions for metastasis. 
Growing insight in the processes 
involved can provide candidate 
biomarkers to predict clinical 
behavior. Since stochastic elements 
influence metastasis, multiparameter 
statistical models based on such 
factors seem appropriate to predict 
biological behavior. Our current 
model, based on only two features 
from the basic requirements for 
metastasis seems to carry promise in 
this respect. 
Chromosomes in the interphase 
nucleus are localized in chromosome 
domains.50. Therefore, it is likely that 
numerical and structural 
chromosome aberrations associated 
with tumor progression are 
accompanied with changes in 
chromatin texture. In a study on 
colorectal carcinomas, an inverse 
relation between chromatin pattern 
and fractional allelic loss was found, 
and it was suggested that both nuclear 
morphology and biologic behavior are 
influenced by accumulated alterations 
in cancer associated genes.51 An 
association between biologic behavior 
and chromatin texture has also been 
[1]I. J. Fidler, Cancer Chemother.Pharmacol. 43 Suppl, S3 (1999). [23]I. J. Fidler, In: Cancer: 
Principles and Practice of Oncology (1997). [30]K. J. Haddadin, Head Neck 21, 517 (1999). 
[33]R. M. Byers, Head Neck 19, 14 (1997)[34]H. Kurita, Int.J.Oral Maxillofac.Surg. 24, 356 
(1995). [35]A. Alvi, Head Neck 19, 500 (1997). [47]M.Takagi, Cancer 69, 1081 (1992).[49]I. 
J. Fidler, Br.Med.Bull. 47, 157 (1991). [50]A. Leforestier, Biophys.J. 65, 56 (1993). [51]J. W. 
Mulder, Am.J.Pathol. 141, 797 (1992). 
116 
Chapter 5—Improved Prediction of Metastasis in Tongue Carcinomas, Combining Vascular 
and Nuclear Tumor Parameters. 
Table 4: Comparison between three different logistic regression models. Model 3 is the presently 
reported bivariate model. 
Model Cross-validated 
sensitivity specificity 
I26 72% 62% 
85% 
90% 
75% 
75% 
DF 
15.946 - 13.385 χ [circularity] - 60.887 χ [SD of 
chromatin condensation] 
4.674 - 0.226 χ [percentage vessels diameter 0-5 
micrometer] 
14.456 - 0.259 χ [percentage vessels diameter 
0-5micrometer] - 124.002 χ [SD of chromatin 
condensation] 
reported for bladder tumors.52 More 
recently, chromatin texture features 
were successfully used in statistical 
models to predict progressive behavior 
in cervical intraepithelial neoplasms53 
and tongue carcinomas.26 
Vascular features have been 
related to metastasis in a number of 
studies. Many studies supporting the 
role of angiogenesis for metastasis 
formation pay too little attention to 
biases, introduced through different 
methodology.385456 The use of CIAS 
has proven pivotal in this respect, 
which limits its use in routine 
practice. Not only is CIAS equipment 
not widely available, the assessment 
itself is not trivial, and needs careful 
consideration to reach good results. 
This combination of high 
immunohistochemical standards and 
CIAS probably limits the use of this 
approach to specialized, well-
equipped centers. 
Our current model shows 
improvement in performance over 
univariate models, constructed 
previously, as shown in table 4. The 
nuclear morphology parameters alone 
in model 1 reached a sensitivity of 
72%, vascular morphology parameter 
alone in model 2 reached 85%, both 
combined in the present model 
attained 90%. Indeed, the presence of 
metastases in tongue carcinomas was 
correctly identified in 90% of 
metastasized tumors from this series. 
The 10% misclassification is a 
[17]E. J. Hannen, submitted (2001). [26]E. J. Hannen, J.Pathol. 185, 175 (1998). [38]E. J. 
Hannen, Anal.Celi Pathol. (2001). [52]R. van Velthoven, J.Pathol. 173, 235 (1994). [53]A. 
G. Hanselaar, Anal.Celi Pathol. 16, 11 (1998). [54]K. Axelsson, J.Natl.Cancer Inst. 87, 997 
(1995). [55]S. S. Forootan, Cancer Detect.Prev. 23, 137 (1999). [56]J. S. De Jong, Lab.Invest. 
73, 922 (1995). 
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deficiency of the model, and addition 
of other parameters is probably 
necessary to improve results. In the 
non-metastasized tumors, 25% of 
cases were misclassified. This relatively 
high percentage can not exclusively be 
attributed to the shortcomings of the 
model, because micrometastases may 
have been missed during routine 
examination of the neck dissection 
specimen, as shown earlier.57 Thus, 
the lower percentage of correct 
classification in the latter group may 
be partially caused by such sampling 
error. 
The most important result of the 
present study is that the absence of 
metastasis appeared highly 
predictable, based on tumor 
characteristics independent of tumor 
classification. Given a prevalence of 
30% neck metastasis in tongue 
carcinomas, as reported for clinically 
negative necks45,58, our model can give 
95% certainty that metastases are 
indeed absent, if accordingly classified 
(table 3). To the best of our 
knowledge, these are the best results 
published so far. Regarding the 
clinical relevance of reliable statistical 
models to predict metastatic capacity 
of tongue carcinomas, the 
encouraging results of our first 
attempts to construct multiparameter 
logistic regression models based on 
tumor biologic features justify efforts 
to improve the model, and to validate 
the results in a prospective study. 
Addition of more parameters could 
theoretically improve results, but 
carries the risk of so called overfitting 
the model. Therefore, it is conceivable 
that in the future features are not 
simply added to this model, but used 
to replace ones introduced earlier. 
Candidates are not limited to biologic 
features, but may be derived from 
clinical data such as tumor thickness, 
which has shown independently 
related to metastasis in several 
studies.,H',9 Bearing in mind that the 
model is going to be used for 
treatment planning, selection should 
also be guided by practical motives. 
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The issues in this thesis are: 
What predicts metastasis in tongue 
carcinoma? Are newly identified 
parameters related to metastasis better 
in predicting metastatic behavior in 
individual patients, than traditionally 
used features? Are they reproducible, 
can they be used in daily practice? 
The clinical relevance in these 
questions lies in a crucial hallmark of 
cancer: acquiring metastatic 
potential.12 Seeding of daughter 
clones throughout the patients body 
makes irradication of the tumor 
burden improbable, as well as chances 
of patient survival questionable. Our 
approach has been to quantify 
metastasis-related factors in a 
retrospective setting, and employing 
statistical models to test their 
prognostic value. 
From a prevailing mechanistic 
metastasis model, features were 
selected resonating tumor and tumor-
host characteristics. Until recent, the 
search for influential factors was 
directed at independently operating 
mechanisms. However, the concept of 
multiple steps needed to accomplish 
metastasis, led us to the insight that 
not one single factor suffices to 
manage metastasis formation. The 
continued search for novel 
prognosticators for metastasis in a 
subsidiary way reflects the impotence 
of individual factors alone. Metastasis 
formation is the result of a sequence of 
acquired qualities united in a 
symbiosis of malignant cells. Image 
analysis rendered consistent results 
with improved detail' (chapter 3), 
logistic regression models established 
preliminary validation of these two 
basics for individual cases.4 (chapters 
1 and 4)1 Therefore, we proceeded 
with combining the two that had 
proven related to metastasis 
individually, into a regression model5 
(chapter 5). The findings suggest that 
this concept justifies continuation 
with other factors. The number of 
candidate factors to include into such 
a model is extensive, especially as new 
ones are identified on a regular basis.6 
9
 When potentially relevant factors 
have been found in screening, we 
should assure their prognostic value in 
prospective studies, and assert their 
clinical relevance in patient 
[1]E. J. Hannen, submitted (2001). [2]E. J. Hannen, submitted (2001). [3]E. J. Hannen, Anal.Cell 
Pathol. (2001). [4]E.J. Hannen, J.Pathol. 185, 175 (1998). [5]E.J. Hannen, Cancer (2001). 
[6]I. J. Fidler, J.Natl.Cancer Inst. 88, 1700 (1996). [7]B. A. Yoshida, J.Natl.Cancer Inst. 92, 
1717 (2000). [8]A. F. Chambers, J.Nad.Cancer Inst. 89,1260 (1997). [9]M.J. Frederick, Am J. Pathol. 
156, 1937(2000). 
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counseling. Based on the above 
hypothesis, we should look for 
combinations of factors, besides new 
single factors. Ultimately, not 
presence of metastases, but improved 
survival and quality of live are main 
endpoints. 
The following three paragraphs 
address some additional issues that 
may lead the way to future 
prospective studies. 
Angiogenesis 
Metastasis depends on multiple 
qualities, partially tumor related, 
partially tumor-host related, and 
possibly host related. In 1889, Paget 
postulated that metastasis is not a 
random process, but that selected 
malignant cells interact at favorable 
sites to form daughter tumors.10 
However, historically the escape of 
malignant cells into the vascular 
compartment was regarded pivotal in 
metastasis formation, long after that 
report. Recent findings directed the 
scientific community in re-evaluating 
Pagets ideas."12 
Highly sensitive detection 
methods have revealed that circulating 
malignant cells from HNSCC are 
much more ubiquitous that assumed 
until now'314, and that shedding into 
the vasculature is not likely rate-
limiting in metastasis. The 
importance of subclinical 
disseminated disease therefore also 
merits re-appraisal.15 Apparently, 
equally important is not so much how 
many, but which malignant cells have 
disseminated.'6"18 Most recently, 
metastasis patent cells appeared better 
capable of entering into the 
bloodstream, than non metastatic 
tumor cells.19 This is another 
indication, that (some of) the stations 
that compose the metastatic route are 
regulated. 
These findings help explain that 
microvessel density studies yield 
conflicting results.' Not only are in 
some studies methodological and 
statistical requirements unsatisfactory, 
host vasculature relates to metastasis 
in a more complex fashion than 
assumed. Tumor microvessels can 
serve as means of transportation, but 
only predisposed cells enter, and even 
[1]E.J. Hannen, submitted (2001).[10]S. Paget, Lancet8,98 (1889). [11]A. B. Al Mehdi, Nat.Med. 
6,100 (2000). [12]D. J. Ruiter, Lancet Oncology 2, 109 (2001). [13]R. H. Brakenhoff, Clin.Cancer 
Res. 5,725 (1999). [14]A. Zippelius, Ann.N.YA=ad.Sci. 906,110 (2000). [15]K. Pantel, J.Nad.Cancer 
Inst. 91, 1113 (1999). [16]T. Reynolds, J.Nad.Cancer Inst. 90, 1690 (1998). [17]S. B. Fox, 
J.Nad.Cancer Inst. 89, 1044(1997). [ISJD.Theodorescu, Int.J.Cancer 47, 118(1991). [19]J. 
B. Wyckoff, Cancer Res. 60, 2504 (2000). 
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then, a minority establishes 
metastasis.20"22 Furthermore, from our 
research it appeared that microvessel 
density can reliably be measured, but 
it is suggested that not all vessels are 
functional, in terms of transport. It 
appeared that very small microvessels 
are more numerous in non-
metastasized tumors, while the 
slightly larger ones are more often 
found in the metastasized tumors. 
This result suggests that only 
particular vessels contribute to 
metastasis. 
First, the majority of minute 
vessels may reflect domination of 
factors that stimulate the proliferation 
and migration of endothelial cells, e.g. 
FGF-1 , F G F ^ 2 1 and VEGF24. 
Conversely, it may reflect the lack of 
factors, that enhance tube formation 
and vascular differentiation, e.g. 
TGF-ß2 5 and TNF-a 2 6 . Both 
mechanisms are needed to result in 
vessels that actually transport 
malignant cells. 
Second, in a recent paper by 
Goldbrunner et al. on vascularization 
in human glioma xenografts, two 
distinct patterns of neovascularization 
were identified. Initiating at 24 hrs. 
post implantation into rat cerebral 
cortices, both microvessels sprouting 
from pre-existing vessels, as well as 
individual endothelial cells migrated 
toward to glioma xenografts.27 It is not 
clear whether microvessels < 5 
micrometer represent single, 
individual cells, or skimming 
transsections through microvessel 
walls, but if they do, they are not 
suited for transport of malignant cells. 
Third, in a corrosion cast study 
on rat tongue vessels, Castenholtz 
reported that initial lymphatics were 
characterized by a greater and widely 
varying diameter (15-50 
micrometer), in comparison to blood 
capillaries.28 Since anti-CD34 is not 
with certainty known to exclusively 
identify blood vessels, but maybe also 
lymphatic endothelium, it is possible 
that our observation reflects the fact 
that in metastasized tumors the higher 
proportion large vessels is determined 
by a greater percentage lymphatic 
vessels. 
[20]L. Weiss, Adv.Cancer Res. 54, 159 (1990). [21]]. E. Price, J.Natl.Cancer Inst. 73, 1319 
(1984). [22]K. J. Luzzi, Am.J.Pathol. 153, 865 (1998). [23]F. Bussolino, Eur.J.Cancer 32A, 
2401 (1996). [24]T. Veikkola, Semin.Cancer Biol. 9, 211 (1999). [25]M. S. Pepper, Cytokine 
Growth Factor Rev. 8,21 (1997). [26]J. R. Jackson, FASEB J. 11,457 (1997). [27]R. H. Goldbrunner, 
J.Neurosci.Res. 55, 486 (1999). [28]A. Castenholz, Scanning microsc 3, 315 (1989). 
124 
General Discussion 
Researchers have paid little 
attention to the role of lymphatics in 
metastasis, until recently.29"32 Lymph 
vessels are non existing in epithelia, 
and for a long time its was assumed 
that there are no lymphatics in 
carcinomas either. Anatomical and 
developmental studies on lymphatics 
are few, and date back to the 40's (for 
an overview, see ref.31). Unique 
markers for lymphatics have only 
recently been found", and this has 
further hampered clear distinction 
between blood and lymph 
vessels.30,34,35 It is still not clear how 
lymphogenic HNSCC metastases 
should be viewed in the light of 
enhanced blood vessel supply. The 
monoclonals used to visualize blood 
vessels may cross react with 
lymphatics, or anatomical 
connections between blood and 
lymph vessels are more numerous 
than presumed. Ultimately, perhaps 
circulating cells complete the circle 
through the human body, to 
eventually hatch in the lymph nodes 
of the neck, possibly because of 
favorable soil conditions.'6 
Further possible explanation for 
the higher content in vessels with a 
larger diameter, was suggested in 
Konerding et al.37 He reported that 
human endometrial carcinoma 
xenografts in nude mice exhibited 
considerable differences in vascular 
diameter in the tumors producing and 
secreting significant amounts of the 
angiogenic factor FGF-2, as opposed 
to the tumors that did not. These 
tumors showed a more aggressive 
behavior than the ones lacking FGF-
2. This finding seems to support that 
tongue carcinomas with larger caliber 
vessels are under the influence of 
specific angiogenic factors. 
Finally, an interesting 
observation was made by a group 
studying artificial tissue enginering.38 
Endothelial cells and smooth muscle 
cells were pipetted onto biodegradable 
scaffolds. Only those placed under a 
pulsatile pressure gradient, developed 
into functional arteries. Since the 
human vascular system is a parallel 
flow system with a pulsatile pressure 
gradient, sprouting of too many 
[29]S. A. Eccles, Recent Results Cancer Res. 157, 41 (2000). [30]M. Jeltsch, SCIENCE 276, 
1423 (1997). [31]J. Wilting, Cell Tissue Res. 297, 1 (1999). [32]R. M. de Waal, Am.J.Pathol. 
150, 1951 (1997). [33]S. Banerji, J.Cell Biol. 144, 789 (1999). [34]R. Clarijs, J.Pathol. 193, 
143 (2001). [35]A. Saaristo, Am.J.Pathol. 157,7 (2000). [36]E. Ruoslahti, Annu.Rev.Immunol. 
18, 813 (2000). [37]M. A. Konerding, Am.J.Pathol. 152, 1607 (1998). [38]L. E. Niklason, 
SCIENCE 284, 489(1999). 
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microvessels may cause a severe drop 
in pressure gradient, hampering these 
microvessels to grow into functional 
vessels. 
With these findings, the 
emphasis in tumor vascularization has 
shifted from the number of vessels, to 
the morphogenesis and functioning of 
vessels.'9,40 It appears that tumor 
vasculature is distinct from normal 
vasculature in endothelial 
characteristics36,41·42, and 
morphologically. It makes sense to 
assume that function differs as well.43 
Possibly perfusion as determined by 
contrast enhanced dynamic spin echo 
imaging can quantitate transport 
patent vessel capacity better than 
immunohistochemically stained tissue 
sections 44 
Genetic considerations 
Recently, new evidence for 
regulatory function of the specific 
folding of DNA has been implicated 
for gene expression 45-48 Many 
physiological processes influence the 
folding and unfolding of DNA, 
possibly masking minor genetic 
differences. Included in the model we 
developed, one tumor characteristic is 
the intra-tumoral variation of 
condensation of the DNA in the cell 
nucleus. It appeared that the variation 
in condensation was decreased in 
metastasized tumors.4 These findings 
are not easily translated into the 
findings from our CGH study 
(chapter 2)2 Here, metastasized 
tumors were found to exhibit more 
genomic aberrations, while this was 
seen in only a minority of tumors for 
each aberration. This provides 
circumstantial evidence that the 
heterogeneity between tumors may be 
increased in metastasized tumors4, but 
it bares no testimony on intra-tumoral 
variation. However, no contradiction 
is implicated either, and since DNA 
folding is under the control of plural 
mechanisms besides genomic 
constitution, these findings were 
foreseeable. Nevertheless, relatively 
[2]E. J. Hannen, submitted (2001).[4]E. J. Hannen, J.Pathol. 185, 175 (1998). [36]E. Ruoslahti, 
Annu.Rev.Immunol. 18, 813 (2000). [37]M. A. Konerding, Am.J.Pathol. 152,1607 (1998).[38]L. 
E.Niklason, SCIENCE 284, 489 (1999). [39]S. Yang, Am.J.Pathol. 155,887(1999). [40] W. 
G. Roberts, Am.J.Pathol. 153, 1239 (1998). [41]B. St Croix, SCIENCE 289, 1197 (2000). 
[42]W. Risau, Circ.Res. 82, 926 (1998). [43]R. S. Kerbel, Carcinogenesis 21, 505 (2000). [44]C. 
F. van Dijke, Radiology 198, 813 (1996). [45]M. S. Santisteban, Cell 103, 411 (2000). [46]H. 
N. Cai, SCIENCE 291, 493 (2001). [47]E. Muravyova, SCIENCE 291, 495 (2001). [48]A. 
C. Bell, SCIENCE 291, 447 (2001). 
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unrefined features, such as nuclear 
morphology4 disclose differences 
between metastasized and non-
metastasized tongue carcinomas. Part 
of the detected information is 
presumably a reflection of genetic 
differences between the two 
phenotypes. 
Further focussing on 
chromosomal differences in ref.2 
confirmed that indeed the genome of 
metastasized SCC of the tongue 
showed increased alterations that may 
impel the findings of our nuclear 
morphology study.4 
Screening for predicting factors 
thus moves more and more towards 
genetic substrates.749·50 Candidate 
suppressor genes, as opposed to 
oncogenes, emerge favorite for several 
reasons. First, the most frequent 
genetic aberrations in HNSCC 
progression models are deletions.^^ 
Second, although not a single gene is 
capable of advancing tumor cells 
through the cascade of metastasis, a 
single metastasis suppressor gene is 
enough to form an obstacle. 
Inactivation of such a gene could 
suffice to complete the sequence, and 
thus be crucial. 
Including novel, even more 
specific techniques into our 
armamentarium may elucidate exactly 
which genes are up, and down 
regulated, respectively, by analyzing 
transcription modifications and 
finally protein expression. Once the 
exact influential factors of metastasis 
have been established, annotation to 
their function and timing in the 
process of metastasis becomes 
opportune. Although the steps of 
metastasis are separately 
distinguishable, some may be linked. 
Since genes can be switched on and 
off again during tumor progression, 
and since both the on and off 
expression may be required for 
completion, a variety of cascades is 
imaginable along which the sequence 
proceeds, entangled with the tumor 
environment, realizing that paracrine 
effects may exercise influence.52''1 In 
this respect, detaching from the 
parent neoplasm is the contrary of 
attaching to endothelial cells to exit 
the circulation.'6 Also, many steps in 
[2]E. J. Hannen, submitted (2001). [4]E. J. Hannen, J.Pathol. 185, 175 (1998). [7]B. A. Yoshida, 
J.Natl.Cancer Inst. 92, 1717 (2000). [36]E. Ruoslahti, Annu.Rev.Immunol. 18, 813 (2000). 
[49]G. F. Greene, Am.J.Pathol. 150, 1571 (1997). [50]Y. Kitadai, Clin.Cancer Res. 1, 1095 
(1995). [51]U. Bockmuhl, Cancer Res. 57, 5213 (1997). [52]I. J. Fidler, J.Natl.Cancer Inst. 
87, 1588 (1995). [53]I. J. Fidler, Cancer Chemother.Pharmacol. 43 Suppl, S3 (1999). 
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the formation of new vessels are 
shared with the process of metastasis. 
Possibly, a high angiogenic potential 
creates enough paracrine effects for 
carcinoma cells that lack in e.g. extra 
cellular matrix degrading capacity to 
come loose from their mother tumor. 
In this conceptual point of view, a 
microenvironment is conceivable, 
where cancer cells are mutually 
dependent on each others' selected 
qualities, to meet all requirements for 
metastasis, since chances are small that 
all these are united in one single clone 
of cells.12 
This is the territory of 
stochastics, where chances determine 
the eventual result in a pool of 
factors.5'1 Since multiple elements are 
involved in the metastatic sequence, 
mathematical models such as ours can 
be regarded as linked conditional 
probabilities. This may explain why 
only seldom very small tumors 
metastasize: odds are smaller that all 
conditions are favorable in a few 
clones, than in a big assortment of 
clones, i.e., a large tumor. Although 
selection of subpopulations is crucial 
in metastasis18, circumstantial and 
empirical evidence is supportive of the 
stochastic character of metastasis. In 
general, metastasis is a relatively late 
phenomenon, when subclinical 
disease is included in the time frame.54 
The fact that many malignant cells are 
being shed from a tumor daily, and 
the fact that malignant cells can be 
detected in peripheral blood samples 
of carcinoma patients, set against the 
in this context relative low frequency 
of clinically detectable metastases, 
indicates that the majority of cells do 
not complete the sequence.22 A higher 
tumor load nevertheless increases risk 
of metastasis and the more genetically 
instable cells available, the higher 
chances are of sharing the right 
qualities to fulfill the course. 
The factors brought into our 
research were derived from a scientific 
hypothesis where a strict role was 
attributed to each separately. From the 
above deduction it becomes clear that 
this is a simplification of reality, and 
in this light it is remarkable that based 
on a single parameter, e.g., 
angiogenesis1·22, or nuclear 
morphology422, such striking 
prediction results were obtained. It is 
pragmatic to assume that further 
single parameter prospective studies 
[1]E.J. Hannen, submitted (2001).4]E. J. Hannen, J.Pathol. 185,175(1998). [12]D. J. Ruiter, 
Lancet Oncology 2, 109 (2001). [ISlD.Theodorescu, Int.J.Cancer 47, 118 (1991). [22] K.J. 
Luzzi, Am.J. Pathol. 153, 865 (1998). [54]Wai-YuanTan, Stochastic models of carcinogenesis 
(1991). 
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will show less favorable results. Much 
more is to be expected from 
multiparameter models5, fed by novel 
features from tumor biology research. 
Attractive candidates are genetic 
aberrations, now being unclosed by 
micro-array technology. The 
acquisition of these qualities are the 
result of accumulated alterations in 
the genome of cancer cells, ultimately 
causing its death, due to damage so 
severe, that vital cell functions are 
compromised. Overzealous search for 
aberrations in the tumor genome 
however underestimates the influence 
of genes that need to function 
properly, to avoid elimination 
through the apoptotic cascade. Thus, 
not only aberrantly expressed genes, 
but also normally functioning genes 
may improve the model. 
Clinical considerations 
In the first place, refinement of 
prognostic information facilitates 
improved clinical testing by ensuring 
compatibility of treatment groups." 
In treatment planning, the clinical 
impact of our findings will probably 
be most important in the group of 
patients that are without evidence of 
metastasis by conventional methods. 
If assured, that chances of metastasis 
were nil, radical local treatment could 
cure such patient. Our proposed 
logistic regression model selected 
patients without metastases with 95% 
certainty3, which is the best result 
published ever. For patients in the at-
risk group, adjuvant treatment of the 
neck would be recommendable, 
systemic adjuvant treatment might be 
considered.43,36 In the end, the 
partially stochastic nature of the 
process of metastasis excludes the 
possibility to achieve perfectly correct 
prediction of metastasis based on 
selected biologic features.57 
[5]E. J. Hannen, Cancer (2001). [43]R. S. Kerbel, Carcinogenesis 21, 505 (2000). [55]W. L. 
Donegan, CA Cancer J.Clin. 47, 28 (1997). [56]B. Vikram, CA Cancer J.Clin. 48, 199 (1998). 
[57]L. L. Gleich, Head.Neck 19, 276 (1997). 
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The purpose of this thesis has 
been to study tumor-related biologic 
factors, potentially of interest to 
predict metastasis in HNSCC. 
The General Introduction gives 
an overview of some issues involved in 
diagnosing and treating HN cancer, 
such as epidemiological data, clinical 
presentation of some forms of HN 
cancer, pathologic considerations in 
HN cancer, and features currently 
available to assess metastatic potential. 
Although technical advances have 
improved tracking metastases 
considerably, still the issue of 
treatment of the neck without clinical 
evidence of metastasis, remains 
controversial. Elective treatment 
inflicts harm on a majority of patients 
that would never have developed neck 
metastases, abstinence of treatment 
may increase mortality and morbidity 
of patients that emerge with 
metastases after treatment of the 
primary tumor, that might have been 
cured by simultaneous treatment of 
the neck. The use of tumor derived 
factors that are related to the process 
of metastasis, to predict rather than 
trace metastasis could help solve this 
issue. 
The two major topics of 
investigations in this thesis are 
introduced in the next two 
paragraphs, namely genetic 
aberrations and angiogenesis. An 
oncogenesis model is proposed, based 
on data available in the literature. A 
growing insight into the genetic 
machinery that drives neoplastic 
progression has identified a number of 
aberrations that may have prognostic 
significance. Experience in predicting 
metastasis with their use, and the use 
for individual patients rather than 
groups of patients, is still limited. 
Angiogenesis is put in relation to 
tumor growth and metastasis. 
Microvessel density as an intermediate 
endpoint of angiogenesis, and the 
limitations of its quantification in 
histologic tissue sections are discussed. 
Problems with reproducibility of 
measurements may explain the 
conflicting results in microvessel 
density studies in the HN area. 
The final paragraphs contain an 
outline of this thesis and some 
remarks to the methods employed in 
our research. Image analysis to render 
more detailed information as to the 
microvasculature and the need for 
high quality tissue sections are 
discussed. Finally, the role of statistical 
prediction models to calculate the risk 
of metastasis in individuals, rather 
than groups is explained. 
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Chapter 1 reports the results 
from our studies on morphological 
details in nuclei from tongue SCCs. 
Data recorded with image analysis 
disclosed differences between 
metastasized and non-metastasized 
tongue SCC. A logistic regression 
model selected two features that 
correctly identified the metastatic 
status of 68% of individual patients. 
This finding may be a reflection of a 
different genetic composition of 
metastasized tumors, since it is likely 
that this influences nuclear 
morphology. The relative high 
percentage correct classifications is 
striking when we realize that so much 
other factors influence the 
morphology features studied. 
Chapter 2 reports data from 
malignant cell nuclei in more detail, 
focussing on chromosomal differences 
between metastasized and non-
metastasized tongue SCC, obtained 
from CGH analysis. We showed that 
chromosomal aberrations are more 
numerous and more frequently 
involved in metastasized tongue 
SCCs. Some regions that are putative 
candidates for future genetic studies 
are indicated. The genes that so far 
have been identified and annotated in 
those regions may be related to 
metastasis. 
Chapter 3 introduces the subject 
of assessing angiogenesis. Here we 
discuss some of the methodological 
implications of studying vasculature 
in tissue sections with image analysis. 
Image analysis carries major 
advantages, but it needs superior 
staining quality of the tissue sections. 
Reproducibility of measurements was 
evaluated in the context of a new 
immunohistochemical protocol to 
stain blood vessels. The selection of 
hot spots of neo-vascularization is 
heavily prone to subjective 
interpretations. Averaging the 
measurements in the 10, rather than 
one field of highest vascularization, 
warrants better reproducibility. 
Chapter 4 reports the results 
from our study on tongue SCC with 
the technique described in Chapter 3. 
Most striking is our finding higher 
blood vessel counts in non-
metastasized tumors than in 
metastasized, contrary to other 
tumors reported in literature. This 
seemingly contradiction may be 
caused by a substantial amount of 
non-functional, very small vessels in 
non-metastasized tumors that 
although included in the total sum, 
does not contribute to metastasis 
formation. A logistic regression model 
identified the metastatic status of 
individual patients in 80% correctly. 
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Chapter 5 combines the results 
from chapter 1 and 4, by introducing 
them into one logistic regression 
model. Together, the two features 
reached 82.5% of correct 
classification overall, the best so far 
reported for individual patients. This 
may be interpreted as a reflection of 
the multifactorial complex process 
that metastasis is thought to be. 
The General Discussion 
addresses possible future directions of 
investigation, based on the main 
results of our research. High-risk 
patients for metastasis may benefit 
from multiparameter prediction 
models such as ours, when they are 
offered regional and possibly systemic 
treatment, low-risk patients by 
restricting treatment to irradication of 
the primary tumor, thus withholding 
unnecessary morbidity from 
treatment beyond local. 
Novel features may be added to 
our model, or may replace others, to 
further improve predictions, doing 
justice to the multi-event cascade that 
leads to metastasis. Ultimately, data 
from a patient's own tumor may guide 
tailor made treatment plans, and 
optimize patient counseling. 
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Dit proefschrift heeft tot doel het 
bestuderen van biologische factoren, 
die van belang kunnen zijn om 
metastaserend gedrag van Hoofd-hals 
plaveiselcel carcinomen (HHPCC) te 
voorspellen. 
De Algemene Introductie geeft 
een overzicht van enige zaken met 
betrekking tot de diagnostiek en de 
behandeling van HH kanker, zoals 
epidemiologische gegevens, de 
presentatie in de kliniek van enige 
vormen van HH kanker, 
pathologische overwegingen in HH 
kanker, en middelen heden ten dage 
voorhanden om aanleg om te 
metastaseren aan te tonen. Hoewel 
technische vooruitgang ertoe heeft 
geleid dat het opsporen van 
metastasen aanmerkelijk is verbeterd, 
blijft de kwestie van de behandeling 
van de hals zonder aanwijzingen voor 
metastasen controversieel. Electieve 
behandeling zou onbedoelde schade 
toebrengen aan de meerderheid van 
patiënten die immers nooit 
metastasen zou hebben gekregen, 
behandeling nalaten kan echter 
verhoogde mortaliteit en morbiditeit 
betekenen voor patiënten die na 
behandeling van de primaire tumor 
metastasen blijken te hebben, die 
mogelijk hadden kunnen zijn 
weggenomen bij directe behandeling 
van de hals. Factoren ontleend aan de 
tumor zelf, die betrokken zijn bij 
metastaseren, om metastasen te 
voorspellen, in plaats van op te 
sporen, zijn mogelijk een oplossing 
voor deze kwestie. 
De twee belangrijkste 
onderwerpen van ons onderzoek 
worden in de volgende paragrafen 
geïntroduceerd namelijk genetische 
afwijkingen en angiogenese. Een 
oncogenese model wordt voorgesteld, 
gebaseerd op data uit de literatuur. 
Groeiend inzicht in de genetische 
machinerie aan de basis van 
neoplastische veranderingen heeft een 
aantal afwijkingen opgeleverd, die 
mogelijk van prognostisch belang zijn. 
Hun gebruik bij het voorspellen van 
metastasen, in het bijzonder voor 
individuele patiënten in plaats van 
voor groepen van patiënten is nog 
beperkt. Angiogenese wordt in relatie 
tot tumor groei en métastase geplaatst. 
Vaatdichtheid, als afspiegeling van 
angiogenese, en de beperkingen van 
haar kwantificering in histologische 
coupes worden bediscussieerd. 
Problemen met de 
reproduceerbaarheid van de metingen 
kunnen als mogelijke oorzaak gezien 
worden voor de tegenstrijdige 
berichtgeving hierover in de H H 
literatuur. 
De laatste paragraaf bevat een 
overzicht van het proefschrift en licht 
de gebruikte methoden toe. 
Computer ondersteunde beeldanalyse 
om meer gedetailleerde informatie 
met betrekking tot de 
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microvasculatuur en de noodzaak van 
coupes van superieure kwaliteit 
worden geadstrueerd Ten slotte wordt 
de rol van statistische modellen om 
het risico van het optreden van 
metastasen in individuele patiënten in 
plaats van groepen patiënten te 
schatten uitgelegd. 
Hoofdstuk 1 meldt de resultaten 
van ons onderzoek naar 
vormgerelateerde details in de 
celkernen van tong PCC. Met behulp 
van beeldanalyse werd het mogelijk 
verschillen tussen gemetastaseerde en 
niet gemetastaseerde tong PCC aan te 
tonen. Een logistisch regressie model 
selecteerde twee parameters, waarmee 
het metastaserend gedrag in 68% van 
de individuele patiënten correct werd 
voorspeld. Dit resultaat is mogelijk 
een afspiegeling van een veranderde 
genetische samenstelling van 
gemetastaseerde tumoren, want dit 
lijkt van invloed op deze 
kernparameters. Het relatief hoge 
percentage correcte voorspellingen is 
des te opvallender wanneer we ons 
realiseren dat zoveel andere factoren 
hierop van invloed zijn. 
Hoofdstuk 2 meldt gegevens van 
kwaadaardige kernen in groter detail, 
door te focussen op chromosomale 
verschillen tussen gemetastaseerde en 
niet gemetastaseerde tong PCC, zoals 
gevonden in CGH analyse. Wij 
toonden aan dat er meer 
chromosomale afwijkingen gevonden 
werden in gemetastaseerde tumoren, 
en ook vaker. Chromosomale regio's 
die mogelijk toekomstig onderzoek 
verdienen worden genoemd. De 
genen die in deze regio's gedacht 
worden te liggen kunnen wellicht in 
verband staan met metastaserend 
gedrag. 
Hoofdstuk 3 gaat over hoe 
angiogenese te meten. Enige 
methodologische uitgangspunten in 
het bestuderen van vaatdichtheid in 
weefsel coupes worden uit de doeken 
gedaan. Beeldanalyse heeft grote 
voordelen, maar veronderstelt 
uitstekende kwaliteit van de 
immunohistochemische kleuringen. 
Reproduceerbaarheid van de 
metingen werd getest in het licht van 
een nieuwe kleuringtechniek om 
vaten aan te tonen. Het selecteren van 
gebieden met hoogste vaatdichtheid 
blijkt erg gevoelig voor vertekening als 
gevolg van verschillen in interpretatie 
door onderzoekers. Wanneer echter 
de tien hoogste velden worden 
gemiddeld, blijkt dit probleem 
grotendeels opgelost. 
Hoofdstuk 4 meldt de resultaten 
van onze studie op tong PCC, met de 
methode beschreven in hoofdstuk 3. 
Het feit dat wij meer vaten telden in 
niet gemetastaseerde tumoren dan in 
wel gemetastaseerde, was het meest 
opvallend, temeer in vergelijking met 
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delen van de literatuur. Deze 
ogenschijnlijke tegenstelling kan 
wellicht verklaard worden uit het feit 
dat een aanzienlijk deel van de getelde 
vaten in de niet gemetastaseerde 
tumoren een erg kleine diameter 
vertoonde, waardoor ze niet 
functioneel zijn. Met een logistisch 
regressiemodel was 80% van de 
individuele patiënten correct te 
voorspellen naar metastaserend 
gedrag. 
Hoofdstuk 5 combineert de 
resultaten van hoofdstukken 1 en 4, 
door de gegevens in een logistisch 
regressiemodel te verenigen. De twee 
parameters samen bereikte een 
ongeëvenaard resultaat van 82,5% 
correcte voorspellingen. Dit resultaat 
kan gezien worden in het licht van de 
vele factoren die hun invloed hebben 
op het metastaseringsproces. 
De Algemene Discussie geeft 
mogelijke toekomstige richtingen aan, 
gebaseerd op de belangrijkste 
resultaten van ons onderzoek. 
Patiënten die een hoog risico blijken 
te dragen voor de ontwikkeling van 
metastasen op basis van de door ons 
ontwikkelde modellen, kunnen 
hiervan profijt hebben, omdat hen 
toegevoegde therapie kan worden 
aangeboden; patiënten die een laag 
risico hebben kunnen beperkter 
behandeld worden, waardoor hen 
eventuele morbiditeit onthouden kan 
worden. 
Nieuwe parameters zullen 
waarschijnlijk worden toegevoegd aan 
ons model, of andere vervangen, met 
als doel de voorspellingen verder te 
verbeteren, daarmee recht doend aan 
het ware karakter van metastasering in 
verschillende stappen. Uiteindelijk 
zullen factoren van een patient's eigen 
tumor ons in staat stellen een op maat 
gesneden behandelvoorstel te maken, 
en een individuele begeleiding bij de 
beslissing aan te bieden. 
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Stellingen behorend bij het proefschrift 
Predictive Models for Tongue 
Carcinoma Metastasis 
door 
Egied J.M. Hannen 
Nijmegen, woensdag 24 October 2001 
1. Logistische regressiemodellen op basis van multipele parameters 
voorspellen het optreden van lymfkliermetastasen bij individuele 
patiënten met een tongcarcinoom beter dan die op basis van solitaire 
parameters, (dit proefschrift) 
2. De veronderstelling dat uitsluitend bloedvaatjes in het 
tumorstroma met een diameter groter dan 10 micrometer betrokken 
zijn bij metastasering verdient nader onderzoek, (dit proefschrift) 
3. De in de literatuur gerapporteerde verschillen in vaatrijkdom 
van tongcarcinomen berusten voor een belangrijk deel op verschillen 
a) in de gevoeligheid van de detectiemethode, en b) de methoden die 
gebruikt worden voor weefsel selectie en vaatdichtheidsmeting. 
(dit proefschrift) 
4. Chromosoom 7q lijkt betrokken bij de metastasering van het 
tongcarcinoom. (dit proefschrift) 
5. De chromatinetextuur lijkt belangrijker als prognostisch 
kenmerk dan een aantal gangbare, immuunhistochemisch te bepalen 
merkstoffen. (dit proefschrift) 
6. Bij de interactie tussen tumorcellen en het bijbehorende stroma 
speelt de extracellulaire matrix een belangrijke rol. (C. C. Park, M. J. 
Bissell, and M. H. Barcellos-Hoff. Mol.Med.Today 6: 324-329 2000) 
7. De aanwezigheid van lymphangiogenese in tumoren bij de 
mens is nog niet afdoende bewezen. (R. Clarijs, D. J. Ruiter, and R. 
M. de Waal. J.Pathol. 193: 143-146 2001) 
8. De zogenaamde 'vascular channels' in tumoren zijn 
waarschijnlijk als artefact te beschouwen. (D. M. McDonald and A. J. 
Foss. Cancer Metastasis Rev. 19: 109-120 2000) 
9. Bij de behandeling van speekselkliertumoren van een hoge 
maligniteitsgraad lijkt in de nabije toekomst een grotere rol te zijn 
weggelegd voor medicamenteuze behandeling, omdat recente studies 
hebben aangetoond dat het c-kit proto-oncogen in de meeste adenoid 
cystische carcinomen tot expressie komt en de androgeen-receptor in 
bijna alle salivary duct carcinomen. (Y. M. Jeng, C. Y. Lin, and H. C. 
Hsu. Cancer Lett. 154: 107-111 (2000) en C. Y. Fan, J. Wang, and E. 
L. Barnes. Am.J.Surg.Pathol. 24: 579-586 (2000) 
10. Waar communicatie faalt, brengt telecommunicatie geen 
uitkomst. 
11. Indien de trefzekerheid op het heren toilet van het OK complex 
een indicatie is voor de handvaardigheid van het personeel, is dat 
zorgelijk voor het welzijn van de patiënten. 
12. Of de levensduur van dure objecten afhangt van de superieure 
kwaliteit of van de voorzichtigheid waarmee ze behandeld worden, 
verdient nader onderzoek. 
13. Wetenschap is geen democratie in de zin dat wat de meeste 
stemmen zeggen, geldt. 
14. Er worden meer artikelen geconcipieerd met de knip&plak 
module van de tekstverwerker, dan met originele gedachtevorming. 
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